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ABSTRACT 
The placental weight ratio (PWR) is a common proxy for the balance between 
fetal and placental growth, and is defined as the placental weight over the birth weight. 
The objectives were (1a) to establish PWR distributions by gestational age for the overall 
population and (1b) for small, average and large for gestational age infants and (2) to 
determine what pregnancy related conditions were associated with the PWR. The data 
were obtained using a hospital based retrospective cohort. Nonparametric quantile 
regression was used for the first and multinomial logistic regression for the second 
objective. The results show how the PWR changes across gestation. SGA infants had 
higher PWR’s than AGA and LGA infants. The multivariable analyses showed that the 
majority of risk factors were associated with a PWR>90
th
 percentile. The overall curves 
offer population standards, and the multivariable analysis suggests that the placenta may 
have particular compensatory response, each with a distinct pathophysiologic 
mechanism, but similar PWR outcome. 
Keywords: Placenta Weight, Birth Weight, Placental Weight Ratio, Quantile Regression, 
Fetal Growth, Pregnancy 
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CHAPTER 1: INTRODUCTION AND OBJECTIVES 
 
1.1 Background and Overview 
 
Fetal Growth Restriction (FGR) is defined as a fetus that has not reached its 
growth potential because of genetic or environmental factors. FGR is associated with an 
increased risk for perinatal morbidity and mortality.
1,2
 Small for gestational age (SGA) is 
widely used as an indicator for FGR, since FGR cannot be measured.
3
  
 
Fetal growth depends on placental growth; the placental weight ratio (PWR) is a 
common proxy for the balance between fetal and placental growth. Placental weight is 
the most common way to characterize placental growth, and it is a summary of many 
dimensions of placental growth. The placental weight measurement includes the laterally 
expanding growth of the chorionic disc and arborization of the villous and vascular 
nutrient exchange surface, which is reflected in the increasing thickness of the chorionic 
disk. Placental weight has been found to be lower in SGA infants than in average for 
gestational age infants (AGA) and large for gestational age infants (LGA).
4–8
 
 
The PWR is defined as the placental weight divided by the birth weight, and it 
changes across gestation as the placenta matures. The PWR decreases as gestational age 
increases.
9
 Placental hypertrophy and reduced fetal growth have been postulated to be an 
adaptation to maintain placental function in pregnant women with complications such as 
malnutrition. If this is true, a pregnancy with impaired fetal growth, resulting in a SGA 
infant, should have an increased PWR compared to those infants who are AGA or 
LGA.
4,10
 However, other factors such as timing and severity of various pregnancy 
complications can also alter the PWR.  
 
Placental weight and placental weight ratio (PWR) have been found to be 
predictive of maternal disease, obstetric outcome, perinatal morbidity and mortality, and 
childhood growth and development.
11–16
 While percentile curves for birth weight are 
available for a variety of jurisdictions and populations, percentile curves for the PWR are 
  
 
2 
not. Many conditions that could affect placental growth and the PWR, such as 
preeclampsia, have been minimally studied with regards to their effect on the PWR. More 
specifically, the effects of maternal lifestyle conditions on placental weight between 
different gestational age groups have yet to be studied. Mean birth weight and placental 
weight significantly increase from SGA to LGA infants, yet the PWR is significantly 
increased in SGA infants.
5–7,17,18
 Placental weight has been shown to be high in 
comparison to birth weight when fetal nutrient or oxygen is reduced. This is believed to 
be a compensatory mechanism. 
 
A high PWR is significantly correlated with short-term adverse perinatal 
outcomes.
19
 If the pattern of placental growth is associated with differences in the 
efficiency of placental function, as reflected in the PWR, this may have physiological 
implications. Since placental weights differ between SGA, AGA and LGA infants, size 
distribution trajectories to determine when and how they differ across gestational ages 
and percentiles will be useful for both research and clinical practice.  
 
Thompson et al.
20
 created birth weight to placental weight ratio curves using the 
Norwegian Birth Registry with all singleton live births in Norway from January 1999 to 
December 2002 (n= 198, 971). These curves were a significant contribution to the 
literature. Moreover, no population curves to date have looked at the differences between 
SGA and LGA across gestational age. Searching the existing literature we found only one 
additional set of PWR percentile curves in a Canadian population.
9 However, the sample 
size is small (n=20,309). Finally, previous studies that have looked at atypical PWRs 
have not used a population standard to identify abnormal PWRs.17,21,22  
 
1.2 Objectives 
 
This thesis consists of two distinct, yet highly dependent investigations. Both 
objectives were addressed using data from the perinatal database in London, Ontario. The 
specific objectives are outlined below. Objective 1a and 1b are addressed in this thesis as 
  
 
3 
one investigation and objective 2 as another. Therefore, they are presented separately in 
the later chapters.  
 
Objective 1: 
a. To establish placental weight ratios (PWR) distributions by gestational age 
in a Canadian sample.  
b. To investigate whether the PWR distributions varies by fetal growth 
adequacy, thus stratifying the PWR distributions by fetal size: SGA, AGA, 
& LGA.  
 
Objective 2:  
To determine what pregnancy related conditions and lifestyle behaviours are associated 
with the PWR.  
 
1.3 Structure of Thesis Document 
 
In accordance with the standards outlined by Western University School of 
Graduate and Postdoctoral Studies, this thesis is presented in the integrated-article 
format. A comprehensive overview of the related literature and the methods common to 
both investigations is covered in Chapters 2 and 3, respectively. The work comprising the 
specific investigations is presented as two manuscripts. Chapter 4, Population-Based 
Placental Weight Ratio Distribution Curves, addresses Objective 1a) and 1b), as outlined 
above, while Chapter 5, Determinants of Placental Weight Ratios, examines Objectives 
2), also outlined above. Lastly, Chapter 6, Integrated Discussion, summarizes the main 
findings of this thesis and their relationship to one another. 
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CHAPTER 2: LITERATURE REVIEW 
2.0 Overview 
 
 Fetal Growth Restriction (FGR) is defined as a fetus that has not reached its 
growth potential because of genetic or environmental factors.
1
 Small for gestational age 
(SGA) is widely used as an indicator for FGR, since FGR cannot be measured. Fetal 
growth depends on placental growth; the placental weight ratio (PWR) is a common 
proxy for the balance between fetal and placental growth. The PWR is defined as the 
weight of the placenta divided by the birth weight. Placental weight has been found to 
differ between SGA, average for gestational age infants (AGA) and large for gestational 
age infants (LGA).
2–6
 Many conditions that could affect placental growth and the PWR 
have been minimally studied with regards to their effect on the PWR. A list of 
definitions relevant to this chapter can be found in Appendix A.  
 
2.1. Small for Gestational Age Infants  
2.1.1. Fetal Growth Restriction and Small for Gestational Age 
 
Fetal growth restriction (FGR) is a term used to define a fetus who has not met its 
growth potential because of genetic or environmental factors. SGA is widely used as a 
statistical indicator of FGR, since FGR is not measurable. The most common definition 
of SGA refers to an infant that weighs less than the 10
th
 percentile for their gestational 
age and sex, as defined by the World Health Organization in the International 
Classification of Diseases Version 10, as per code P05.1.
7
 However, this definition does 
not distinguish between those who are constitutionally small and those who are growth 
restricted.  
 
From 1995 to 2004, the rate of SGA, relative to a fixed population standard, 
decreased among singleton births in Canada. This may be due to the increase in maternal 
size prior to pregnancy and weight gain during pregnancy, reduced cigarette smoking, 
changes in sociodemographic factors,
8
 as well as more frequent use of ultrasound assisted 
dating.
9
 Therefore, the prevalence of SGA in the Canadian population is currently 
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estimated to be 7.2% in infants born after 37 weeks gestation, 6.5% in infants between 34 
and 36 weeks gestation, and 11.5% in infants born before 33 weeks gestation.
8
 The 
incidence of SGA varies among populations and increases with decreasing gestational 
age.  
 
Anthropometric data from infants born at different gestational ages have been 
used to generate a multitude of cross-sectional growth curves, however they are 
inconsistent and vary at each gestational ages based on differences in maternal 
characteristics and inaccurate measurements of body size and estimates of gestational 
age.
10,11
 The majority of the literature surrounding fetal growth suffers from one or more 
methodological problems including errors in reporting gestational age using last 
menstrual period, biologically implausible birth weights for gestational age, insufficient 
sample sizes at low gestational age, non-generalizable samples,
12–15
 and inadequate 
statistical modeling techniques such as a lack of smoothing of distribution curves.
16,17
 
Therefore, Kramer et al.
18
 created sex specific birth weight distributions using the 
Canadian national linked file of singleton births and infant deaths for births between 1994 
and 1996, for which gestational age is based mostly on early ultrasound estimates. The 
reference is based on singletons with gestational ages between 22 and 43 weeks and 
comprises 347,570 males and 329,035 females. Kramer et al.
18
 assumed a normal 
distribution for birth weight at each gestational age and used the expectation-
maximization algorithm to exclude infants with gestational ages that were more 
consistent with 40-week births than with the recorded gestational age. Distributions of 
birth weight at the corrected gestational ages were then statistically smoothed. The means 
and standard deviations were also tabulated to allow calculation of z scores in addition to 
percentiles.
18
 
 
The categorization into male and female specific curves is ideal because males 
weigh more than females at each gestational age.
18
 However, in preterm births, the 
average estimated fetal weight is greater than the average weight of term infants because 
more SGA infants are born prematurely compared to AGA infants. Therefore, estimated 
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fetal weight growth curves will classify more infants as SGA than birth weight 
gestational standards.
19
 
 
2.1.2.  Risk Factors for SGA 
 
There are many risk factors for SGA infants which will be individually discussed 
in more detail below. A conceptual model indicating the risk factors for SGA infants, a 
decreased placental weight, and those covariates which are risk factors for both can be 
found in Appendix C. Also, a table showing which risk factors increase or decrease the 
placental weight, and are associated with either SGA or LGA, can be found in Appendix 
F.  
 
2.1.2.1. Maternal Height 
 
Maternal height has a proven positive association with infant birth weight. In a 
large study of births from the Swedish Birth Register between 1992 and 2001, women 
were categorized based on height into the following categories: <160cm, between 160cm 
and 170cm, and >170cm. Birth weights decreased slightly but monotonically with 
decreases in maternal height.
20
 Kramer et al.
21
 have also demonstrated that low maternal 
height is a risk factor for decreased birth weight in a meta analysis using effect 
magnitudes weighted for sample size.
21
 Therefore, it has been shown that SGA rates are 
inversely proportional to maternal height.
22
 
 
2.1.2.2. Maternal Weight and Pregnancy Weight Gain 
 
An association has been elucidated between pre-pregnancy weight and birth 
weight. SGA rates are inversely proportional to maternal weight and a higher proportion 
of neonates of small and light mothers were found to be SGA.
22,23
 Many studies have 
found an association between pregnancy weight gain and infant birth weight. Maternal 
weight at birth, pre-pregnancy weight and weight gain during pregnancy have been found 
to be responsible for 10% of the variance in fetal weight.
24
 A low pregnancy weight gain 
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is associated with a lower birth weight based on gestational age, despite various methods 
of characterizing gestational weight gain. Also, mothers who were underweight before 
pregnancy were more likely to deliver infants of a lower weight.
25
 Variations across 
studies in exposure categories, outcome measures, and timing of measurement prevented 
calculation of summary measures in a recent systematic review,
26,27
 yet there was strong 
evidence to support associations between inadequate gestational weight gain and 
decreased birth weight and fetal growth (SGA).
28,29
 Therefore, an infant’s birth weight 
has clear associations with both a woman’s pre-pregnancy weight and pregnancy weight 
gain.  
 
2.1.2.3. Nutritional Deprivation  
 
Although it is not seen as a major problem in developed countries, severe 
maternal deprivation during pregnancy can have a major impact on birth weight. During 
the Dutch famine of 1944 to 1945, the mean caloric intake fell from 750 to 450 
kilocalories per day, and correspondingly, the average infant birth weight fell 250 grams. 
Also, during the World War II German siege, Leningrad suffered from a period of 
prolonged starvation, more so than the Dutch Famine, with a diet of nearly no protein 
which caused the average birth weight to fall 500 grams during this period.
30
 
 
Modest degrees of nutrition deprivation also have an effect on birth weight. This 
measure is typically captured through pre-pregnancy weight and pregnancy weight 
gain.
24
 Furthermore, celiac disease, which is marked by malabsortion of nutrients, has 
also been associated with FGR.
31
 Markers of nutritional deprivation associated with 
lower fetal growth include low weight gain during pregnancy,
32
 inadequate daily calorie 
intake, protein deficiency,
33,34
 and assorted micronutrient deficiencies including 
calcium,
33
 iron,
35,36
 folate, 
35–37
 and zinc.
38
 In developing countries, nutritional 
deprivation is the major source of SGA infants,
39
 but less of a concern in developed 
countries where malnutrition is uncommon.  
 
2.1.2.4. Exercise during Pregnancy  
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The evidence on the effect of exercise during pregnancy on fetal growth depends 
not only on the type of exercise, but also on the timing of the exercise during pregnancy. 
A study by our research group found that exercising five or more times a week during 
pregnancy was associated with reduced fetal growth.
40
 Another study indicated that 
vigorous exercise, defined as being out of breath or heavily breathing, was associated 
with an approximate three-fold increase in SGA.
41,42
 These results are congruent with 
previous research that shows that high intensity exercise is associated with reduced fetal 
birth weight. This is possibly mediated by reduced uterine blood flow.
43
 
 
In a Cochrane Review by Kramer et al.
44
 no effect was found on the risk of 
delivering a SGA infant in women who were sedentary and then increased aerobic 
exercise during pregnancy. Also, in women who were sedentary and then increased 
aerobic exercise, a 49.49g mean difference was found in birth weight when compared 
with controls. However, the difference was not significant. Also, when there was a 
reduction in exercise in physically fit women birth weight decreased by 151g, but again 
the difference was not significant. Increase, then reduction in exercise in physically fit 
women had a significant increase in birth weight by 460g compared to women who 
maintained their level of aerobic exercise. Reduction, then increase in exercise in 
physically fit women resulted in a significant decrease in mean birth weight when 
compared to women who maintained the same level of aerobic exercise. Increase in 
exercise in overweight women resulted in a small (5g), but significant reduction in birth 
weight when compared to controls.  
 
On the other hand, Clapp et al.
45
 found that when women began regular, 
moderate-intensity weight bearing exercise in early pregnancy their offspring were 
significantly heavier compared to controls who did not exercise. The difference in birth 
weight was the result of an increase in both lean body mass and fat mass.
45
 Furthermore, 
another study by Clapp et al.
46
 found that the offspring of the women who were randomly 
assigned to a high volume of exercise in mid and late pregnancy were significantly lighter 
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(3.39 kg vs 3.81 kg) and thinner (8.3% fat vs 12.1% fat) than those offspring born of 
women who were randomly assigned to reduce their exercise volume after the 20th week.  
 
2.1.2.5. Parity 
 
Parity is associated with an increased risk of delivering a SGA infant. The growth 
rate of the fetus of primaparous women is lower than that of multiparous women. When 
based on a single population standard for SGA, primiparae had significantly higher rates 
of SGA at all gestational ages. However, when SGA was defined based on parity specific 
standards, primiparae did not have higher SGA rates than multiparae after 37 weeks.
47
 
 
2.1.2.6. Interpregnancy Interval  
 
A short interpregnancy interval has been associated with low birth weight and 
FGR. This association may be mediated through depletion in folic acid.
48
 The odds ratio 
for SGA was statistically significant, and progressively increased, as the interpregnancy 
interval shortened from 18 months to 6 months.
49
 However, a long interpregnancy 
interval has also been associated with SGA infants. Interpregnancy interval longer than 
60 months is also associated with a risk of delivering an SGA infant or an infant with low 
birth weight, defined as weight below 2500 grams.
49
  
 
2.1.2.7. Maternal Age 
 
FGR is the most common among pregnancies at both extremes of reproductive 
bearing age.
50,51
 
 
2.1.2.8. Emotional Distress 
 
The literature is divided on whether psychosocial stress is a risk factor for SGA, 
yet the evidence for psychosocial stress as a risk factor is more convincing. It has been 
shown that infant birth weight depends on the mother's mood during pregnancy. High 
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levels of anxiety and depression during pregnancy influence the infant's development 
through biological mechanisms of stress that include: prolonged exposure to 
corticotrophin-releasing hormone, brief periods of exposure to glucocorticoids, and 
decreased availability of substrate to the fetus. As a result, the infant is born smaller.
52,53
 
The evidence arguing for a relationship between psychosocial stresses and SGA is more 
persuasive. In contrast, in a cohort of more than 70,000 pregnant women in Norway, the 
association between emotional distress during pregnancy and delivering a SGA infant 
was estimated, after adjustment for a number of factors known to be associated SGA to 
be non-significant with an adjusted OR of 1.6.
54
  
 
Emotional distress activates the hypothalamic–pituitary–adrenal axis and the 
sympathetic nervous system, which increases the secretion of corticotrophin-releasing 
hormones.
55
 Elevated levels of corticotrophin-releasing hormone have been found to be 
associated with intrauterine growth restriction and preterm birth.
56,57
 
 
2.1.2.9. Smoking  
 
Cigarette smoking during pregnancy is well established within the literature as a 
cause of fetal growth restriction.
1,21,26,58,59
 Smokers have an increased risk of having a 
SGA baby with relative risks ranging from 1.3 to 10.0.
60–62
 
 
A retrospective cohort study of 13,661 deliveries, which adjusted for confounding 
variables of smoking including parity, age, ethnicity and BMI, found that the adjusted 
odds ratio of smoking for the occurrence of growth restriction was 1.9 and that, if causal, 
smoking accounted for 13.9% of SGA infants. Furthermore, progressive levels of 
cigarette consumption resulted in a greater risk of growth restriction. A dose response 
relationship, therefore, has been demonstrated between cigarette smoking during 
pregnancy and growth restriction of the infant.
63
 Fetal growth may no longer be restricted 
once smoking ceases depending on when the smoking cessation occurs in the 
pregnancy.
24,64
 Results from observational studies show that if the mother stops smoking 
during the first trimester then the rates of SGA are similar to that of non-smokers.
65
 Also, 
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other studies indicate that if mothers stop smoking before the third trimester then the rate 
of SGA is similar to that of non-smokers.
61,64,66  
 
Smoking is hypothesized to affect birth weight through a number of different 
mechanisms. First, the carbon monoxide inhaled from the cigarette deprives both the 
fetus and the placenta of oxygen, which creates hypoxic conditions for the fetus by 
allowing carbon monoxide to bind to maternal haemoglobin in place of oxygen. Second, 
carcinogens cross the placenta and further inhibit fetal growth. Nicotine also acts as an 
appetite suppressant, which may lead to uterine vasoconstriction.
21
  
 
2.1.2.10. Alcohol Consumption  
 
A recent meta-analysis that included thirty-six case studies and cohort studies 
between January 1980 and August 2009 examined the effect of maternal alcohol 
exposure on the risk of low birth weight and SGA. The findings indicated that the overall 
dose–response relationship for low birth weight and SGA showed no effect up to 10g of 
pure alcohol/day (an average of about 1 drink/day), but with level of alcohol exposure 
above 10g of pure alcohol/day the relationship showed a monotonically increasing risk 
for both low birth weight and SGA. Therefore, the dose-response relationship indicates 
that heavy alcohol consumption during pregnancy increases the risks of SGA whereas 
light to moderate alcohol consumption shows no effect on fetal growth.
67
 Results from 
previous studies have agreed with Patra et al’s findings, but lacked large enough sample 
sizes to make generalizable conclusions.
1,68
 
 
2.1.2.11. Toxins from Medications 
 
Exposure to medications including warafin, anticonvulsants, antineoplastic agents 
and folic acid antagonists have been shown to result in FGR infants.
69,70
 Evidence 
regarding the effect of anti-hypertensive medications during pregnancy on the growth of 
the fetus is divided. One recent systematic review found that taking anti-hypertensive 
medications for mild to moderate hypertension did not increase the frequency of 
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delivering an SGA infant.
71
 However, another meta-analysis showed that fetal growth 
was significantly impaired by the reduction in mean arterial pressure induced by 
antihypertensive therapy. They found that a 10 mmHg fall in mean arterial pressure was 
associated with a 176 g decrease in birth weight. This effect was unrelated to the type of 
hypertension or choice of medication.
72
 
 
Results of epidemiological studies examining the effect of maternal caffeine 
consumption on the risk of low birth weight or an SGA infant are conflicting. Several 
studies observed that maternal caffeine intake ranging from 200 to 400 mg per day was 
associated with a mean decrease in birth weight of about 100 grams,
73,74
 while other 
studies either were not able to show any significant association with birth weight or 
demonstrated reduction in mean birth weight only at caffeine intake exceeding 600 mg 
per day.
75–77
 Many of the available epidemiologic studies have been criticized for 
inadequately controlling for important risk factors for low birth weight, particularly 
smoking. However, one well-designed large prospective study assessed caffeine 
consumption from all known sources, objectively quantified intake, and adjusted for 
smoking and alcohol use. This study found that mean caffeine consumption >200 mg/day 
over the course of pregnancy was associated with reduction in birth weight of 60 to 70 
grams. Also, the risk of FGR increased linearly in a dose-response relationship, with no 
plateau, yielding odds ratios of 1.2 to 1.5 compared to women who consumed less than 
100 mg caffeine per day.
78
 Another prospective cohort found that compared with mothers 
who consumed fewer than two cups of coffee per day, the adjusted odds ratios of 
delivering an SGA infant for mothers who consumed two to three, four to five, and six or 
more cups of coffee per day were 1.38, 1.50, and 1.87, (P <0.01).
79
 
 
2.1.2.12. Chronic Hypertension 
 
Cardiovascular disease, high blood pressure, and chronic hypertension have all 
been linked to low birth weight.
80
 Chronic hypertension is also associated with an 
increased risk of many vascular disorders of pregnancy, including preeclampsia and 
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pregnancy induced hypertension, which are also strongly associated with reductions in 
birth weight.
81
  
 
Chronic hypertension is shown to exert its effects differently on both term and 
preterm infants. A study by Catov et al.
82
, that adjusted for potential confounders, found 
that chronic hypertension was associated with a 5.5-fold increased risk for preterm SGA. 
The cause of this may involve an inadequate vascular response to pregnancy associated 
with abnormal placentation and may represent a pathogenesis distinct from that leading to 
term SGA. It has also been reported that chronic hypertension presented a 3.4-fold 
increase in risk of preeclampsia among nulliparous women and a 5.4 fold increase of 
preterm preeclampsia. Together, these results indicate a strong and convincing 
relationship between chronic hypertension and risk for both preeclampsia and SGA, 
especially for the more severe subtypes of each condition.
82
  
 
2.1.2.13. Gestational Hypertension 
 
Pregnancy outcomes of patients with mild gestational hypertension are generally 
favorable. The mean birth weight and rates of fetal growth restriction are similar to those 
without gestational hypertension.
83,84
  
 
However, pregnancies with severe gestational hypertension have increased rates 
of SGA infants. These rates are significantly higher than the rates in the general 
obstetrical population without gestational hypertension and similar to rates reported for 
women with severe preeclampsia.
83,85,86
 A study by Buchbinder et al.
83
 compared 
outcomes in women who developed severe gestational hypertension with women who 
stayed normotensive or developed mild gestational hypertension or mild preeclampsia. 
They found that the rate of delivery of SGA infants was 20.8 and 6.5 to 4.8 percent, 
respectively for the 3 groups mentioned above. Since there were only 24 patients with 
severe gestational hypertension, this small sample limits the interpretation of these 
results.  
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2.1.2.14. Preeclampsia 
 
Women with preeclampsia are more likely to deliver a SGA infant than in women 
without preeclampsia.
87
 
 
In preeclampsia, cytotrophoblast cells penetrate the decidual portion of the spiral 
arteries, but fail to infiltrate the myometrial segment.
88,89
 The spiral arteries do not 
succeed in developing into large, tortuous vascular channels. Instead of developing 
normally, the vessels stay narrow, which results in placental hypoperfusion and potential 
fetal asphyxia. This defect has been associated with preeclampsia with or without FGR, 
FGR without maternal hypertension as well as second trimester fetal death, placental 
infarcts, placental abruption, premature rupture of membranes, and preterm labor.
90
 
Environmental, immunological, and genetic factors all appear to play a role in this 
process.
91
 
 
Preeclampsia is an etiologically diverse disorder that occurs in two subsets: one 
with normal or enhanced placental function and another with placental dysfunction and 
fetal growth restriction, which often occurs with asymmetric fetal body proportion. A 
study has established that in newborns of women with preeclampsia, mean birth weight, 
and ponderal index (PI) were lower than in women without preeclampsia.
92
 Early-onset 
preeclampsia, defined as onset <34 weeks, is associated with placental vascular lesions 
and reduced uteroplacental blood supply, leading to reduced birth weight. As a result, 
preeclampsia and FGR in general might share a pathophysiologic mechanism.
93,94
 The 
pathophysiology of early-onset preeclampsia differs from late onset disease in terms of 
neutrophil function and cytokine levels.
95
 
 
Birth weight in preterm preeclampsia is substantially lower than in term 
preeclampsia.
96–98
 This may be due in part to the fact that SGA infants are 
overrepresented in preterm preeclampsia. However, in term preeclampsia, both SGA and 
LGA offspring appear to be over-represented compared to the distribution in women 
without preeclampsia, yet mean birth weight does not differ greatly from that of 
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normotensive pregnancies.
97
 The increase in LGA infants may possibly be related to 
greater placental perfusion due to elevated cardiac output and blood pressure.
92,99
  
 
2.1.2.15. Residing at High Altitude 
 
Living at a high altitude is associated with preplacental hypoxia and in turn a 
lower birth weight. A direct relationship between increasing altitude and lower birth 
weight was established in Denver, Colorado, Tibet and Peru.
100–102
 A study in Peru that 
looked at the relationship between women living at different elevations and birth weight 
established that for each 500 meter increase in altitude above 2000 meters birth weight 
decreased 65 grams.
101
 This association may be due to the lower cardiac output of women 
living at higher altitudes.
103
  
 
2.1.3. Fetal Growth Restriction and Placental Weight 
 
Placental weight has been shown to be directly correlated and associated with 
birth weight.
3–5,104
 A higher proportion of SGA infants have placenta weights in the 
lowest 10
th
 percentile of placental weights than LGA and AGA infants. Also, SGA 
infants have a lower number of placenta’s with weights above the 10th percentile than 
both AGA and LGA infants.
105
 
 
 
2.2. Excess Fetal Growth and Large for Gestational Age 
 
Measures of LGA typically include comparison of birth weight to the birth weight 
distribution of another similar population, which will be used to determine LGA status in 
this thesis. The most common definition of LGA refers to an infant that weighs greater 
than the 10
th
 percentile for gestational age and sex.
7,18
  
 
2.2.1. Risk Factors for LGA 
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LGA infants can be constitutionally large because of genetic factors. In addition, a 
variety of maternal conditions, pregnancy complications, or fetal abnormalities can result 
in increased growth. Some of the main risk factors for LGA such as obesity and 
gestational diabetes have both been associated with poor pregnancy outcomes including 
excess fetal growth, increased rates of caesarean section, higher incidences of shoulder 
dystocia, congenital malformations, heart problems, hyperbilirubinemia, and 
hypoglycaemia at delivery.
106–109
 
 
A conceptual model indicating the risk factors for LGA infants, an increased 
placental weight, and those covariates which are risk factors for both can be found in 
Appendix D. Also, a table showing which risk factors increase or decrease the placental 
weight and are associated with either SGA or LGA can be found in appendix F. 
 
2.2.1.1. Pre-Pregnancy Obesity 
 
Studies have looked at maternal obesity’s effect on excess fetal growth, regardless 
of maternal glucose tolerance, and have found that obesity is associated with excess fetal 
growth. 
110–112
 Obese women with insulin resistance and hyperglycaemia are at a higher 
risk for delivering LGA infants. Obese women with normal glucose tolerance tests also 
have an increased risk for delivering an infant that has excessive fetal growth.
113
 
 
2.2.1.2. Gestational Diabetes 
 
Increased risk of excess fetal growth has been associated with gestational 
diabetes, especially when the diabetes is poorly controlled.
113,114,115
 In gestational 
diabetes, the beta-cells are not capable of compensating for the increased insulin demand, 
and hyperglycemia develops.
109
 During gestational diabetes, the level of diabetes control 
by the woman determines the level of risk for excess fetal growth. In pregnancies 
complicated by gestational diabetes, poor glycemic control is more likely to result in a 
LGA infant than in those pregnancies with good glycemic control.
113,115,116
 High levels of 
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fetal insulin lead to excess fetal growth due to the subsequently high levels of growth 
hormones, because of the storage of excess glucose.
109
  
 
The mechanism involves excessive delivery of nutrients to the fetus, resulting in 
fetal hyperglycemia, hyperinsulinemia, and increased growth, particularly of insulin-
sensitive tissues such as the liver, muscles, and subcutaneous fat.
117,118
 The risk of 
developing gestational diabetes is higher in obese women than in women of normal 
weight; both obesity and gestational diabetes, however, add independently to the risk of 
excess fetal growth.
108
  
 
2.2.1.3. Maternal Weight Gain 
 
Pregnancy weight gain has continually been shown to be associated with infant 
birth weight. Excess weight gain during pregnancy has been associated with both insulin 
resistance and higher birth weight infants.
119
 Literature consistently shows that higher 
weight gains during pregnancy increase the risk of delivering a LGA infant.
120,121
 Only 
about 35% of women actually gain the weight recommended by Institute of Medicine 
(IOM) guidelines
122
 for all BMI categories. About 22% of women gain less weight than 
is recommended for their pre-pregnancy weight, and 43% gain more. As maternal pre-
pregnancy BMI increases, the correlation with infant birth weight weakens. For obese 
women, there is no correlation between their weight gain during pregnancy and the 
infant’s birth weight.122 Obese women have large infants regardless of how much weight 
they gain during pregnancy.  
 
2.2.1.4. Obesity, Pre-PregnancyWeight and Pregnancy Weight Gain 
 
When women have gestational diabetes, are obese pre-pregnancy and exceed 
recommendations for pregnancy weight gain there is an increased risk of excess fetal 
growth above that which would be expected from gestational diabetes alone.
108
 
Therefore, while obesity and excess weight gain during pregnancy have similar 
pathophysiologies and adverse pregnancy outcomes, they act in distinct ways. In 
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pregnancies complicated by gestational diabetes an LGA infant can result even when 
weight gain targets are achieved and not exceeded during pregnancy.
108
  
 
2.2.1.5. Pregnancy Nutrient and Diet 
 
Maternal nutrition, defined by the mother’s diet, has an impact on the 
environmental conditions experienced by the growing fetus. The specific effects of 
maternal nutrition on the fetus depend on both the quality of the maternal diet and the 
point at which nutrition was measured during pregnancy.
123
 The effects of malnutrition 
differ depending upon the timing during gestation of the deprivation. If severe 
macronutrient deprivation occurs during early pregnancy, infant birth weight is not 
affected, but placental weight increases as described earlier. In contrast, macronutrient 
deprivation during the last trimester of pregnancy results in both reduced placental 
weights and reduced birth weights, as mentioned previously.
124
 
  
2.2.1.6. Parity 
 
Macrosomia occurs more often at higher parities. In a study using birth certificate 
data, the proportion of infants with birth weights greater than 4500 g was significantly 
greater as parity increased from one to six or more.
125
 In another report, birth weight 
typically increased from 80 to 120 g in each successive pregnancy up to five.
126
  
 
2.2.1.7. Sex 
 
Male infants weigh more than female infants throughout gestation; as a result, 
more macrosomic infants are male. In one report, males were more likely than females to 
have increased birth weights.
125,127
 
 
2.2.2. Excess Fetal Growth and Placental Weight 
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Placental weight has been shown to be directly correlated and associated with 
birth weight.
3–5,104
 A higher proportion of LGA infants have placenta weights in the 
highest 10
th
 percentile than SGA and AGA infants. Also, LGA infants have a lower 
number of placenta’s with weights below the 10th percentile than both AGA and SGA 
infants.
105
 Furthermore, LGA infants have been found to have lower PWRs than SGA 
and AGA infants.
128
 
 
2.3. The Placenta 
2.3.1. Structure and Formation of the Placenta 
 
The placenta is a fetal organ that consists of an umbilical cord, membranes and 
parenchyma. Many maternal and fetal disorders may begin with the placenta, since the 
interface between the mother and the infant occurs at the placenta. Therefore, 
examination of the placenta may provide information on the impact of maternal disorders 
on fetal growth restriction.
129
 The development of the placenta is a highly regulated 
process. The placenta serves various roles throughout a pregnancy including preventing 
the rejection of the fetal allograft, enabling gas exchange, transporting nutrients, 
eliminating fetal waste and secreting peptide and steroid hormones.
129
  
 
The development of the placenta is a continuous process that begins at the time of 
fertilization. The first three days of development occur in the fallopian tube and on the 
fourth day the morula enters the uterus. By the 6
th
 day post fertilization, the blastocyst 
implants in the uterine lining, typically in the upper anterior or posterior wall of the 
uterus. By the 13
th
 day after fertilization, the trophoblast erodes deeper in the deciduas 
and forms the lacunae. The lacunae then becomes the intervillous space. The progenitor 
villous trophoblast cells proliferate throughout gestation and differentiate along two 
pathways to form either extravillous trophoblast (EVT) or syncytiotrophoblast. EVT that 
invades decidua is the interstitial EVT and EVT that invades and remodels the spiral 
arteries is the endovascular EVT.
129
 
 
2.3.2. Characterization of Placental Growth 
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Placental weight is the most common way to characterize placental growth and it 
is a summary of many dimensions of placental growth. The placental weight 
measurement encompasses the laterally expanding growth of the chorionic disc and 
arborization of the villous and vascular nutrient exchange surface, which is reflected in 
the increasing thickness of the chorionic disk.
130
 The average human placental weight 
varies between studies ranging from 438g to 680g.
3,104,131,132
  
 
The expansion of the chorionic plate, beginning early in pregnancy, is the 
principle determinant of the ability of the placenta to translate its mass into birth 
weight.
130
 As chorionic disk area and thickness increase, birth weight and placental 
weight also increase and the PWR increased after they adjusted for gestational age, 
parity, race, and infant gender.
133
 
 
2.3.3. The Placental Weight Ratio 
 
The PWR, the ratio of placental weight to birth weight, changes across gestation 
as the placenta matures. If the pattern of placental growth is associated with differences 
in the efficiency of placental function as reflected in the PWR, then the PWR has both 
physiologic and functional implications.
130
 When PWRs are compared between AGA and 
SGA infants based on gestational age, SGA infants are found to have higher ratios than 
AGA infants.
2,134
 This occurs since the ratio decreases with gestational age, so when fetal 
weight increases the ratio decreases.
2
  
 
The placenta has been shown to have a functional reserve capacity, but there is still a 
higher PWR, defined as less than the 10
th
 percentile, in SGA infants. Therefore, the PWR 
may be a better indication of SGA fetuses than placental weight alone.
135
 The PWR has 
been found to be predictive of maternal disease, obstetric outcome, perinatal morbidity 
and mortality and childhood growth and development. A high PWR was associated with 
increased risk of the aforementioned.
136–141
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2.3.4. The Placenta and Fetal Growth  
2.3.4.1. The Role of Placental Function and Fetal Growth Restriction 
 
The adequate transfer of oxygen to the fetus is dependent on both the 
development of the uteroplacental and fetal placental circulations. Therefore, three 
categories of fetal hypoxia have been proposed to explain the effect of the placental 
function on both fetal and placental growth. The three categories: preplacental hypoxia, 
uteroplacental hypoxia and post placental hypoxia are described in detail below.
142,143
 
 
2.3.4.1.1. Preplacental Hypoxia 
 
Preplacental hypoxia is when the placenta and fetus become hypoxic because of 
reduced oxygen content within maternal blood, such as a pregnancy at high altitude, 
smoking
144
 and maternal anaemia. These conditions result in reduced intraplacental 
oxygen content, predominately branching angiogenesis and reduced vascular impedance. 
Interestingly, all of these complications are associated with excessive placental weight.
142
 
 
Pregnancies at high altitude results in increased capillary volume fraction
145–147
 
and increased capillary branching.
148
 The density of villous cytotrophoblasts is 
increased.
142
 Similar findings occur in pregnancies complicated by maternal anaemia. 
Endothelial proliferation is increased, resulting in excessive branching angiogenesis, and 
decreased mean capillary diameter,
149
 but an increased capillary volume fraction.
150
 
Consequently, the placenta maintains oxygen transfer through a thinning of the placental 
barrier.
151
 Also, the proliferation of the villous cytotrophoblast decreases as the severity 
of the disease increases.
149
  
 
All of the conditions listed above are representative of typical cases of placental 
adaptation to preplacental hypoxia. Hypoxia affects the entire organ, since the origin of 
hypoxia is located before the placenta. A conceptual model showing these proposed 
pathways can be found in appendix G.  
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2.3.4.1.2. Uteroplacental Hypoxia 
 
Uteroplacental hypoxia is when normally oxygenated maternal blood has 
restricted entry into the uteroplacental tissues due to either occlusion or failed trophoblast 
invasion of the uteroplacental arterioles. This situation represents late onset FGR with 
preserved end diastolic flow volume, and term preeclampsia. This condition results in 
reduced intraplacental oxygen content, predominately branching angiogenesis and 
reduced vascular impedance.
142,143
 
 
A variety of pathways can cause restricted access of normally oxygenated 
maternal blood into the uteroplacental tissues. These pathways include: damage to the 
endothelium,
152
 focal villous placental ischemia and infarction,
153
 and release of 
proinflammatory cytokines, interleukins 6 and 8.
154
 More detailed mechanisms can be 
found in a conceptual model in appendix H.  
 
2.3.4.1.3. Postplacental Hypoxia  
 
Postplacental hypoxia occurs when normally oxygenated blood enters the 
intervillous space, either at normal or reduced rate, but there is a defect in the 
fetoplacental perfusion. This defect prevents the fetus from receiving sufficient oxygen, 
yet the placenta receives sufficient oxygen.
143
 There is a clear relationship between the 
amount of uteroplacental flow reduction and both the fetal and placental size.
155
 In one 
study that looked at placentas from pregnancies with abnormal umbilical artery Dopplers, 
74% of the placental weights were below the 10
th
 percentile.
156
 
 
Histological studies of placentas from FGR infants have consistently shown 
features that suggest a diminished fetal perfusion of the villous vessels. In many 
pregnancies complicated by FGR it has been shown that they have an abnormal uterine 
artery Doppler, which was indicative of increased resistance in the placental vascular bed. 
This has been confirmed in many recent studies which have found similar results.
157–160
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This relationship has been further evaluated through Doppler ultrasounds of the umbilical 
vein, which have also shown a diminished perfusion in fetuses suffering from FGR.
161,162
 
 
Placentas affected by FGR with abnormal uterine artery Doppler indices tend to 
demonstrate morphological abnormalities of the terminal villi. There are two hypotheses 
behind the reasoning for this. The first is that the abnormality is a defect in the terminal 
villous tree which results in reduced capillary size, and therefore, increased 
resistance.
163,164
 The second hypothesis and the one that receives more support is that the 
primary event in most of these cases is a reduced uteroplacental flow leading to a 
placental fetal stem vasoconstriction. Secondary to those changes are changes in the 
terminal villous development and perfusion.
165
 This hypothesis was further developed to 
include a reduction in placental vascularity as the cause of the increased vascular 
resistance.
166
 This has been supported by evidence that the number of arteries in the 
tertiary stem villi are due to an arrest in placental angiogenesis.
143,167
 These effects may 
be further mediated by the effects of oxygen through the VEGF directed angiogenesis.
168
 
Therefore, terminal villi from pregnancies complicated by fetal growth restriction and 
absent or reverse end-diastolic flow tend to be thinner, elongated, poorly branched, 
hypovascular, and have a reduction in their total volume.
169–172
 However, one study found 
no significant correlation between uterine artery Doppler and terminal villi.
173
 
 
Hypoxic conditions, such as decreased uteroplacental blood flow has been shown 
to be associated with increased apoptosis or shedding of apoptotic nuclei.
174,175
 Evidence 
also exists to support placental apoptosis as being greater in pregnancies complicated by 
postplacental FGR than during normal pregnancies.
176–180
 Furthermore, decreased 
uteroplacental blood flow has also been associated with placental infarcts,
181–183
 which is 
in turn is associated with a reduction in fetal size.
181
  
 
There has been considerable support from clinical experiments regarding the link 
between fetal and maternal circulation. A reduction in maternal blood flow to the 
placenta results in an increased vascular resistance within the fetal placental vasculature 
as well as a decreased fetal perfusion of the villi.
184
 Therefore, it has been concluded that 
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growth restricted infants with absent or end-diastolic artery Doppler indices most likely 
have a high placental flow resistance due to vasoconstriction, and decreased placental 
weight. More detailed mechanisms can be found in a conceptual model in Appendix I.  
 
2.3.4.2. The Role of Placental Weight and Fetal Growth Restriction 
 
Placental weight has been shown to be directly correlated and associated with 
birth weight.
3–5,104
 Using 317, 688 births from the Medical Birth Registry of Norway, it 
has been demonstrated that in pregnancies with SGA offspring, approximately 60% of 
pregnancies were in the lowest deciles of placental weight, but offspring that were not 
SGA were evenly distributed throughout the remaining placenta deciles.
185
 Other studies 
have found similar results, indicating a significant association between birth weight and 
placental weight.
186–188
 An association has also been found between small placental 
volumes in the second trimester based on ultrasound examination and the subsequent 
birth of an SGA infant.
4,5
 
  
On the other hand, previous studies have also demonstrated that SGA infants have 
a higher proportion of placental weights at both extremes.
3–5,104,105
 This is postulated to be 
an indication of an inefficient placenta with a reduced ability to maintain fetal growth.  
 
Salafia et al.
130
 have demonstrated that there are four additional measures other 
than placental weight, the most common dimension, to define placental growth including 
placental disk thickness, placental disk shape, placental chorionic disk diameter, and the 
location of the umbilical cord. These growth measures were created to capture different 
aspects of placental growth that are related to placental function. After categorizing disk 
thickness and area into three categories: ≤10th percentile, ≥90th percentile, and between 
the 10
th
 and 90
th
 percentiles for each chorionic plate area category, it was found that as 
the disk thickness increases, the PWR decreased.
130
 
 
It should be noted that the placenta and fetus follow different growth patterns 
during gestation. The human placenta follows an S-shaped growth curve whereas fetal 
  
 
28 
growth follows an exponential pattern with most growth occurring in the third trimester. 
The placental reaches its peak growth between 28-30 weeks gestational and the fetal does 
not reach its highest growth until close to term gestation.
2
 Thus, the PWR decreases 
during gestation.  
 
Most studies have indicated that fetal growth is dependent on the weight of the 
placenta.
2–5
 However, a few studies state that this implies that the placenta has no 
functional reserve capacity. Studies indicate that the placenta can undergo thirty to forty 
percent inactivation of its villous population without any effect on fetal growth or 
development. Consequently, the placenta has a significant functional reserve capacity.
189–
192
 Gruenwald suggests that since the placenta is a fetal organ it shares in growth 
depressions. Therefore, the small fetus not only has a small liver and heart, but also a 
small placenta. Thus, the placenta is small because the fetus is small, and not vice 
versa.
193
 This was supported by Lang et al.
155
 when he showed that a restriction in 
uteroplacental blood flow resulted in a significant decrease in placental weight, as well as 
reductions in the fetal heart, liver, lungs and thymus weight,
155
 significant of 
postplacental hypoxia. Consequently, Gruenwald
193
 concludes that the placenta mass 
cannot directly limit the fetus weight, but rather the placenta is small because the fetus is 
small.  
 
2.3.4.3. Placental Function and Placental Weight  
 
Reduction in placental size in pregnancies complicated by FGR is postulated to 
operate through a reduction in uteroplacental blood flow rather than as a result of an 
intrinsic defect in placental growth.
135
 Lang et al. 
155
 have found that moderately 
restricted uteroplacental blood flow results in a lower placental weight (302±24) than 
normal blood flow, and severely restricted uteroplacental blood flow in an even smaller 
placenta (274±61).
155
  
 
Chronic maternal under-perfusion of the fetal villi, postplacental hypoxia, often 
results in a placenta that weighs less than the 10
th
 percentile based on population norms. 
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In this ischemic placenta, the villi become smaller and smaller as the ischemia progresses 
and many large syncytial trophoblastic knots form.
129,194–196
 Furthermore, a decrease in 
placental blood flow has been shown to be associated with a decrease in placental 
weight.
197
 Finally, animal models have shown that an increase in placental apoptosis 
results in a decrease in placental weight.
198,199
 As previously mentioned an increase in 
apoptosis is characteristic of postplacental hypoxia which results in early onset FGR.  
 
On the other hand, clinical situations such as preeclampsia that result in impaired 
oxygen delivery to the placenta result in excess peripheral villous capillarization. Other 
conditions that result in excess branching angiogenesis include pregnancy at high 
altitude, maternal smoking and maternal anemia. All of these categories are associated 
with excessive placental weight. Increased development of the peripheral villous tree may 
be the reason why these pregnancies are associated with normal umbilical artery Doppler. 
FGR presenting in late gestation is associated with accelerated maturation of the 
placenta.
142
  
 
2.3.4.4. The Role of the Placental Weight Ratio, Placental Function and 
Placental Weight  
 
Fetal body weight in late gestation correlates positively with placental weight 
during both normal pregnancy conditions and also when placental weight is reduced 
experimentally either by direct placental manipulations or by indirect alterations of 
environmental conditions during development.
132,200
 When placental growth is 
compromised experimentally, more fetus is often produced per gram of placenta than in 
normal circumstances; therefore, there is a lower PWR.
201,202
 
 
In pregnant sheep and rats, placental efficiency, which is measured using the 
PWR, is increased in late gestation when fetal and placental weight are reduced by 
maternal heat stress, glucocorticoid administration, under- and overnutrition and by 
restriction of placentation or uterine blood flow.
203–206
 A large placenta per fetal weight 
appear to be less efficient regardless of whether overgrowth is produced genetically or by 
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environmental manipulations.
207
 In recent mouse experiments, it has been proven that the 
lightest placenta in the litter is the most efficient, as reflected in the PWR, than the largest 
placenta in the litter.
208
 They showed that 30% more fetus was produced by the lightest 
placenta than the heaviest placenta in the litter. However, longitudinal measurements of 
the PWR were not available in the study, but the fetal growth trajectory during the late 
gestation appeared to differ with regards to placental size. This study is consistent with 
other studies that show that fetal weight is positively correlated with birth weight at 17 
days of pregnancy, but not later. They concluded that the naturally smaller placenta is 
able to support the growth spurt of the mouse during late gestation.
208
  
 
SGA infants have a higher proportion of placental weights at both extremes.
3–
5,104,105
 This is postulated to be an indication of an inefficient placenta with a reduced 
ability to maintain fetal growth. Therefore, this body of literature concludes that small 
fetuses have small placentas. However, low PWR’s are indicative of an increased 
efficiency of the placentas of the smaller fetuses, whereas, high PWR’s are indicative of a 
potential failed compensation.  
 
2.3.4.5. Animal Models relating Fetal Weight, Placental Weight and Placental 
Function 
 
The sheep has been extensively studied as an experimental model for FGR with 
poor placental substrate supply to the fetus induced using a range of methods, including 
ablation of the majority of the endometrial caruncles prior to conception, induction of 
hyperthermia, ligation of an umbilical artery or embolization of the placenta in late 
gestation and maternal overnutrition in the pregnant adolescent ewe. The extent and 
range of fetal physiologic adaptions to chronic placental insufficiency are determined by 
the duration of the exposure and the degree of the severity of substrate supply restriction. 
A reduction in placental size or transport capacity leads to an impairment of transfer 
between the mother and fetus. It is well established that in sheep variations in placental 
weight explain up to 80% of the variation in fetal weight from early in gestation.
134,209,210
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Uterine carunclectomy results in fetuses that have a reduced placental mass 
resulting in chronic fetal hypoxia and hypoglycaemia across late gestations and growth 
restriction.
211–213
 The fetus responds to the reduction in substrate availability by activation 
of the HPA axis and sympathetic nervous system.
214,215
 
 
Ambient temperatures during pregnancy also influence fetal growth, specifically 
high ambient temperature in the first trimester of pregnancy have been shown to be 
associated with lower birth weight.
216
 There is a reduction in both absolute uterine and 
umbilical blood flow in the hyperthermic fetus.
217
 Both placental and fetal weight are 
reduced by approximately 50% in growth restricted fetuses of hyperthermic ewes at 135 
days of gestation, and the PWR is significantly increased.
218
 The reduction in placental 
weight is not due to a decrease in the number of the placentomes, but instead due to a 
reduction in the size of the placentomes.
218
 Key changes occur in placental vascular 
growth factors and their receptors and may reflect a compensatory response that 
contributes to the decrease in placentome size. These smaller placentomes have a reduced 
capacity for oxygen and nutrient transport to the fetus.
218
  
 
Single umbilical artery ligation causes reduced placental blood flow and, 
therefore, a reduction in substrate transfer from the ewe to the fetus. Relative to fetal 
weight, there is a decrease in umbilical blood flow with increasing gestational age.
219
 
This results in chronic hypoxia and a growth restricted fetus. Single umbilical artery 
ligation fetuses are about 22% smaller than control fetuses.
220
 The fetal adaptations to this 
insult included early activation of the HPA axis.
221
 Placental embolization results in acute 
decreases in placental substrate supply leading to fetal hypoxia and growth 
restriction.
222,223
  
 
Increased nutrient intake during pregnancy in adolescent ewes results in increased 
maternal weight gain, but decreased placental growth and a growth restricted fetus.
224
 
Increased food intake results in reduced uterine and umbilical blood flow.
225
 Both 
placental and fetal weights are decreased from as early as 95 days of gestation. The 
decrease in placental weight is due both to a decrease in the number and the weight of the 
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placentosomes.
226
 In addition, the fetus is hypoxic
 
and exhibits brain sparing.
225
 There is 
a decrease in umbilical uptake of both oxygen and glucose in the FGR fetuses of high 
compared with moderate nutrient intake adolescent ewe fetuses.
226
 However, there is no 
difference in the glucose transfer capacity on a placental weight basis between the two 
groups.
225
 In addition, there is no difference in placentome GLUT-1 or GLUT-3 mRNA 
expression in FGR fetuses at 81 or 133 days gestation.
226
 This finding is important 
because it suggests that the FGR fetus is the result of a small placenta rather than altered 
placental function. Adolescent overfeeding leads to decreased placental size, not 
placental function, which results in reduced fetal substrate supply and FGR. In response 
to the reduced substrate supply, the fetus does not activate the HPA axis, contrary to 
observations in the other four sheep models of FGR, possibly due to a more moderate 
degree of chronic fetal hypoxia.
226
 
 
2.3.5. Risk Factors for Abnormal Placental Weights 
 
A variety of risk factors for extreme placental weights have been identified in the 
literature. Many maternal anthropometric measurements have been found to be positively 
associated with placental weight including: maternal height,
227
 early or pre-pregnancy 
maternal weight,
5,227,228
 early or pre-pregnancy body mass index (BMI),
229,230
 and 
maternal weight gain.
227,228,230
 A number of medical conditions have also been shown to 
be associated with placental weight, and they include: diabetes mellitus which results in a 
larger placenta,
231–233
and hypertension
234
 and decompensated cardiac disease
235
 which are 
both associated with lower placental weights.  
 
Parity is positively associated with placental weight,
227,228,3
 as is maternal life 
stress.
236
 Results are divided on the proposed association between maternal age and 
placental weight,
228,237
 and infant sex and placental weight.
2,3,230
 However, placental 
weight is higher in African Americans
228
 and lower in those of Asian ethnicity
238
 when 
compared to all other ethnic groups.  
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Some placental factors, such as placenta abruption, placental previa and 
antepartum hemorrhage are not individually associated with placental weight,
229
 but as a 
group are associated with a decreased PWR.
188
 Also, both abnormal cord insertion, 
marginal and velamentous, and cord length below 25cm are associated with a decreased 
placental weight.
2,229
 In addition, a single umbilical artery is also associated with a 
reduced placental weight.
229
 Furthermore, abnormal cord insertion has also been found to 
be associated with a high PWR.
239
 However, other factors were not controlled for in the 
aforementioned study. Eccentricity of cord insertion is associated with a sparser chorionic 
vascular distribution, and, ultimately, with a reduced transport efficiency of the placental 
vasculature. The latter results in a reduced birth weight for a given placental weight. 
Velamentous and even marginal cord insertion has been moderately associated with small 
placentas and small fetuses. 
239
 
 
Some of the more complex associations and their mechanisms are described 
below including the roles of pregnancy nutrition, gestational diabetes, psychosocial 
stress, smoking, preeclampsia and anaemia on placental weight. Two conceptual models 
indicating the risk factors for SGA and LGA infants, an increased or decreased placental 
weight, and those covariates which are risk factors for both fetal and placental growth can 
be found in appendix C and D. Also, a table showing which risk factors increase or 
decrease the placental weight and are associated with either SGA or LGA can be found in 
appendix F. Finally, a conceptual model showing proposed pathways for an abnormal 
PWR can be found in appendix E.  
 
2.3.6. Mechanisms for Risk Factors of Abnormal Placental Weights 
2.3.6.1. Pregnancy Nutrition  
 
Placental weight correlates with nutrition during pregnancy, but the effects of 
maternal under-nutrition depend on the timing and duration of the nutritional deprivation. 
A highly cited example that outlines this is the Dutch Famine of 1944-1945 in which 
women who were subjected to starvation during their third trimester had low placental 
  
 
34 
weight. However, the PWR’s were unaltered when compared to women who were not 
malnourished.
124
 
 
Animal models of maternal nutritional deprivation confirm that nutritional 
deprivation is able to limit placental growth, thereby limiting fetal growth. However, it 
has been found that placental total glucose transport capacity was normal when expressed 
based on a unit weight-specific placental basis. Therefore, the investigators concluded 
that the major limitation to fetal growth is the small size of the placenta rather than 
alterations in its nutrient metabolism or transfer capacity.
6
 
 
Both under- and over-nutrition during pregnancy affect placental size, although 
the specific effects depend on the severity, duration and gestational age at the onset of 
nutritional change.
124,240
 In sheep, moderate undernutrition during the peri-conceptual 
period alone has no effect on placental weight in late gestation,
241,242
 but when the period 
of undernutrition is during the period of rapid placental growth, placental weight is 
frequently increased near term.
243–245
 This overgrowth appears to act as a compensatory 
mechanism for the reduced nutrient availability early in gestation as fetal weight is 
normal, or even enhanced, in late gestation after normal nutrition has been restored.
246
 
Similar compensatory increases in placental weight have been observed in response to 
undernutrition in pregnant pigs, rats and humans.
124,247
 By contrast, moderate 
undernutrition during mid to late gestation when the placenta has formed tends to reduce 
placental weight near term.
243–245
 When nutrient deprivation occurs throughout pregnancy 
in sheep and rats, fetal and placental weights both decrease, but usually more fetus is 
produced per gram of placenta than in normally nourished animals; therefore, the PWR is 
lower.
240,247,248
 Similar increases in placental efficiency are observed when placental and 
fetal growths are retarded by glucocorticoid administration during late gestation.
205,249
 
Exposure to poor nutrition or glucocorticoids at critical stages of placental development, 
therefore, appears to increase the efficiency with which the small placenta transfers 
nutrients to the fetus.
250
 Therefore, placental weight may be increased or decreased 
depending on the timing or duration of the maternal under or over nutrition based on a 
combination of epidemiological and animal studies.  
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2.3.6.2. Gestational Diabetes  
 
It has been noted by several authors that the placentas from women with 
gestational diabetes are often increased in weight when compared to women who had 
only one abnormal oral glucose tolerance test.
234,251–255
 
 
A high PWR has also been found in women with gestational diabetes, which the 
authors indicated is from an increased placental weight rather than a decreased birth 
weight.
252
 However, another study has found a significantly lower PWR for women with 
gestational diabetes compared to women with no glucose intolerance.
256
 Nevertheless, a 
significantly higher placental weight was found in this study, so the decreased ratio is the 
result of lower birth weights. These findings were based on a placental weight of one 
standard deviation away from the established value for appropriate-for-gestational age 
infants from non-diabetic pregnancies.  
 
There is a modification in placental glucose transporters, yet there is an 
unchanged transplacental glucose transport in gestational diabetes.
257
 Amino acid 
transport may also be altered in diabetes.
258
 Furthermore, the placental structure is altered 
in diabetes. The surface and exchange areas are enlarged as a result of the 
hypoproliferation and hypervascularization. Therefore, the maternal-placental oxygen 
supply is reduced, and the fetal oxygen demand is increased.
259,260
 This phenomenon 
could be explained by aerobic metabolism which is stimulated by fetal 
hypersinsulinemia. The low oxygen level upregulates transcriptional synthesis of leptin, 
vascular endothelial growth factor (VEGF) and fibroblast growth factor which promotes 
placental endothelial cell proliferation. The result is enhanced vascularisation of the 
placenta.
261,262
 The hyperglycemia can induce a reduction in trophoblast proliferation 
which delays placental growth and development, especially in early gestation. It has also 
been shown that matrix metalloproteinases (MMP), MMP14 and MMP15, are increased 
in diabetes and are associated with invasion, angiogenesis and proliferation.
263
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2.3.6.3. Smoking 
 
Cigarette smoking is associated with a decreased fetal weight, but of the few 
studies that have looked at maternal smoking and placental weight, there has been no 
significant effect found.
228,264–268
 However, some studies that investigated the PWR found 
a significant difference between the ratios in smokers versus non-smokers. The PWR 
were significantly higher in smokers than in non-smokers in two prospective cohort 
studies.
227,266
 On the other hand, another study found a significantly lower PWR for 
smokers than non-smokers.
264
 Therefore, the results are divided on the effect of smoking 
on the PWR, but the above studies lack a large sample size and are dated.  
 
When a mother smokes during pregnancy the placenta and fetus become hypoxic 
because of reduced oxygen content within maternal blood, referred to as preplacental 
hypoxia. This condition results in reduced intraplacental oxygen content, predominately 
branching angiogenesis, and reduced vascular impedance. The increase in branching 
angiogenesis and thereby reduced vascular impedance, is an adaptive mechanism to the 
hypoxic state. Interestingly this mechanism is associated with excessive placental 
weight.
144
 
 
2.3.6.4. Preeclampsia  
 
Placentas from women with preeclampsia tend, on average, to be smaller than 
those from pregnancies that are uncomplicated.
105,185,228,269
 However, the decrease is only 
slight and the relationship between the two is weak. Also, the PWR is often increased in 
pregnancies that are complicated with preeclampsia,
231,270
 which suggests that there is 
compensatory growth of placental villi in an attempt to overcome an unfavourable 
maternal environment.
208,271
 However, the duration of the disease, and the severity of 
preeclampsia are important determinants of placental abnormality. In a large population 
study, it was found that low placental weight was strongly associated with preterm 
preeclampsia, but less strongly associated with term preeclampsia. Surprisingly, term 
preeclampsia was associated with both low and high placental weights.
272
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According to current knowledge, preeclampsia is initiated by a hypoxic placenta 
which is the consequence of reduced trophoblast invasion and impaired transformation of 
the decidual spiral arteries. Alterations in trophoblast differentiation occur in many 
pathophysiological conditions of pregnancy including both FGR and preeclampsia. The 
mechanism behind this is postulated to be associated with a defect in EVT invasion. 
Some of the spiral arteries are not invaded and some are superficially invaded, which 
leads to a reduced blood flow in the intervillous space and a hypoxic placenta.
273
  
 
EVT apoptosis is seen in normal pregnancy, but in preeclamptic pregnancies 15 to 
50 percent of cells are apoptotic, which is a finding associated with macrophages around 
the spiral arteries.
273
 Furthermore, during normal pregnancy, syncytiotrophoblast 
fragments are dispersed into the mother’s circulation as a result of apoptosis. However, 
the rate of syncytiotrophoblast apoptosis is increased from 2 to 3 percent in a pregnancy 
not complicated by preeclampsia and from 5 to 6 percent in pregnancies complicated by 
preeclampsia.
274
  
 
The mechanism behind term preeclampsia’s effect on FGR is that normally 
oxygenated maternal blood has restricted entry into the uteroplacental tissues due to 
either occlusion or failed trophoblast invasion of the uteroplacental arterioles. This 
situation represents late onset IUGR with preserved end diastolic flow volume. This 
condition results in reduced intraplacental oxygen content with increased predominately 
branching angiogenesis and reduced vascular impedance as an adaptation to the reduced 
oxygen entering the placenta.
142
 
 
2.3.6.5. Anaemia  
 
Many researchers have noted that placentas tend to be heavy in pregnancies 
complicated by both severe and mild maternal anaemia, with the fetus often being small, 
and therefore the PWR increased.
228,275–277
 The increased placental weight, and therefore 
ratio indicate that anaemia, rather than underlying iron deficiency, is the cause for an 
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increased placental ratio.
278–280
However, many of these studies suffer from the 
methodological issue of too few placentas being examined. In contrast, in two large 
studies the weight of the placenta was found to be inversely proportional with the 
maternal haemoglobin concentration.
281,282
 
 
The increased size of the placenta has been understood as a compensatory 
mechanism to overcome the lack of oxygen in the maternal blood, again referred to as 
preplacental hypoxia, as well as the increased trophoblastic proliferation and placental 
angiogenesis that result from anaemia.
283
 In response to a lack of oxygen, the extravillous 
trophoblast of the placenta bed shows an increased depth of invasion.
284
 
 
2.3.7. Outcomes Associated with Abnormal Placental Weight Ratios 
 
Both an abnormally low and abnormally high PWR are associated with adverse 
outcomes. A PWR below the 10
th
 percentile has been found to be significantly associated 
with fetal distress.
285
 Alternatively, placental weight above the 90
th
 percentile was found 
to be significantly associated with newborns requiring neonatal intensive care 
admission.
104
 
 
There are numerous adverse short term outcomes associated with abnormal 
PWR’s. Infants with a high PWR had increased incidence of meconium stained liquor, 
hypocalcaemia, hypomagnesaemia and phototherapy. The incidence of these outcomes 
was maintained even after exclusion of the preterm infants.
286
 The neonates with a high 
PWR had increased incidence of low 1-minute Apgar score, treatment for neonatal 
jaundice and infection, and respiratory complications. After adjusting for the effects of 
preterm birth and vaginal delivery, a high ratio was still associated with low Apgar score, 
respiratory complications, and treatment for infection.
287
 
 
There are several long term outcomes associated with both abnormal PWR’s and 
abnormal placental sizes. Placental insufficiency, as defined by reduced uterine 
perfusion, in the pregnant rat results in low birth weight offspring predisposed them to 
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the development of hypertension.
288
 Barker and his colleagues noted in 1990 that an 
increased placental weight was associated with an increased risk of hypertension in adults 
between 46 and 54 years of age.
289
 In addition, a large prospective cohort found that after 
45 years of follow-up, the sex- and cohort-adjusted hazard ratio for the highest versus the 
lowest third of the PWR was 1.38. Therefore, the authors concluded that a high PWR was 
associated with increased risk of cardiovascular disease and death from cardiovascular 
disease.
137
Also, a reduced placental weight and surface area is associated with 
hypertension in later life, and the effect was strongest among women who were short and 
had a low socioeconomic status. In the offspring of tall, middle class mothers, who were 
likely to have been the best nourished, hypertension was predicted by large PWR. The 
odds ratio rose from 1.0 if the PWR was 0.17 or less to 1.9 if the ratio was more than 
0.21. The authors suggested that the risk of developing hypertension relative to your 
PWR was dependant on the maternal nutritional state.
290
 Two studies have found that in 8 
and 9 year old children an increased placental weight at birth is associated with increased 
systolic blood pressure.
291,292
 
 
2.4. Summary and Rationale for this Study 
 
SGA infants are an important population to examine because mortality and 
morbidity are increased in SGA infants compared to those who are AGA.
92
 Short term 
complications include still birth, abnormal EFH, hypoglycemia, hypocalcemia, 
polycythemia, depression, meconium, 1 minute apgar less than 6, 5 minute apgar less 
than 6, 1 minute apgar less than 3, and in hospital death, all of which increase with 
increasing severity of growth restriction.
106,293–295
 
 
A decreased birth weight shares many of the same risk factors as a decreased 
placental weight. However, some risk factors have differing effects on both placental 
weight and birth weight, but the literature has yet to elucidate these differences. 
Therefore, by determining the risk factors associated with an abnormal PWR, it will 
provide a clearer understanding of the variables that are associated with the relationship 
between fetal and placental growth.  
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Birth weight is correlated with placental weight, yet SGA infants often have high 
PWR ratios indicative of more grams of placenta per gram of birth weight. This is 
postulated to occur as the result of a compensatory mechanism in response to a decrease 
in nutrient or oxygen delivery through the placenta to the fetus. Nevertheless, the timing 
and duration of the reduced nutrient or oxygen supply plays an integral role in both fetal 
and placental growth.  
 
PWR distributions will make a substantial contribution to the literature. While it 
is suspected that PWR may be an important indicator of fetal health, there are few 
population standards for comparison. There are only one other set of PWR percentile 
curves in a Canadian population, and their sample sizes are much smaller than our 
sample. Therefore, our percentiles provide more accurate predictions, especially at the 
extremes
296
 Determining the differences in PWR’s between SGA, AGA and LGA infants 
will provide a better understanding of the relationship between fetal growth and placental 
growth. To date, they will be the first of their kind in the literature. Also, the placenta and 
birth weights follow different patterns of growth during gestation. The creation of 
distributions based on gestational age will provide a better understanding of the 
differences in the ratio of these two measures across gestational age. They will be a 
useful tool to provide standards in the literature for other researcher and clinicians to use. 
Therefore, by creating gender specific PWR distributions by gestational age, it will 
provide deeper insight into critical periods for both fetal and placental growth.  
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CHAPTER 3: METHODS 
 
3.0 Introduction 
This chapter describes the generic methods for the entire thesis including descriptions of 
covariates and outcomes variables and their recoding for analyses, as well as details on 
the specific methods used for each objective. More specifics will be provided in the 
subsequent manuscript chapters.  
 
3.1 Design and Data Source 
This was a retrospective cohort study, using a hospital database of all singleton 
birth records from St. Joseph’s Health Care and Victoria Hospital in London, Ontario. 
The administrative perinatal database housed at Victoria Hospital contained information 
on 58,004 births for the study date range. The perinatal database contains information on 
maternal demographics, perinatal risk factors, and maternal and fetal outcomes. 
Guided by definitions in the Vital Statistics Act, the database prospectively 
collected data on all infants whose birth weight was greater than or equal to 500g or 
whose gestational age was greater than 20 weeks. Relevant data abstraction from the 
medical records was performed and input into the database.  
3.2 The Study Population 
3.2.1 Inclusion and Exclusion Criteria 
The first objective included all singleton births from St. Joseph’s Health Care and 
Victoria Hospital in London, Ontario between April 1, 2001 and March 31, 2011. The 
second objective included all singleton births from both hospitals between June 1, 2006 
and March 31, 2011 due to the availability of covariates of interest in the database. The 
mothers were from London, Ontario and the surrounding area of Southwestern Ontario. 
St. Joseph’s Health Care and the London Health Sciences center are tertiary care centers, 
and therefore data represent mainly urban residents, as well as high risk transfers from 
rural areas that amount to approximately 20% of births at the hospitals. Mothers were 
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predominately from Middlesex County; however, there were mothers from the 
surrounding area.  
Women who delivered an infant before 22 or after 42 weeks were excluded due to 
the small sample sizes present in these categories. Also, unknown or ambiguous genders 
were excluded from the analysis, as the distribution curves were stratified into males and 
females. Infants with major congenital abnormalities and stillbirths were also excluded. 
Lastly, multiple pregnancies were excluded from the analyses. These exclusions are 
highlighted separately for each objective in the study flow charts in Figures 3.1 and 3.2.  
 
3.2.2 Missing Information  
 
For both the first and second objective, any observation with a missing placental 
weight ratio (PWR) or gestational age was excluded from the analyses. For objective two, 
there was missing information for smoking status, preeclampsia, anaemia, placenta 
delivery method, parity, maternal age, and maternal height. Any individual with missing 
information was excluded for this objective.  
 
3.3 Data Collection and Coding 
3.3.1 Predictor Variables  
The following variables were chosen to be extracted from the perinatal database, 
according to the conceptual model, to be considered as predictors of the placental weight 
and/or birth weight. The categorization process is described below for each of the 
predictor variables, where these variables and their coding are summarized in Table 3.1.  
3.3.1.1 Baseline Variables 
3.3.1.1.1 Maternal Height 
Maternal height was treated as a continuous variable because categorizing 
continuous variables is a subjective process that leads to variables with less statistical 
information.
1
 All measurements were converted to metric units for analysis.  
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3.3.1.1.2 Parity 
The number of live births to this mother (counting twins and triplets as 2 and 3 
births, respectively) was used for the parity count. For this study, parity was 
dichotomized for the analysis into nulliparous versus multiparous with women 
completing their first pregnancies as the reference group.  
3.3.1.1.3 Smoking Status 
Smoking status was entered as a binary variable, whether the person smoked 
during the pregnancy or whether they did not. This variable did not account for the 
number of cigarettes smoked. The women who did not smoke were treated as the 
reference group.  
3.3.1.1.4 Maternal Pre-Pregnancy Weight 
The perinatal database considered it acceptable to use weight at presentation, if 
gestational age was 16 weeks or less at presentation. The pre-pregnancy or early 
pregnancy weight from the antenatal record was entered if gestational age was 16 weeks 
or younger, but preferably pre-pregnancy weight was used. The data holds greater 
validity if it can be cross-referenced against other documentation in the chart. The pre-
pregnancy or early pregnancy weight from the antenatal record was not entered unless it 
could be cross-referenced against the Nursing Admission sheet and/or the first 
Obstetrician consult note on Power Chart and/or the Obstetrician or general practitioner 
appointment on the second page of the antenatal history and/or the history taken by the 
clerk on admission. The Nursing Admission sheet shows the weight at admission and the 
self-reported weight gain during the pregnancy. If this corroborated with the other weight 
information the abstractor noted in the chart, then it was entered as pre-pregnancy or 
early pregnancy weight. It was also entered if in the chart it was specifically documented 
as pre-pregnancy weight. If the weight in the antenatal record was taken at gestations 
greater than 16 weeks it was not used and the field was left blank. Therefore, maternal 
pre-pregnancy weight was treated as a continuous variable, and all measurements were 
converted to metric units for analysis.  
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3.3.1.1.5 Maternal Age 
When the mother’s age at time of delivery was entered into the database it was 
calculated by subtracting the mother’s date of birth from the infant’s date of birth. Age 
remained was categorized into mothers <21 years of age, between 22 and 34 years of age 
and <34 years of age for the analyses. 
3.3.1.1.6 Maternal BMI 
Maternal BMI was not directly collected in the database, but the maternal weight 
and height variable were used to calculate maternal pre-pregnancy body mass index 
(BMI) using the equation BMI= weight (kg) / height
2
 (m
2
). BMI was then categorized 
according to the Health Canada Guidelines into four categories: underweight (< 18.5), 
normal weight (18.5-24.9), overweight (25.0-29.9), and obese (30.0+).
2
 Those 
observations with a normal BMI were used for the reference category.  
3.3.1.1.7 Maternal Asthma Status 
Maternal asthma status was coded as a binary variable. The mother was either 
asthmatic or not asthmatic based on information in the patients chart. The mothers who 
did not have asthma were the reference group.  
3.3.1.2  Mid-Pregnancy Variables 
3.3.1.2.1 Gestational Hypertension 
  Gestational hypertension was defined as diastolic blood pressure > 90 mm Hg, on 
at least two occasions at 20 weeks gestation or older, no proteinuria and blood pressure 
elevation detected for the first time during pregnancy. It was coded as gestational 
hypertension even if the physician only noted “elevated blood pressure” in their notes, as 
directed by the Chief of Obstetrics, Dr. Natale. If the diagnosis on the chart was unclear 
then the mentioned guidelines were used to define gestational hypertension.    
An expansion of the definitions was provided in April 2010, as help for coding a 
chart with inconsistent documentation. For example, if the physician noted that the 
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patient had gestational hypertension but lab results showed proteinuria, then the database 
coded preeclampsia, as per Dr. Natale.   
3.3.1.2.2 Preeclampsia 
Severity of hypertensive disorder was recorded as a categorical variable. The 
patient either had no hypertension and proteinuria or gestational hypertension with a 
diastolic pressure >90 mm Hg, on a least two occasions at 20 weeks gestation or lower, 
no proteinuria, and blood pressure elevation detected for the first time during pregnancy. 
The patient could also have been categorized as having mild preeclampsia defined as 
diastolic blood pressure between 90 and 110mm Hg with proteinuria less than 3+ or 
severe preeclampsia defined as diastolic pressure of 110 mm Hg or higher and/or 3+ 
protein and/or any end-organ involvement and treatment with magnesium sulfate or 
eclampsia when seizures occur or unknown. In cases where a physician noted that a 
patient had gestational hypertension but, lab results showed proteinuria, then the data 
abstractor recorded preeclampsia. These guidelines were used when the diagnosis on the 
chart was unclear. If any proteinuria was present it was coded as preeclampsia up to and 
including the third day postpartum based on the diagnostic criteria from the SOGC 
recommendation IIIC from March 2008. Codes followed classification in Creasy-
Resnick, maternal-fetal medicine, 6
th
 edition.
3
 For any case with preeclampsia 
superimposed on chronic hypertension, chronic hypertension was defined based on the 
criteria provided in the hypertension section, and then the appropriate code for 
preeclampsia severity was also entered. For this thesis the data were coded as a binary 
variable, preeclampsia or no preeclampsia present. The group with no preeclampsia was 
treated as the reference group.  
  
3.3.1.2.3 Gestational Diabetes 
Carbohydrate disorders were defined using a categorical variable in the perinatal 
database. Mothers were defined according to the following set of criteria: no 
carbohydrate disorder, carbohydrate intolerance defined as one abnormal reading on a 75 
gram oral glucose tolerance test, gestational onset and diet controlled, gestational onset 
with insulin control or overt diabetes. When cases of gestational onset diabetes were 
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commented on by the doctor as “missed”, it was coded as gestational onset with insulin 
control unless a specific diagnosis of overt diabetes was indicated. In this study, 
gestational diabetes was coded as a binary variable, present or absent. Mothers' with no 
gestational diabetes were used for the reference group.  
3.3.1.3 Umbilical and Placental Conditions 
3.3.1.3.1 Umbilical Cord Risk Factors  
In the database, cord complications were defined categorically depending on the 
presence or absence of a cord complication and the type of complication. For the analysis 
in this study, no complications acted as the reference group. An infant was placed into 
one of the following three categories: no complications, a cord around the neck, in a knot, 
around the body, prolapsed or lacerated or having a short, 2-vessel or velamentous 
umbilical cord. 
3.3.1.3.2 Placental Abruption 
Placental abruption was defined in the database as premature separation of a 
normally implanted placenta after the 20th week of gestation and before the fetus was 
delivered. Placental abruption was categorized as either none, mild, moderate or severe in 
the perinatal database. If the placental abruption was recorded as chronic on the mother’s 
chart, then it was coded as a mild abruption. This addition to the coding manual for 
chronic abruption was added in May/June of 2010. For the purpose of this thesis, the data 
were coded as a binary variable, either abruption (mild, moderate or severe) or no 
abruption. The observations with no placental abruption were used as the reference.  
3.3.1.3.3 Placental Previa 
Placental previa was categorized into five different categories. Placental previa is 
either indicated as not present, marginal, partial, complete or resolved before delivery. 
The database defines placental previa as implantation of the placenta low in the uterus 
either overlying or reaching the vicinity of cervical opening. Prior to May/June of 2010 
the final category listed above, resolved before delivery, was not one of the categories for 
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placental previa. For this thesis, placental previa were treated as a binary variable, and 
women with no placental previa were treated as the reference group. 
3.3.1.4 Late Pregnancy and Delivery Variables 
3.3.1.4.1 Pregnancy Weight Gain 
Weight gain during pregnancy was only documented as a risk factor in the 
perinatal database, and not as an exact weight value. Therefore, a mother was defined as 
having a low pregnancy weight gain if by 30 weeks gestation the mother has gained <10 
pounds or if at delivery the mother has gained <20 pounds. Furthermore, the pregnancy 
weight gain was indicated as high if the mother gained >40 pounds during her current 
pregnancy at the time of delivery. Women who gained within the normal range for 
weight gain during pregnancy were not indicated, so women who were not categorized as 
having a low or high weight gain were presumed to be within normal ranges. Also, the 
exact weight gain was not indicated, but instead recorded as a categorical variable. The 
women with normal weight gain were used as the reference group.  
3.3.1.4.2 Anemia 
In the perinatal database admission hemoglobin was recorded. If admission 
hemoglobin was <100g/L then the patient is defined as anemic. This variable was coded 
as a binary variable, present or absent. Patients with admission hemoglobin within normal 
limits were treated as the reference category.  
3.3.1.4.3 Sex of the Infant 
Sex was defined as either: ambiguous, male, female or unknown if the data was 
missing. Therefore, the sex of the infant was categorized as a binary variable, either male 
or female, for all statistical analysis. Unknown or ambiguous genders were excluded from 
the analysis, as previously mentioned.  
3.3.1.4.4 Placental Delivery 
The database coding manual indicates that a good indication of problems with 
delivery is the interval of time from the infant date of birth to the delivery of placenta, 
  
 
81 
usually 30 minutes or more of placental retention. The placental delivery was categorized 
into spontaneous, expressed or assisted, manual, if 30 minutes or more after vaginal 
delivery of baby and always manual if the delivery was a cesarean section, retained, if 
dilation and curettage, or by scraping or curettage, and finally unknown. This variable 
remained as a categorical variable based on the aforementioned categories, and a 
observations with a spontaneous placenta delivery were used as the reference.  
3.3.1.4.5 Congenital Abnormality 
Congenital abnormality was recorded as a categorical variable, with the following 
categories: no abnormalities, minor abnormalities or major abnormalities. Any major 
congenital abnormalities were excluded from the analyses.  
3.3.2 Outcome Variables  
3.3.2.1 Gestational Age 
 
Gestational age was a key variable for this research, as it allowed an infant to be 
classified as SGA, AGA or LGA and played an integral role in establishing PWR 
distributions by gestational age. Gestational age was recorded in the database as the 
number of completed weeks and the number of completed days. For the purpose of this 
analyses, gestational age remained as a continuous integer variable, but only the 
gestational week was used, not the number of days. 
According to clinical practice, gestational-age estimation in the database was 
derived from the last menstrual period if either first trimester ultrasound was within ± 4 
days of the estimated date of confinement or second trimester ultrasound was within ± 10 
days of the estimated date of confinement. Otherwise, gestational age was corrected on 
the basis of ultrasound measurements that are routinely obtained for all pregnant women 
in the province of Ontario for pregnancy dating. 
 
3.3.2.2 Birth Weight for Gestational Age 
In the database, infant birth weight was recorded in grams as a continuous 
variable. One of the primary outcome measures of interest for this thesis was the birth 
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weight or size for gestational age of the infant at birth. Size for gestational age is a 
categorization based on the normal distribution of birth weights, controlling for infant sex 
and gestational age, in the population. For this study, the continuous birth weight variable 
was categorized into small, average and large for gestational age infants (SGA, AGA and 
LGA) for the analysis. This thesis used the population standards published by Kramer et 
al. in 2001.
4
 A SGA infant was defined as one whose birth weight fell into the lowest 
10% of Canadian births, for their sex and gestational age. LGA infants were defined as 
those whose birth weight fell into the highest 10% of Canadian births, for their sex and 
gestational age. Infants who did not fall into either the lowest or the highest 10% of birth 
weights were considered to be AGA. AGA infants were used as the reference category 
for this analysis. 
 
3.3.2.3 Placental Weight 
 
Another primary outcome measure of interest for this thesis was placental weight. 
Placental weight was entered into the database in grams, and if unknown was left blank. 
This variable has been collected since the beginning of the database at St. Joseph’s 
Hospital, but only since November of 2003 in the LHSC, Victoria Hospital database. For 
objective one of this thesis, placental weight was treated as a continuous variable in order 
to produce accurate distributions. For objective two of this thesis, it was categorized into 
≤10th percentile, ≥90th percentile or in between the 10th and the 90th percentile based on 
the results from objective one, using the overall standards that were created.  
 
3.3.2.4 Placental Weight Ratio  
 
The PWR was calculated by dividing the birth weight by the placental weight for 
each infant that has a birth weight and a placental weight. 
 
3.4 Data Analysis  
3.4.1 Data Cleaning 
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Exploratory univariate analyses detected implausible values, missing values or 
other questionable or extreme values that required attention. Additional work was done to 
clean and quantify the predictor and outcome variables to ensure that implausible values 
were not included. Variables such as maternal height, age and pre-pregnancy weight were 
trimmed at the 1
st
 and 99
th
 percentile in order to remove implausible values. Birth weights 
greater than three standard deviations from the mean were removed, as they were 
presumed to be implausible. The calculation for this can be found in Appendix J. 
Placental weights < 100g or >2500g were also removed, as they were presumed to be 
incorrect. Due to the large size of the population, the implausible or extreme values could 
not be cross checked with the chart information. A diagrammatic representation of this 
can be found in the study flow chart in Figures 3.1 and 3.2.  
 
3.4.2 Statistical Analyses 
3.4.2.1 Placental Weight Ratio Distributions 
3.4.2.1.1 Justification and Explanation: Quantile Regression  
Quantile regression (QR), which was introduced by Koenker and Bassett is way 
to create growth charts.
5
 One of the main advantages of QR is that it does not make any 
distributional assumption beforehand. It is able to model data with heterogeneous 
conditional distributions.
6
 It is also relatively easy to accommodate other covariates 
besides age; however, this function will not be required for the specific aims of this 
thesis. Computationally, QR is fast and stable. It also generalizes the concept of a 
univariate quantile to a conditional quantile given one or more covariates.
7
 Another 
advantage of QR, is that it is robust to extremes of the response variable.
6
 
 
Ordinary least-squares regression models the relationship between one or more 
covariates X and the conditional mean of a response variable Y given X = x. In contrast, 
QR models the relationship between X and the conditional quantiles of Y given X = x, so 
it is especially useful in applications where extremes are important, such as growth 
studies where upper and lower quantiles are critical from a diagnostic perspective.
8
 QR 
also provides a more complete picture of the conditional distribution of Y given X = x 
when both lower and upper, or all quantiles, are of interest. The main advantage of QR 
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over least squares regression is its flexibility for modeling data with heterogeneous 
conditional distributions, such as the PWR ratio.
8
 QR provides a complete picture of the 
covariate effect when a set of percentiles is modeled, and it makes no distributional 
assumption about the error term in the model. 
 
There have been several methods used to construct such age dependent growth 
charts. Early methods fit smoothing curves on sample quantiles of segmented age groups. 
However, these methods are not robust to outliers. Large sample size is needed in order 
to estimate the percentiles in each age group with appropriate precision. The 
segmentation may lose information from nearby groups. To avoid segmentation, Cole 
and Green
9
 developed a Box-Cox transformation-based semiparametric approach from 
the LMS (Lamda-Mu-Sigma) method introduced by Cole. The semiparametric LMS 
method solves penalized likelihood equations.
10
 
 
Generally there is reasonable agreement between LMS curves and QR. However, 
it has been shown that especially in infants, the more parsimonious LMS curves lack the 
flexibility of QR. Also, the LMS method has been shown to overfit in comparison to QR. 
While there is a relatively good agreement between the two methods, LMS imposes more 
structure but QR is more stable and is able to reveal departures from underlying 
assumption of parametric models.
8
 
 
QR, which solves the optimization problem with a general simplex algorithm, is 
computationally expensive. Faster methods have been developed. The worst-case 
performance of the simplex algorithm shows an exponentially increasing number of 
iterations with sample size. Since the general QR fits adequately into the standard primal-
dual formulations of linear programming, the interior point algorithm can be applied. The 
worst-case performance of the interior point algorithm has been proven to be better than 
that of the simplex algorithm.
6,7
 
 
 Several methods for computing confidence intervals of the regression quantiles 
have been proposed in the literature. They can be classified into three categories: the 
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direct method, which computes the confidence intervals, based on the asymptotic 
normality of the estimated regression quantiles; the rank-score method, which computes 
the confidence intervals based on the inversion of the rank-score test; and the resampling 
method, which uses the bootstrap technique.  
 
3.4.2.1.2 Application: Quantile Regression  
 
The first objective to construct PWR distribution curves by gestational age for 
males and females and then to stratify by SGA, AGA and LGA status was accomplished 
using QR. The QUANTREG procedure in SAS 9.3 computes the fitted values of the 
quantile only for a single quantile at a time. Therefore, since fitted values were required 
for multiple quantiles in this analysis, a macro was created. The macro allowed for 
computation of the 3
rd
, 5
th
, 10
th
, 25
th
, 50
th
, 75
th
, 90
th
, 95
th
 and 97
th
 percentiles 
simultaneously in one output. The FITPLOT graph option in QUANTREG was used to 
generate the graphs displayed in the results section which show the smoothed and fitted 
curves without any of the data points. The macro used is displayed in Appendix K.  
QR is a type of regression analysis that aims to estimate either the conditional 
median or other quantiles of the response variable. QR was performed using the interior 
point algorithm with a tolerance of 1E-4 and a step length of 0.25. Markov chain 
marginal bootstraps (MCMB) were implemented to compute confidence intervals for the 
regression quantiles.
7,11
 
The PWR was used as the outcome variable and a quadratic term for gestational 
age was used as the covariate. Using a quadratic term for gestational age produced the 
same results as when cubic B-splines were used with knots at the boundaries (22 and 42 
weeks gestation). Therefore, a quadratic term was used as it allowed for an easier 
interpretation of the significance level of the results at each percentile.  
 
3.4.2.2 Determinants of an Atypical Placental Weight Ratio 
3.4.2.2.1  Application: Multinomial Logistic Regression 
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The second objective that aimed to identify risk factors for abnormal PWR’s was 
completed in SAS 9.3 using multinomial logistic regression with the PROC LOGISTIC 
function. The outcome for this analysis was a PWR ≤10th percentile, between the 10th and 
the 90
th
 percentile or ≥90th percentile, with a PWR between the 10th and 90th percentile as 
the reference group. The PWR standards created in objective 1 (Chapter 3) for overall 
infants were used to establish 10
th
 and 90
th
 percentile cut-offs for use as the outcome 
variable. Variables were entered in chunks,
12
 and the collapsibility criteria were used to 
determine if any of the odds ratios (OR) changed by greater than 10% when another 
chunk was added. Variables were entered in chunks, in temporal sequence, into the 
model. These chunks were: baseline variables; early pregnancy variables; placental and 
cord complication variables; and late pregnancy and post partum variables. Using 
temporally entered chunks allowed associations between variables from different chunks 
to become evident through the model building process, which allowed for a better 
understanding of the associations in the data.
12
 Multinomial logistic regression allowed us 
to use infants with a PWR between the 10
th
 and 90
th
 percentile as the reference group in 
an analysis that simultaneously estimated the odds of a PWR≤10th percentile or ≥90th 
percentile. Entering chunks allowed associations between variables from different chunks 
to become evident through the model building process, which allowed for a better 
understanding of the associations in the data. 
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Table 3.1: Study Variables and Recoding for Analysis 
Variables Available in 
Database 
Coding in the Database Recoding for Analysis  
Birth Date 
 
Recorded as a year and a 
month 
 
Birth Weight 
 
Measured in grams Categorical 
0=SGA 
1=AGA 
2=LGA 
Gestational Week 
 
Measured in weeks Continuous (Integer) 
Placental Weight 
 
Measured in grams Continuous 
Maternal Age 
 
Measured in years Categorical 
<21 years of age 
21-34 years of age 
>34 years of age 
Maternal Height 
 
Measured in inches Continuous 
BMI Not recorded by pre-
pregnancy weight and 
maternal height were used to 
create this variable 
Categorical 
0=BMI <18.5 
1=18.5≤BMI<24.9 
2=24.9≤BMI<29.9 
3=BMI≥29.9 
Parity Recorded as a continuous 
variable 
Binary 
0=primiparous 
1=multiparous 
Admission Hemoglobin  
 
Measured in grams per Liter. Binary 
0=not anaemic (If 
admission hemoglobin in 
≥100g/L) 
1=anaemic (If admission 
hemoglobin is <100g/L) 
Sex 
 
A=Ambiguous 
F=Female 
M=Male 
U=Unknown (missing 
information) 
Binary 
0=Male 
1=Female 
Gestational Diabetes 
 
0=No  
1=Carbohydrate intolerance 
(1 abnormal reading on a 75 
gram oral glucose tolerance 
test (GTT)     
2=Gestational onset, diet 
controlled  
Binary 
0=No (If previously coded 
as 0 , 1 or 4 in the database) 
1=Yes (If previously coded 
as 2 or 3 in the database) 
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3=Gestational onset, insulin 
controlled 
4=Overt. Note: cases of 
gestational onset with 
comment of “missed” by Dr. 
should be coded as 3 unless a 
specific diagnosis of overt 
diabetes has been made. 
Preeclampsia 0=No  
1=Gestational hypertension, 
diastolic > 90 mm Hg, on at 
least 2 occasions at 20 weeks 
gestation or older, no 
proteinuria, blood pressure 
elevation detected for the first 
time during pregnancy. 
Code as gestational 
hypertension even if 
physician only notes 
“elevated blood pressure”, as 
directed by Dr. Natale. 
2=Mild preeclampsia, 
diastolic between 90 and 110 
mm Hg with proteinuria less 
than 3+ 
3=Severe preeclampsia, 
diastolic 110 or higher, 
and/or 3+ protein, and/or any 
end-organ involvement and 
treatment with magnesium 
sulfate 
 4=Eclampsia, seizures occurs  
-8=unknown 
Binary 
0=No (If previously coded 
as 0 or 1 in the database) 
1=Yes (If previously coded 
as 2, 3 or 4 in the database) 
 
Smoking Status 
  
0=No (during pregnancy) 
1=Yes (during pregnancy) 
Binary 
0=No 
1=Yes 
Umbilical Cord 
Complications 
 
0=None 
1=Neck 
2=Knot 
3 =Body  
4=Prolapsed 
5=Laceration 
6=Short 
7=2-vessel 
8=Velamentous 
9=Other 
Categorical 
0=None 
1=Neck, body, prolapsed, 
lacerated, and other 
2=short, 2-vessel and 
velamentous 
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Placental Abruption 
  
0=No 
1=Mild (may be recorded on 
chart as “chronic”) 
2=Moderate 
3=Severe 
Binary 
0=No (If coded in database 
as 0) 
1=Yes (If coded in 
database as 1, 2 or 3) 
Placental Previa 
  
0=No 
1=Marginal 
2=Partial 
3=Complete 
4=Resolved before delivery 
Binary 
0=No (If coded in database 
as 0) 
1=Yes (If coded in 
database as 1, 2, 3 or 4) 
Placenta Delivery 
 
1=Spontaneous  
2=Expressed or assisted 
3=Manual, if 30 minutes or 
more after vaginal delivery 
and always manual if C/S 
delivery 
4=Retained, if D&C or by 
scraping or curettage only 
-8 =unknown 
Categorical 
1=Spontaneous  
2=Expressed or assisted 
3=Manual, if 30 minutes or 
more after vaginal delivery 
and always manual if C/S 
delivery 
4=Retained, if D&C or by 
scraping or curettage only 
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Figure 3.1: Flow chart illustrating the process by which the study population was 
obtained for Objective 1 
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Figure 3.2: Flow chart illustrating the process by which the study population was 
obtained for Objective 2 
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CHAPTER 4: POPULATION BASED PLACENTAL WEIGHT RATIO 
DISTRIBUTIONS 
4.1 Introduction 
Placental weight is the most common way to characterize placental growth, and it 
is a summary of many dimensions of placental growth. The placental weight 
measurement includes the laterally expanding growth of the chorionic disc and 
arborization of the villous and vascular nutrient exchange surface, which is reflected in 
the increasing thickness of the chorionic disk. The expansion of the chorionic plate, 
beginning early in pregnancy, is the principle determinant of placenta transfer capacity to 
facilitate the genetic growth potential of the conceptus.
1
 
 
Fetal growth depends on placental growth. Fetal growth restriction (FGR) is the 
failure of a fetus to reach his/her biological growth potential, most probably due to a 
pathological slow down in the fetal growth rate. Small birth weight for gestational age 
(SGA) is widely used as a statistical indicator of FGR, since FGR is not measurable. 
SGA is defined as birth weight < 10
th
 percentile for gestational age and sex based on a 
population standard.
2
 Placental weight is lower in SGA infants than in average for 
gestational age (AGA) and large for gestational age infants (LGA).
3,45
 
 
The placental weight ratio (PWR) is a common measure of the balance between 
placental and fetal growth. The PWR is defined as the placental weight divided by the 
birth weight, and decreases across gestation as the placental growth slows and fetal 
growth accelerates.
6 
Placental hypertrophy and reduced fetal growth have been postulated 
to be an adaptation to maintain placental function in pregnant women with complications 
such as malnutrition.
7
 If this is true, a pregnancy with impaired fetal growth, resulting in 
a SGA infant, should have an increased PWR compared to those infants who are AGA or 
LGA.
1,8
  
 
Placental weight and the PWR have been found to be predictive of maternal 
disease, obstetric outcome, perinatal morbidity and mortality, childhood growth and 
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development, and fetal origins of adult disease.
9–14
 While percentile curves for birth 
weight are available for a variety of jurisdictions and populations, percentile curves for 
the PWR are not. Thompson et al.
15
 created birth weight to placental weight ratio curves 
using the Norwegian Birth Registry with all singleton live births in Norway from January 
1999 to December 2002 (n= 198, 971). These curves were a significant contribution to 
the literature. Further, no population curves to date have looked at the differences 
between SGA and LGA across gestational age. Searching the available literature, we 
found only one other set of PWR percentile curves in a Canadian population.
6 However, 
the sample size was small (n=20,309). Also, previous studies that have looked at atypical 
PWRs have not used a population standard to identify abnormal PWRs.16–18  
 
 If the pattern of placental growth is associated with differences in the efficiency 
of placental function, and therefore fetal growth, as reflected in the PWR, this may have 
physiological implications. Therefore, it would be useful to have standardized curves in 
order to ascertain normal from abnormal PWR. Accordingly, the first objective of this 
study was to develop standard curves for the PWR across gestational ages in a 
population-based birth cohort. Since literature evidence suggests that placental weights 
differ between SGA, AGA and LGA infants, a second objective was to examine this in 
order to refine the potential applications of the PWR trajectories. Having the knowledge 
of the expected norms of PWR will provide a useful standard for further research. 
 
4.2 Methods 
The study included all singleton births from St. Joseph’s Health Care and Victoria 
Hospital in London, Ontario between April 1, 2001 and March 31, 2011. The perinatal 
database provides targeted information on all births occurring at the hospitals. Anomalies 
(n=881), still births (n=422), and multiple gestations (n=2876) were excluded from the 
analyses. All remaining singletons were included (n=41,441). 
 
Data in the database were entered from the medical chart, delivery records, and 
neonatal records by a dedicated research assistant. Placentas and infants were weighed by 
nursing assistants with an electronic weight scale. Placentas were weighed with 
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membranes and umbilical cord, including the segment of cord used for cord blood 
sampling. No attempt was made to remove placental blood before weighing. Placental 
weight was not collected at both hospitals for the entire duration of the study therefore, 
there were 13,084 missing values. Missingness for categorical variables is outlined in 
Appendix L.  
 
Gestational ages of births recorded in the database ranged from 20 to 44 weeks, 
but only births between 22 and 42 weeks gestation were included in the analyses. 
Gestational age was truncated to the number of completed weeks based on the 
recommendations from World Health Organization and International Classification for 
Disease, and was based on ultrasound or last menstrual period. Birth weight was 
categorized into SGA, AGA and LGA based on Kramer standards.
19
 
Descriptive analyses were performed on all study variables. Implausible values 
and potential errors were excluded from the analyses. Birth weights above or below the 
mean by three SD’s were removed from the analyses. Placental weights that were ≤100 g 
or ≥2500g were also excluded from the analyses. Maternal age, maternal height and pre-
pregnancy weight were all trimmed at the 1
st
 and 99
th
 percentiles to remove any 
erroneous values. Any unknown or ambiguous sexes were also excluded from the 
analyses. 
Placental and birth weight distribution curves, and PWR curves, by gestational 
age were produced stratified by sex. Initially, estimates were restricted to the population 
who reside in London-Middlesex excluding regional referrals from outside London-
Middlesex. This sample, hereinafter referred to as the “city-wide” sample, would be 
expected to produce estimates with high internal validity because they represent a “whole 
population” perspective. A second analysis was done in which PWR curves were 
estimated for the entire sample of births, including referrals from outside London-
Middlesex. Inclusion of the referrals would be necessary for later analyses, stratified by 
fetal size, in order to produce adequate sample sizes at lower gestational ages. The city-
wide PWR distributions were compared to the PWR distributions inclusive of referrals in 
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order to assess their similarity. Finally, the latter sample was used to create PWR 
distribution curves separately for SGA, AGA and LGA infants, again stratified by sex.  
Following the Center for Disease Control and Prevention standards, we created 
growth charts at the 3
rd
, 5
th
, 10
th
, 25
th
, 50
th
, 75
th
, 90
th
, 95
th
 and 97
th
 percentiles. We used 
parametric quantile regression with quadratic terms on gestational age. Non-parametric 
quantile regression was used for the placental and birth weight distributions, but 
quadratic splines at 22, 32 and 42 weeks gestation were used as opposed to a quadratic 
term for gestational age. Quantile regression does not impose any parametric assumptions 
on the response distributions which make it appropriate for the anthropometric 
measures.
20
 Due to the large sample size, the interior point algorithm was used,
21
 and 
resampling was performed using the Markov chain marginal bootstrap.
22
 
4.3 Results 
The final sample were 21255 males and 20186 females (total n=41,441). Of these, 33582 
were residents of London-Middlesex while 7,859 were regional referrals. 
The characteristics of the study sample are given in Appendix L. The mean 
gestational age for the population studied was 38.8 weeks (SD=2.1 weeks), with median 
and mode, respectively, of 39 and 40 weeks gestation. The mean birth weight was 
3,398.6g (S.D=594.8g, minimum 279g, maximum 5,300g). The mean placental weight 
was 675.67g (SD=161.18, minimum 103 g, maximum 2,095g). The PWR had mean of 
0.20 (SD=0.044, minimum 0.023, maximum 1.17). There were 4,259 (7.9%) SGA 
infants, 43,697 (81.2%) AGA infants and 5,878 (10.9%) LGA infants in the study 
sample. The distributions of birth weight, placental weight and gestational age can be 
found in Appendix M.  
Placental Weight, Birth Weight and PWR Distributions  
Figures 4.1 (a) and (b) present placental weight and birth weight distributions for 
males and females, respectively. It can be seen that, because these curves are for the last 
half of gestation, placental growth has to some degree leveled off while fetal growth 
continues at an accelerated pace. PWR standards for the city-wide population are shown 
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in Tables 4.1 and 4.2. All of the percentiles reached a statistical significance of p<0.001. 
Tables 4.3 and 4.4 present the PWR standards when inclusion criteria are relaxed to 
include regional referrals in the sample. 
Comparing the city-wide population to the total sample revealed them to be 
similar, with minute differences presenting themselves at the extreme percentiles at the 
earlier gestational ages. Furthermore, comparing the 10
th
 and 90
th
 percentiles which are 
often used as cut-off points revealed almost no differences, even at the earlier gestational 
ages. The distributions of the PWR curves for the city-wide population are illustrated in 
Figures 4.2 (a) and (b). A visual presentation of the PWR curves, inclusive of regional 
referrals, for males and females are shown in Figures 4.3 (a) and (b), respectively.  
All of the percentiles reached statistical significance of p<0.001. For males, the 
median PWR is 0.1938 and the mean is 0.1994 (SD=0.0428). For females, the median 
PWR is 0.1981 and the mean is 0.2038 (SD=0.0446). The PWR decreases as gestational 
increases and there is more dispersion between the percentiles at earlier gestational ages 
than at later gestational infants.  
In general, the females have higher PWR’s than males. The slightly higher PWR 
in females than in males is consistent across percentiles. For instance, females have 
slightly higher PWRs at both the 3
rd
 and 97
th
 percentile across all gestational ages than do 
males. Using the 50
th
 percentile, the range of values between 22 and 42 weeks gestation 
is 0.2681 for females and 0.2443 for males. Therefore, there is a greater range in values at 
the mean for females. Furthermore, the ranges for these values are greatest at the highest 
percentiles. For both males and females, the ranges at the 90
th
 percentile are more than 2 
times as wide as at the 10
th
 percentile. At the 10
th
 percentile the ranges for males and 
females between 22 and 42 weeks gestation are 0.1622 and 0.1728, and the ranges at the 
90
th
 percentile for males and females are 0.3514 and 0.4667. Tables 4.3 and 4.4 show the 
exact values at each gestational age by percentile.  
Placental Weight Ratio Distribution Curves Stratified by SGA, AGA and LGA status 
 PWR distributions for the entire sample, inclusive of regional referrals, were used 
in an analysis of SGA, AGA and LGA. The proportion with PWRs <10
th
 percentile, 
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between the 10
th
 and the 90
th
 percentile and >90
th
 percentile are presented in Table 4.5. 
There are a higher proportion of SGA infants for both males and females in the extreme 
PWR groups. Furthermore, there are fewer LGA infants in the lowest PWR group. More 
detailed descriptions and graphics of the SGA and LGA PWR curves can be found in 
Appendix N with their accompanying tables and diagrams.  
 The median PWR curves for each of SGA, AGA and LGA are presented in 
Figures 4.4 (a) and (b). These show graphically how the PWR changes across gestation 
between SGA, AGA and LGA infants at the median. Specifically, they show that there is 
a greater dispersion in the PWR in SGA infants than in AGA and LGA infants, especially 
in the earlier gestational ages. When comparison is made between LGA and AGA infants 
the AGA infants show more dispersion at the earlier gestational ages than do the LGA 
infants. It can then be concluded that the dispersion at the earlier gestational ages is 
greatest in SGA infants than in both LGA and AGA infants.  
Furthermore, at the earlier gestational ages both male and female SGA infants 
have higher PWR’s than male and female AGA and LGA infants. The differences in 
PWR’s were the most pronounced at the higher percentiles and at the earlier gestational 
ages, as shown in Appendix N. SGA infants had much higher PWR’s in early gestation 
than both SGA and AGA infants at the early gestation. On the other hand, LGA infants 
have lower PWR’s at the earlier gestational ages when compared to AGA infants.  
However, the PWR’s at term gestations are nearly identical in both SGA and 
LGA infants. In fact, LGA infants have slightly higher median ratios at term than both 
SGA and AGA infants. Due to the greater dispersion at the earlier gestational ages in 
SGA infants, the ranges of PWR’s between the 22 and 42 week of gestation is higher in 
SGA infants than the AGA and LGA infants. This range difference is the greatest at the 
highest percentiles, but the range in PWR’s between 22 and 42 weeks at the lower 
percentiles is also the greatest in SGA infants. Therefore, as gestational age increases the 
PWR’s become more similar between SGA, AGA and LGA infants, yet the PWR is still 
higher in SGA infants, especially at the higher percentiles. 
AGA Placental Weight Ratio Distribution Curves 
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There are 16,994 males and 16,764 females who met the criteria for classification as 
AGA. All of the percentiles attained a significance level of p<0.001.  
Males have a median PWR of 0.1933 and a mean PWR of 0.1990 (SD=0.0424). 
Females have a median PWR of 0.1977 and a mean PWR of 0.2032 (SD=0.0441). Again, 
the PWR decreases as gestational increases and there is more dispersion between the 
percentiles at earlier gestational ages than at later gestational infants. 
Figures 4.5 (a) and (b) show the distributions graphically, and Tables 4.6 and 4.7 
provide exact PWR values for each of the aforementioned percentiles by gestational age. 
Using Tables 4.6 and 4.7, it is evident that there is a greater range in PWR’s between the 
22 and 42 weeks of gestation at the 50
th
 percentile for females than males. The range for 
males is 0.2507 and 0.2646 for females. The same pattern holds at the extreme values, 
such as the 10
th
 and 90
th
 percentiles.  
4.4 Discussion  
The results of this study contribute to the current literature by creating gender-
specific PWR percentile curves which will be a useful tool in further research. While 
PWR is an important indicator of fetal health, there are few population standards for 
comparison. Compared to the only other available set of PWR percentiles in a Canadian 
population,
6
 our results complement this literature and now provide more precise PWR 
predictions, particularly at the extreme percentiles, due to our larger sample size.  
4.4.1 Comparisons with Previous Research 
In this sample of Canadian births, the mean weight of the placentas was 675 g, 
and the mean PWR was 0.20. Comparing these results with other studies can be 
confusing because variation in methods of preparation and storage can alter mean 
placental weights.
23
 Benirschke and Kaufman estimate the mean weight of placenta at 38 
weeks gestation, without cord and membranes, as 470 g
24
; our figure for term placentas is 
675g but includes the cord and membranes after the cord was cut. The Canadian study 
that used similar sample preparation had a median placental weight of 680g for boys and 
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668g for girls. The decline in PWR with increasing gestational age seen here is similar to 
that described by many others.
23,25,26
 
Our birth weight curves differ from the Kramer et al.
27
 birth weight distributions 
in that our birth weights are somewhat larger. Our population includes more recent data 
and it has been demonstrated that, generally birth weights are increasing.
28
 This might be 
expected since we use more recent data and birth weight is increasing over time due to 
increases in maternal anthropometry, reduced cigarette smoking, and changes in 
sociodemographic factors.
28
 Also, Kramer’s curves did not include the Ontario 
population due to poor data quality
27
; therefore, the characteristics of the study 
populations are different.  
Searching the available literature, we came across a small number of studies that 
present the relation between placenta weight to birth weight and only two of these 
reported percentiles curves for the PWR.
6,15
 Thompson et al.
15
 reported placental 
percentile curves for a Norwegian population, and Almog et al.
6
 presented PWR curves 
for a Canadian population. Comparison of our results that include regional referrals with 
Almog’s Canadian standards reveals close resemblance between the two populations, 
such as median 40 week PWRs (0.1938 and 0.19 for males and 0.1981 and 0.20 for 
females respectively). The differences between PWRs for males and females, which 
repeat in both studies as well as ours, may reflect different metabolic programming 
between the sexes. Dombrowski et el.
25
 published data on placental weight and placental 
to birth weight ratio in North American population. However, their study is based on data 
from 1984 to 1991, over two decades ago, and contained data mostly a black population 
(81.4%), so the results cannot reasonably be compared. 
 
Our standards also include earlier gestational ages than both of the 
aforementioned studies. Both of the abovementioned studies have gestational age 
standards starting at 24 weeks; however, our standards provide estimates at 22 and 23 
weeks as well. Comparison of our results to Thompson’s are not possible, as he examined 
the ratio of the birth weight to the placental weight, and our results examined the inverse 
ratio. However, comparisons of our results inclusive of regional referrals to Almog’s 
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curves reveal very similar standards. Our results have slightly lower PWRs at all 
gestational ages and percentiles.
6
  
 
 The placenta and fetus follow different growth patterns during gestation.
3
 The 
placenta follows an S-shaped growth curve whereas fetal growth follows an exponential 
pattern in mid pregnancy, with most growth occurring in a linear fashion during the third 
trimester.
3
 In the earlier gestational ages the birth weight is low in comparison to the 
placental weight as a result of the higher growth rate of the placenta earlier in gestation. 
Moreover, our placental growth curves show how the majority of placental growth occurs 
before 33 weeks gestation. This accounts, at least in part, for the higher PWRs at earlier 
gestations. Previous authors have shown that the placenta responds to the interruption of 
the fetal villous circulation in the first half of gestation by initiating compensatory 
hyperplasia.
29 In conclusion, because placental growth occurs at the earlier gestational 
ages this is where the greatest differentiation of PWRs is expected to be observed.  
 
Of interest, the PWR curves are similar whether inclusive or exclusive of the 
referral population. This may be because, at earlier gestations, the vast majority of 
regional births occur in this tertiary referral center. Thus, the lower gestations represent a 
“whole population”. At later gestational ages, where one might expect the referral 
population to represent a biased sample of higher risk births, the actual numbers 
contributed by regional referrals are much smaller and thus would not substantially affect 
the percentile estimates for term and near-term births. Since the larger sample does not 
exclude regional referrals, it is not speculated to be biased.  
 
Stratification by Fetal Growth Adequacy 
 
This research is also novel in its examination of percentile curves stratified by 
fetal growth adequacy, specifically focusing upon how PWRs may change across 
gestational age between SGA, AGA and LGA infants. However, previous studies have 
indicated that overall, SGA infants have higher PWR’s,3,5 and that SGA infants have a 
higher proportion of placental weights at both extremes, but none of these studies have 
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looked at the relationships across gestation or between percentiles.
4,17,30–32
 Alternatively, 
the literature suggests that a higher proportion of LGA infants have placenta weights 
above the 90
th
 percentile and a lower share of placental weights below the 10
th
 percentile 
than SGA and AGA infants.
32
 Furthermore, PWRs have been found to be the lower in 
LGA infants than in AGA and SGA infants.
33
  
 
Our curves show that there is a greater dispersion in the PWR in SGA infants than 
in AGA and LGA infants, especially at the earlier gestational ages. As gestational age 
advances, the PWRs become more similar between SGA, AGA and LGA infants, yet the 
PWR is still higher in SGA infants. At the earlier gestational ages across all percentiles 
the SGA standards are much higher than the AGA standards. Our results agree with the 
literature, since SGA infants have higher PWRs than their AGA counterparts. The results 
go beyond what the previous literature indicates, and demonstrate how the PWR differs 
throughout gestation between SGA and AGA infants between the percentiles. The SGA 
infants with PWRs within the highest percentiles may represent the group of infants with 
failed compensation and, therefore, a high PWR. Finally, our results show that, at earlier 
gestational ages in male infants, LGA infants generally have lower PWRs than AGA 
infants. This pattern holds true across all percentiles until the 33
rd
 week of gestation, 
when the LGA and AGA standards become more similar. However, the differences 
between the LGA and AGA standards are not as pronounced as the differences between 
the SGA and AGA standards. 
 
The SGA group studied had PWRs that were generally higher than the respective 
AGA values, whereas values for infants in the LGA groups were not altered, particularly 
at term. Therefore, the SGA infant can generally be seen as under grown in relation to 
placental size, suggesting functional rather than size constraints for the placenta.  
 
Salafia et al.
1
 showed that an elevated PWR may be an indication of an inefficient 
placenta with a reduced ability to maintain fetal growth. Indeed Kingdom and 
Kaufmann
34
 report that preplacental or uteroplacental hypoxia with adaptive placental 
growth is a primary cause for growth restriction at term. However, the nonplacental 
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chorion and amnion also contribute to overall placental weight, and more so for SGA 
infants;
26
 this may also account, at least in part, for the higher PWR of infants in the SGA 
group. On the other hand, low PWR’s are indicative of an increased efficiency of the 
placentas of the smaller fetuses, whereas, high PWR’s are indicative of a potential failed 
compensation.
35–41
 Therefore, it is suggested that the PWR can be used as a predictor for 
placental functional efficiency. The literature on this subject concludes that small fetuses 
have small placentas. Based on these conclusions and the fact that our results show that 
SGA infants have a higher PWR than AGA and LGA infants, we propose that this may 
be due to a failed compensation of the placenta in SGA infants.  
 
4.4.2 Study Strengths and Limitations 
A major strength of the study is the available sample size. The perinatal database 
provided a large number of observations with matching placental weight, birth weight 
and gestational age. This allowed for the creation of accurate standards, and for the 
resulting percentile curves to be stratified by fetal growth adequacy standard. The internal 
validity of the study is strong because every birth at St. Joseph’s Hospital and Victoria 
Hospital was captured.  
 
Birth weights vary widely from country to country
27,42
 and as such it might be 
considered appropriate that birth weight percentiles should be based on data from the 
actual country or at least from a comparable country. This is often not the case and can 
lead to inappropriate use of the percentiles in a population where the distribution of birth 
weight is shifted, particularly to the left. Therefore, our results are generalizable to other 
tertiary care centers in Canada, and possibly the United States of America. Also, the 
study of placental weight at the time of delivery is a crude measure of placental growth 
and development. However, when it is collected in a routine manner and related to birth 
weight, it provides information of biological importance.  
 
4.4.3 Conclusions and Future Directions 
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These PWR distribution curves make a substantial contribution to the literature, as 
they indicate how the PWR changes across gestation by percentile for SGA, AGA and 
LGA infants. The curves that are stratified by fetal growth adequacy are the first of their 
kind. They demonstrate that PWR declines across gestation by percentile, yet distinctly, 
they further show that overall the PWRs are higher for SGA than AGA infants, and that 
the PWRs are lower for LGA infants than for AGA infants. These trends are most 
pronounced at the highest percentiles (>90
th
 percentile) and at the earlier gestational ages 
(22-28 weeks).  
The PWR distribution curves provide a standard that researchers can apply as a 
reference standard to identify infants who have abnormal PWRs. Depending on the 
purpose of the analysis, researchers may chose to use the population distribution curves 
or may use the AGA curves as their reference population. Identifying infants with high 
PWRs is important for patient care in both the short and long term. Neonates with a high 
PWR had increased incidence of low 1-minute Apgar score, require treatment for 
neonatal jaundice and infection, and respiratory complications.
43
 Furthermore, in recent 
years, birth weight, sometimes in conjunction with placental weight, has been associated 
with the development of a series of diseases later in life.
9
 These analyses have included 
birth weight, placental weight and even the PWR; however, the relative magnitude of the 
latter, in terms of percentiles, has not been previously available for all gestational ages in 
a Canadian population.  
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Table 4.1: City-Wide Male Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.2549 0.2769 0.3050 0.3714 0.4333 0.5052 0.5711 0.6556 0.7267 
23 0.2443 0.2648 0.2910 0.3520 0.4098 0.4764 0.5377 0.6142 0.6786 
24 0.2342 0.2533 0.2776 0.3335 0.3875 0.4491 0.5061 0.5750 0.6330 
25 0.2246 0.2423 0.2649 0.3161 0.3664 0.4232 0.4761 0.5380 0.5901 
26 0.2154 0.2319 0.2529 0.2995 0.3464 0.3988 0.4479 0.5033 0.5498 
27 0.2068 0.2220 0.2415 0.2839 0.3276 0.3758 0.4213 0.4707 0.5121 
28 0.1986 0.2127 0.2308 0.2693 0.3099 0.3543 0.3965 0.4404 0.4771 
29 0.1909 0.2040 0.2207 0.2557 0.2934 0.3343 0.3734 0.4123 0.4446 
30 0.1837 0.1958 0.2113 0.2430 0.2780 0.3157 0.3521 0.3863 0.4148 
31 0.1770 0.1882 0.2026 0.2313 0.2638 0.2985 0.3324 0.3626 0.3876 
32 0.1708 0.1811 0.1944 0.2205 0.2508 0.2828 0.3145 0.3411 0.3630 
33 0.1651 0.1746 0.1870 0.2107 0.2389 0.2686 0.2982 0.3218 0.3410 
34 0.1599 0.1686 0.1802 0.2018 0.2281 0.2558 0.2837 0.3047 0.3216 
35 0.1552 0.1632 0.1740 0.1940 0.2186 0.2445 0.2709 0.2898 0.3049 
36 0.1510 0.1584 0.1685 0.1870 0.2101 0.2346 0.2598 0.2771 0.2908 
37 0.1472 0.1541 0.1637 0.1811 0.2029 0.2261 0.2505 0.2667 0.2793 
38 0.1440 0.1504 0.1595 0.1761 0.1968 0.2192 0.2428 0.2584 0.2704 
39 0.1412 0.1472 0.1560 0.1720 0.1918 0.2136 0.2369 0.2524 0.2642 
40 0.1389 0.1446 0.1531 0.1689 0.1880 0.2096 0.2326 0.2485 0.2605 
41 0.1371 0.1425 0.1509 0.1668 0.1854 0.2069 0.2301 0.2469 0.2595 
42 0.1359 0.1410 0.1493 0.1656 0.1839 0.2058 0.2293 0.2474 0.2611 
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Table 4.2: City-Wide Female Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.2274 0.2668 0.3011 0.3692 0.4344 0.5427 0.5960 0.6651 0.6891 
23 0.2209 0.2565 0.2880 0.3507 0.4115 0.5101 0.5610 0.6256 0.6490 
24 0.2146 0.2466 0.2756 0.3332 0.3897 0.4792 0.5277 0.5882 0.6109 
25 0.2085 0.2372 0.2638 0.3165 0.3690 0.4499 0.4962 0.5526 0.5748 
26 0.2026 0.2282 0.2525 0.3007 0.3495 0.4224 0.4665 0.5190 0.5405 
27 0.1969 0.2196 0.2418 0.2858 0.3310 0.3966 0.4386 0.4874 0.5083 
28 0.1915 0.2115 0.2318 0.2718 0.3137 0.3724 0.4124 0.4577 0.4779 
29 0.1862 0.2038 0.2223 0.2587 0.2975 0.3500 0.3881 0.4300 0.4496 
30 0.1811 0.1965 0.2134 0.2465 0.2824 0.3292 0.3655 0.4042 0.4231 
31 0.1762 0.1897 0.2051 0.2352 0.2684 0.3102 0.3448 0.3804 0.3986 
32 0.1715 0.1833 0.1974 0.2247 0.2555 0.2929 0.3258 0.3586 0.3761 
33 0.1670 0.1773 0.1903 0.2152 0.2438 0.2772 0.3087 0.3387 0.3555 
34 0.1627 0.1718 0.1838 0.2065 0.2331 0.2633 0.2933 0.3208 0.3369 
35 0.1586 0.1667 0.1779 0.1988 0.2236 0.2510 0.2797 0.3048 0.3202 
36 0.1547 0.1620 0.1726 0.1919 0.2152 0.2404 0.2679 0.2908 0.3054 
37 0.1510 0.1578 0.1679 0.1859 0.2079 0.2316 0.2579 0.2787 0.2926 
38 0.1475 0.1540 0.1638 0.1808 0.2018 0.2244 0.2496 0.2686 0.2818 
39 0.1442 0.1506 0.1602 0.1766 0.1967 0.2190 0.2432 0.2604 0.2729 
40 0.1412 0.1476 0.1573 0.1733 0.1928 0.2152 0.2386 0.2542 0.2659 
41 0.1383 0.1451 0.1550 0.1708 0.1900 0.2131 0.2357 0.2500 0.2609 
42 0.1356 0.1431 0.1532 0.1693 0.1883 0.2127 0.2346 0.2477 0.2578 
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Table 4.3: Inclusive of Regional Referrals Male Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 
Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.2646 0.2925 0.3127 0.3685 0.4281 0.5069 0.5803 0.6849 0.7777 
23 0.2526 0.2783 0.2976 0.3495 0.4052 0.4780 0.5461 0.6405 0.7239 
24 0.2413 0.2648 0.2832 0.3314 0.3835 0.4505 0.5136 0.5985 0.6731 
25 0.2305 0.2519 0.2696 0.3142 0.3629 0.4244 0.4829 0.5589 0.6252 
26 0.2204 0.2398 0.2568 0.2980 0.3435 0.3998 0.4540 0.5216 0.5802 
27 0.2108 0.2285 0.2446 0.2827 0.3251 0.3767 0.4268 0.4867 0.5382 
28 0.2018 0.2178 0.2332 0.2684 0.3079 0.3551 0.4014 0.4541 0.4991 
29 0.1934 0.2078 0.2225 0.2549 0.2917 0.3349 0.3777 0.4240 0.4630 
30 0.1855 0.1985 0.2126 0.2425 0.2767 0.3162 0.3557 0.3961 0.4298 
31 0.1783 0.1900 0.2034 0.2309 0.2628 0.2989 0.3355 0.3707 0.3996 
32 0.1716 0.1821 0.1949 0.2203 0.2501 0.2832 0.3171 0.3476 0.3723 
33 0.1655 0.1750 0.1872 0.2106 0.2384 0.2688 0.3004 0.3269 0.3479 
34 0.1600 0.1686 0.1802 0.2019 0.2279 0.2560 0.2854 0.3086 0.3265 
35 0.1551 0.1628 0.1739 0.1941 0.2184 0.2446 0.2722 0.2926 0.3081 
36 0.1507 0.1578 0.1683 0.1872 0.2101 0.2347 0.2608 0.2790 0.2925 
37 0.1470 0.1535 0.1635 0.1813 0.2030 0.2262 0.2511 0.2678 0.2800 
38 0.1438 0.1499 0.1594 0.1763 0.1969 0.2192 0.2431 0.2590 0.2703 
39 0.1412 0.1470 0.1561 0.1722 0.1919 0.2137 0.2369 0.2525 0.2637 
40 0.1392 0.1448 0.1535 0.1691 0.1881 0.2096 0.2325 0.2483 0.2599 
41 0.1378 0.1434 0.1516 0.1669 0.1854 0.2070 0.2298 0.2466 0.2591 
42 0.1370 0.1426 0.1504 0.1657 0.1838 0.2059 0.2288 0.2472 0.2613 
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Table 4.4: Inclusive of Regional Referrals Female Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 
Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.2763 0.2886 0.3266 0.3777 0.4566 0.5596 0.7037 0.8268 0.8995 
23 0.2639 0.2759 0.3106 0.3585 0.4312 0.5252 0.6563 0.7691 0.8348 
24 0.2522 0.2637 0.2955 0.3402 0.4070 0.4926 0.6114 0.7144 0.7736 
25 0.2410 0.2522 0.2810 0.3229 0.3841 0.4618 0.5690 0.6628 0.7159 
26 0.2304 0.2412 0.2674 0.3064 0.3625 0.4327 0.5292 0.6142 0.6616 
27 0.2203 0.2308 0.2545 0.2909 0.3421 0.4055 0.4919 0.5687 0.6108 
28 0.2108 0.2209 0.2424 0.2764 0.3230 0.3801 0.4572 0.5262 0.5635 
29 0.2019 0.2117 0.2311 0.2627 0.3052 0.3564 0.4250 0.4867 0.5196 
30 0.1935 0.2030 0.2205 0.2499 0.2886 0.3346 0.3953 0.4503 0.4792 
31 0.1857 0.1949 0.2107 0.2381 0.2733 0.3145 0.3682 0.4170 0.4422 
32 0.1785 0.1873 0.2017 0.2272 0.2593 0.2963 0.3436 0.3866 0.4087 
33 0.1718 0.1804 0.1934 0.2172 0.2465 0.2798 0.3215 0.3594 0.3787 
34 0.1657 0.1740 0.1859 0.2082 0.2350 0.2651 0.3020 0.3351 0.3521 
35 0.1602 0.1681 0.1792 0.2000 0.2248 0.2523 0.2850 0.3139 0.3290 
36 0.1552 0.1629 0.1733 0.1928 0.2158 0.2412 0.2705 0.2958 0.3093 
37 0.1508 0.1582 0.1681 0.1865 0.2081 0.2319 0.2586 0.2806 0.2931 
38 0.1469 0.1541 0.1637 0.1811 0.2017 0.2244 0.2492 0.2686 0.2804 
39 0.1436 0.1506 0.1601 0.1766 0.1965 0.2187 0.2424 0.2595 0.2712 
40 0.1409 0.1477 0.1572 0.1731 0.1926 0.2148 0.2380 0.2535 0.2653 
41 0.1388 0.1453 0.1552 0.1704 0.1900 0.2127 0.2363 0.2506 0.2630 
42 0.1372 0.1435 0.1538 0.1687 0.1886 0.2124 0.2370 0.2507 0.2641 
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Table 4.5: Placenta Weight Ratio Distributions for SGA, AGA & LGA Infants based upon the Inclusive of Regional Referrals 
Standards 
Inclusive of Regional 
Referrals Standards 
Expected % Males Females 
SGA  AGA LGA SGA AGA LGA 
>90
th
 10% 13.18% 9.74% 9.82% 11.68% 9.66% 11.69% 
10-90
th
 80% 74.42% 80.22% 81.64% 77.56% 80.22% 80.14% 
<10
th
 10% 12.10% 10.04% 8.53% 10.76% 10.12% 8.16% 
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Table 4.6: Inclusive of Regional Referrals AGA Male Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 
Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.2685 0.2919 0.3167 0.3713 0.4342 0.5047 0.5832 0.6764 0.7461 
23 0.2561 0.2779 0.3013 0.3520 0.4106 0.4759 0.5483 0.6330 0.6961 
24 0.2443 0.2646 0.2865 0.3336 0.3882 0.4486 0.5152 0.5919 0.6489 
25 0.2332 0.2520 0.2725 0.3162 0.3670 0.4228 0.4839 0.5531 0.6043 
26 0.2227 0.2400 0.2593 0.2997 0.3469 0.3984 0.4544 0.5166 0.5624 
27 0.2127 0.2287 0.2468 0.2842 0.3279 0.3754 0.4268 0.4824 0.5232 
28 0.2034 0.2182 0.2351 0.2696 0.3102 0.3539 0.4009 0.4505 0.4867 
29 0.1947 0.2083 0.2241 0.2560 0.2935 0.3339 0.3769 0.4210 0.4528 
30 0.1867 0.1991 0.2139 0.2433 0.2781 0.3153 0.3547 0.3937 0.4217 
31 0.1792 0.1905 0.2045 0.2316 0.2638 0.2981 0.3343 0.3687 0.3932 
32 0.1724 0.1827 0.1958 0.2208 0.2507 0.2824 0.3157 0.3460 0.3675 
33 0.1661 0.1756 0.1878 0.2110 0.2388 0.2682 0.2989 0.3256 0.3444 
34 0.1605 0.1691 0.1806 0.2021 0.2280 0.2554 0.2839 0.3075 0.3240 
35 0.1555 0.1634 0.1742 0.1942 0.2183 0.2440 0.2707 0.2917 0.3063 
36 0.1511 0.1583 0.1685 0.1872 0.2099 0.2341 0.2594 0.2781 0.2913 
37 0.1473 0.1539 0.1636 0.1812 0.2026 0.2257 0.2499 0.2669 0.2789 
38 0.1442 0.1502 0.1594 0.1761 0.1965 0.2186 0.2421 0.2580 0.2693 
39 0.1416 0.1472 0.1560 0.1719 0.1915 0.2131 0.2362 0.2514 0.2623 
40 0.1397 0.1449 0.1534 0.1688 0.1877 0.2090 0.2321 0.2471 0.2581 
41 0.1384 0.1432 0.1514 0.1665 0.1850 0.2063 0.2299 0.2451 0.2565 
42 0.1377 0.1423 0.1503 0.1653 0.1836 0.2051 0.2294 0.2454 0.2576 
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Table 4.7: Inclusive of Regional Referrals AGA Female Placental Weight Ratios by Gestational Age for the 3
rd
 through the 
97
th
 Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.2763 0.2848 0.3235 0.3729 0.4526 0.5495 0.7036 0.7643 0.8835 
23 0.2639 0.2726 0.3078 0.3542 0.4276 0.5160 0.6562 0.7136 0.8207 
24 0.2522 0.2609 0.2929 0.3365 0.4040 0.4843 0.6114 0.6654 0.7612 
25 0.2410 0.2497 0.2787 0.3196 0.3815 0.4544 0.5690 0.6200 0.7050 
26 0.2304 0.2391 0.2653 0.3037 0.3603 0.4262 0.5292 0.5771 0.6522 
27 0.2203 0.2291 0.2526 0.2886 0.3403 0.3997 0.4919 0.5368 0.6027 
28 0.2108 0.2195 0.2407 0.2744 0.3215 0.3749 0.4572 0.4992 0.5566 
29 0.2019 0.2106 0.2295 0.2610 0.3040 0.3520 0.4249 0.4642 0.5138 
30 0.1935 0.2021 0.2192 0.2486 0.2877 0.3307 0.3952 0.4319 0.4744 
31 0.1857 0.1942 0.2095 0.2371 0.2726 0.3112 0.3680 0.4022 0.4383 
32 0.1785 0.1869 0.2007 0.2264 0.2587 0.2934 0.3434 0.3750 0.4055 
33 0.1718 0.1801 0.1926 0.2166 0.2461 0.2774 0.3212 0.3506 0.3761 
34 0.1657 0.1738 0.1852 0.2077 0.2347 0.2632 0.3016 0.3287 0.3501 
35 0.1602 0.1681 0.1786 0.1997 0.2246 0.2506 0.2845 0.3095 0.3273 
36 0.1552 0.1629 0.1728 0.1926 0.2157 0.2398 0.2699 0.2929 0.3080 
37 0.1508 0.1583 0.1677 0.1863 0.2080 0.2308 0.2579 0.2789 0.2919 
38 0.1469 0.1542 0.1634 0.1810 0.2015 0.2235 0.2484 0.2676 0.2792 
39 0.1436 0.1506 0.1599 0.1765 0.1963 0.2180 0.2413 0.2588 0.2699 
40 0.1409 0.1476 0.1571 0.1729 0.1923 0.2142 0.2369 0.2527 0.2638 
41 0.1388 0.1451 0.1551 0.1702 0.1895 0.2121 0.2349 0.2493 0.2612 
42 0.1372 0.1432 0.1538 0.1684 0.1880 0.2118 0.2355 0.2484 0.2618 
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Figure 4.1: City-Wide Placenta and Birth Weight Percentile Distributions by Gestational 
Age 
A) Males 
 
B) Females 
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Figure 4.2: City-wide Placental Weight Ratio Distributions by Gestational age 
A) Males 
 
B) Females 
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Figure 4.3: Inclusive of Regional Referrals Placental Weight Ratio Distributions by 
Gestational Age  
A) Males 
 
B) Females 
 
 
 
 
 
 
120 
 
 
 
Figure 4.4: Inclusive of Regional Referrals SGA, AGA and LGA Median Placental 
Weight Ratio Distributions by Gestational Age 
A) Males 
 
B) Females 
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Figure 4.5: Inclusive of Regional Referrals AGA Placental Weight Ratio Distributions 
by Gestational Age 
A) Males 
 
B) Females 
 
 
122 
 
 
 
CHAPTER 5: DETERMINANTS OF PLACENTAL WEIGHT RATIOS 
 
5.1. Introduction  
 
The placental weight ratio (PWR) is a measure of the balance between fetal and 
placental growth. The PWR is defined as the placental weight divided by the birth 
weight, and it decreases across gestation as the placenta matures, concurrent with 
increased transport capacity and corresponding increases in fetal weight.
4
 Recent reports 
indicate that placental weight and the PWR are predictive of maternal disease, obstetric 
outcome, perinatal morbidity and mortality, and childhood growth and development.
1–6
 
 
It is postulated that in situations involving complications such as preeclampsia, a 
disproportionally large placental indicative of placental hypertrophy occurs and have 
been postulated to be an adaptation to maintain placental function, though the adaptation 
is insufficient and fetal growth is impacted. If this is true, a pregnancy with impaired fetal 
growth, resulting in a small for gestational age (SGA) infant, should have an increased 
PWR compared to those infants who are appropriate for gestational age (AGA) or large 
for gestational age (LGA).
5,6
 However, other maternal factors and pregnancy 
complications can also alter the PWR, but have been minimally studied in the 
epidemiologic literature.  
 
Therefore, the relationship of the PWR to maternal baseline factors and pregnancy 
complications needs to be explored. Preeclampsia, intrauterine growth restriction 
(IUGR), and placental abruption, conditions that constitute ischemic placental disease 
(IPD), have been shown to exert their effects differently in term infants than in preterm 
infants, potentially resulting from different pathophysiological mechanisms.
7
 Therefore, 
the purpose of this large-scale population study is to evaluate the various risk factors 
associated with atypical PWRs in (a) term infants, (b) infants born between 32 and 37 
weeks gestation and (c) infants born between 21 and 33 weeks gestation.  
 
5.2. Methods 
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The study included all singleton births from St. Joseph’s Health Care and Victoria 
Hospital in London, Ontario between June 1, 2006 and March 31, 2011. The time 
window was selected based on a start date for which all of the covariates of interest were 
collected in the database. The perinatal database provides specific information on all 
births occurring at the hospitals. The data are prospectively entered from the medical 
chart, delivery records, and neonatal records by a committed research assistant. For the 
time window examined in the present study, the sample available was after exclusion of 
congenital anomalies (n=414), stillbirths (n=193), and multiple gestations (n=1,374), as 
well as exclusion of those for whom placental weight was missing (n=4,812). The latter 
occurred because placental weight was not collected at both hospitals for the entire 
duration of the study window. Gestational ages of births recorded in the database ranged 
from 20 to 44 weeks, but only births between 22 and 42 weeks gestation were included in 
the analyses.  
 
Placentas and infants were weighed by nursing assistants with an electronic 
weight scale immediately after delivery. The placentas were weighed with the 
membranes and umbilical cord, including the segment of cord used for cord blood 
sampling, and no attempt was made to remove placental blood before weighing.  
 
Descriptive analyses were carried out on all study variables. Implausible values 
and potential errors were excluded from the analyses. Birth weights above or below the 
mean by three SD’s were removed from the analyses. Placental weights that were ≤100 g 
or ≥2500g were also excluded from the analyses. Maternal age, maternal height and pre-
pregnancy weight were all trimmed at the 1
st
 and 99
th
 percentiles to remove any 
erroneous values. Any unknown or ambiguous sexes were also excluded. For analysis, 
gestational age was truncated to the number of completed weeks based on the 
recommendations from World Health Organization and International Classification for 
Disease, and was based on ultrasound or last menstrual period. Birth weight was 
categorized into SGA, AGA and LGA based on Kramer standards.
8
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Univariable and multivariable analyses were stratified by gestational age 
categories of ≥ 37 weeks, 32-37 weeks and <32 weeks. This stratification was based on 
both conceptual and statistical grounds, since research has identified different risk factors 
for placental and fetal growth disturbances at different gestational ages. Thus, 
stratification will provide more meaningful information on how various risk factors 
influence both placental and fetal growth, as captured in the PWR, at different points in 
gestation. Statistically it was anticipated that there would therefore be interaction between 
factors influencing PWR and gestational age category. Stratification provides an 
opportunity to evaluate this interaction within clinically meaningful gestational age 
categories.  
   
Multivariable analysis of the factors associated with a PWR <10
th
 percentile or 
>90
th
 percentile was carried out using multinomial logistic regression with chunked entry 
of variables entered in order of temporality, based on a hypothesized conceptual model. 
During the model building process, variable pruning was conducted using p-to-remove of 
<0.20. For the final model, this was adjusted to p<0.05. PWR between the 10
th
 and 90
th
 
percentile was the reference group. The chunks were: baseline variables (parity, smoking 
status, maternal asthma, age, BMI, maternal height); mid-pregnancy variables 
(gestational diabetes, preeclampsia); placental and cord complication variables (placental 
previa and abruption, cord complications); and late pregnancy and postpartum variables 
(gestational weight gain, birth weight category, anaemia, placental delivery).  
 
5.3. Results  
 
The final sample were 10,404 males and 9,812 females (total n=20216). The 
mean gestational age for the population studied was 38.8 weeks (SD=2.1 weeks). There 
were 17,838(80.44%) infants with PWRs between the 10
th
 and 90
th
 percentile, 2,084 
(9.40%) infants with PWRs ≤10th percentile, and 2,253 (10.16%) of infants with PWRs 
≥90th percentile. Infants with a PWR between the 10th and the 90th percentile were the 
reference category for all of the analyses. 
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  The mean age for participants was 29 years and the mean height is 64.8 inches. 
Approximately 18% of the population smoked, 3.0% had preeclampsia, 3.5% had 
anaemia before delivery, 4.1% had gestational diabetes, 30% had an underweight pre-
pregnancy BMI, 13% had an overweight BMI and 9% had an obese pre-pregnancy BMI, 
and 31% had some form of an umbilical cord complication. The distributions of these 
risk factors by gestational age category are outlined in Table 5.1.  
 
Two of the key covariates that showed an association with an atypical PWR, were 
smoking and preeclampsia. These two factors were tested to determine if they had 
significant interactions with gestational age category. At a significance level of p<0.05, 
both smoking and preeclampsia had significant interactions with gestational age category. 
The results of the interactions can be found in Appendix O. 
 
The results of the univariable and multivariable regression are presented in Tables 5.2 
and 5.3 respectively by gestational age category. The results outlining each model in the 
model building process can be found in Appendix P.  
  
For infants born at ≥37 weeks gestation, factors associated with a reduced risk of 
PWR<10
th
 percentile were: multiparity, smoking, abnormal BMI, gestational diabetes, an 
umbilical cord around the neck or body, a knot in the cord, or a prolapsed or lacerated 
cord, and being LGA. Factors associated with an increased risk of PWR<10
th
 percentile 
were: a short, 2-vessel or velamentous umbilical cord insertion, SGA infants, and any 
assisted placental delivery methods increased the odds of a PWR <10
th
 percentile. 
Conversely, the risk of PWR >90
th
 percentile was higher for: multiparity, smoking, 
abnormal BMI, preeclampsia, placental abruption, a cord around the neck or body, a knot 
in the cord, or a prolapsed or lacerated cord, both SGA and LGA infants and maternal 
anaemia. Findings that were significant in the univariable, but fell out of statistical 
significance when controlled for other factors in the multivariable model was increased 
effect of a PWR<10
th
 percentile that resulted from increasing maternal height. Finally, 
maternal age <21 year of age increased the odds of a PWR >90
th
 percentile in the 
univariable, but was no longer significant in the multivariable.  
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For infants born between 32 and 37 weeks gestation, multiparity attenuated the 
odds of a PWR <10
th
 percentile. Alternatively, factors associated with all increased the 
odds of a PWR >90
th
 percentile were: multiparity, smoking, preeclampsia, placental 
abruption, a cord around the neck or body, a knot in the cord, or a prolapsed or lacerated 
cord, a short, 2-vessel or velamentous umbilical cord insertion, and maternal anaemia.  
 
Turning attention to the infants born at ≤32 weeks gestation, factors associated 
with attenuated odds of a PWR<10
th
 percentile were: multiparity, placental abruption, 
and manual placental delivery. Conversely, factors associated with increased odds of a 
PWR<10
th
 percentiles were: increasing maternal height, short, 2-vessel or velamentous 
umbilical cord insertion and retained placental delivery. Multiparity, increasing maternal 
height and placental previa all increased the odds of a PWR >90
th
 percentile. A finding 
that was significant in the multivariable but fell out of significance in the univariable was 
preeclampsia’s effect on increasing the odds of a PWR <10th percentile  
 
5.4 Discussion 
5.4.1 Main Findings and Implications 
 
The results will be presented in the context of preplacental, uteroplacental, postplacental, 
and carbon monoxide hypoxia, as well as IPD, umbilical cord and placental 
complications and key baseline characteristics, for the discussion.  
 
Baseline Factors 
 
The majority of the baseline factors were associated with a hypertrophic growth 
response of the placenta in relation to birth weight.  
 
High BMI has been identified as predictor of a higher PWR by some 
investigators,
9–11
 but an elevated ratio has not been previously associated with an 
underweight BMI group.
12
 We found that the PWRs are elevated at BMIs both above and 
127 
 
 
 
below the normal BMI range in term infants. Physiological research shows that maternal 
body compositions are associated with changes in the ability of the placenta to transfer 
maternal nutrients to the fetoplacental compartment through increases in the placental 
System A amino acid transporter. Furthermore, System A activity was found to be higher 
in placentas which were large in relation to birth weight.
13
 Increased awareness on the 
importance of health pre-pregnancy weight, and thereby infants at high risk for elevated 
PWRs, would have implications for the health care system, the health of the mother and 
the health of the child.  
 
The literature shows that a positive association exists both between placental 
weight
9,14,15
 and birth weight with parity. 
16
 Our results indicate that throughout all 
gestational age categories, being multiparous increases the odds of having a PWR≥90th 
percentile, and the effect is most pronounced in the infants born at ≤32 weeks. The 
physiological role of the placenta in mediating the effects of parity needs further 
investigation.  
 
Results are divided on the proposed association between maternal age and 
placental weight.
14,17
 However, SGA is the most common among pregnancies at both 
extremes of reproductive bearing age.
18,19
 Increasing maternal height is associated with 
both an increased odds of a PWR ≥90th and a PWR ≤10th percentile in infants born at the 
earliest gestational ages. Height is an non-modifiable characteristic due to its genetic 
contribution.
20
 Other studies have looked at the effect of maternal height on both birth 
and placental weight, and have found a positive association
9,22
; yet, no other study to 
date, that we are aware of, has examined the relationship between maternal height and the 
PWR.  
 
Ischemic Placental Disease 
 
IPD has been shown to exert its effects differently in term and preterm infants
7,23
. 
Ananth et al.
23
 have shown that among infants with IPD the frequency of SGA is higher 
in term than in preterm infants. Interestingly, SGA was only significantly associated with 
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atypical PWRs in term infants. Ananth et al.
23
 have also shown that IPD in preterm birth 
is more likely to include the mother and the fetus through not only SGA, but also the 
addition of preeclampsia and placental abruption. Preeclampsia and placental abruption 
share a significant number of risk factors which supports the proposed common 
underlying pathophysiology.
24
 Our results have shown that preeclampsia and placental 
abruption increase the odds of a PWR ≥90th percentile in the highest two gestational age 
categories. Moreover, the effect of placental abruption and preeclampsia in infants born 
between 32 and 37 weeks on a PWR ≥90th percentile is slightly increased compared to 
term infants.  
 
Preplacental Hypoxia 
 
Preplacental hypoxia, a reduction in maternal blood oxygen content, occurs when 
the placenta and fetus become hypoxic due to conditions such as maternal asthma and 
maternal anaemia.
25
 Many researchers have noted that placentas tend to be heavy in 
pregnancies complicated by both severe and mild maternal anaemia, with the fetus often 
being small, and therefore the PWR increased.
14,22,26–29
 In term infants, maternal anaemia, 
were associated with amplified odds of having a PWR≥90th percentile. The increased size 
of the placenta has been understood as a compensatory mechanism to overcome the lack 
of oxygen in the maternal blood, as well as the increased trophoblastic proliferation and 
placental angiogenesis that results from anaemia.
30
 In response to the lack of oxygen, the 
extravillous trophoblast of the placenta bed shows an increased depth of invasion and the 
villi appear hypercapillarized.
31
 
 
Uteroplacental Hypoxia 
 
Uteroplacental hypoxia occurs when normally oxygenated maternal blood has 
restricted entry into the uteroplacental tissues due to either occlusion or failed trophoblast 
invasion of the uteroplacental arterioles. Uteroplacental hypoxia represents late onset 
growth restriction with preserved end diastolic flow volume, and term preeclampsia.
25
 
Both low and high placental weight has been shown to be associated with term 
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preeclampsia.
32
 Our results exhibit that individuals with preeclampsia who deliver an 
infant at term have increased odds of a PWR ≥90th percentile. These results are congruent 
with current literature which shows that the PWR is often increased in pregnancies that 
are complicated with preeclampsia.
33,34
 This suggests that there is compensatory growth 
of placental villi in an attempt to overcome an unfavourable maternal environment.
35,36
 
However, our results do not show increased odds for having a PWR ≤10th percentile, 
thereby indicating a potentially smaller placenta. This may be the result of, at least in 
part, that we do not have the timing of diagnosis for preeclampsia. Nevertheless, it has 
been suggested that the majority of pregnancies with preterm preeclampsia do result in a 
preterm delivery.
37
  
 
It has been found that low placental weight is strongly associated with preterm 
preeclampsia.
32,38
 Interestingly, in the univariable analysis preeclampsia’s effects in terms 
infants showed a protective effect on having a PWR≤10th percentile and a strengthened 
effect on having a PWR≥90th percentile. On the other hand, infants born between 32 and 
37 weeks only had increased odds of having a PWR≥90th but were not significantly 
protected against a PWR≤10th. Finally, in infants born at ≤32 weeks both the odds of 
having a PWR≥90th and ≤10th were increased, but they were only significantly increased 
for having a PWR≤10th. Therefore, the direction of the effect changed as the pregnancy 
progressed. This may represent the two different forms of preeclampsia that have been 
proposed.
39
 However, these effects fell out of significance in the multivariable analysis.  
 
Postplacental Hypoxia 
 
Postplacental hypoxia is when oxygenated maternal blood enters the intervillous 
space at a normal or reduced rate, but a defect in fetoplacental perfusion prevents the 
fetus from receiving sufficient oxygen.
25
 We had focused the discussion of postplacental 
hypoxia on gestational diabetes, as it is the only risk factor with this hypoxia type 
available in the database. Placental adaptations in mothers with pre-gestational diabetes 
resemble those adaptations seen in other postplacental hypoxia conditions. It has been 
noted by several authors that the placentas from women with gestational diabetes often 
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weigh more.
40–45
 However, the literature is inconclusive on the effect of gestational 
diabetes on the PWR.
41,46
 In our  highest gestational age categories, gestational diabetes 
was associated with increased odds of a PWR ≥90th and protective against a PWR ≤10th 
percentile. Increased levels of haemoglobin and erythropoietin provide evidence that 
fetuses in mothers with pre-diabetes are hypoxic. The literature proposes that the surface 
and exchange areas are enlarged as a result of the hypoproliferation and 
hypervascularization in gestational diabetes.
47
 Therefore, the maternal placental oxygen 
supply is reduced, and the fetal oxygen demand is increased.
48,49
 This phenomenon could 
be explained by aerobic metabolism which is stimulated by fetal hypersinsulinemia 
which can result in reduced trophoblast proliferation. The low oxygen levels up regulate 
transcriptional synthesis of leptin, VEGF and fibroblast growth factor which promotes 
placental endothelial cell proliferation. The result is enhanced vascularisation of the 
placenta.
50,51
 
 
Carbon Monoxide Hypoxia 
 
Maternal smoking presents itself as carbon monoxide hypoxia. While this seems 
similar to preplacental hypoxia, and the changes in fetal capillaries and peripheral villi do 
reflect the effects in preplacental hypoxia, the morphology and oxygen diffusion 
conductance’s are not mirrored.52,53 Cigarette smoking is associated with a decreased 
fetal weight. The few studies that have looked at maternal smoking and placental weight 
have found conflicting results,
14,54–58
 as are the results on the role of smoking on the 
PWR.
9,54,56
 Our results indicate that in term infants and infants born between 32 and 37 
weeks gestation, smoking increases the odds of having a PWR ≥90th percentile and 
attenuates the odds of having a PWR ≤10th percentile. When a mother smokes during 
pregnancy, the placenta and fetus become hypoxic because of a reduction of oxygen 
content within the maternal blood along with an increased vascular resistance on the fetal 
side of the placenta. These conditions result in reduced intraplacental oxygen content, 
predominately branching angiogenesis and reduced vascular impedance. The increase in 
branching angiogenesis and thereby reduced vascular impedance is an adaptive 
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mechanism to the hypoxic state. This mechanism is associated with excessive placental 
weight.
59
  
 
The number of women who smoke during pregnancy is high despite current 
recommendations for mothers to quit. Targeting women who smoke during pregnancy 
and aiding them in quitting may be an effective strategy to reduce decreases in birth 
weight accompanied by increases in placental weight.  
 
Placental and Umbilical Cord Complications 
 
Any type of force that compresses umbilical cords may lead to diminished blood 
flow in umbilical vessels and subsequent fetal hypoxia or circulatory compromise. 
Mechanical cord compression can be caused by cord entanglements and cord prolapse, or 
it may occur from an abnormal configuration of the cord such as true knots, hypercoiling, 
abnormally short or long cords, abnormal cord insertions, or strictures.
60
 These 
complications are often associated with decreased fetal weight, and both marginal and 
velamentous cord insertion are associated with an increased placental weight and reduced 
metabolic efficiency.
61–63
 In addition, a single umbilical artery is also associated with a 
reduced placental weight.
61
 Furthermore, abnormal cord insertion has also been found to 
be associated with a high PWR.
64
 Our results show that a short, 2-vessel or velamentous 
cord insertion are associated with increased odds of a PWR ≥90th percentile in infants 
born between 32 and 37 weeks, and increased odds of a PWR ≤10th percentile in terms 
infants and infants born ≤32 weeks. On the other hand, a cord around the neck or body, 
knot in the cord, prolapsed or lacerated cord is also associated with a PWR ≥90th 
percentile in all infants born at >32 weeks.  
 
Literature on this topic indicates that some placental factors, such as placenta 
abruption, placenta previa and antepartum hemorrhage are not individually associated 
with placental weight,
61
 but as a group are associated with a decreased PWR.
12
 Our 
results partially disagree with these findings. We found no association between placental 
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previa and the PWR, but we did note that placental abruption strengthened the odds of 
having a PWR ≥90th percentile.  
 
5.4.2 Strengths and Limitations 
 
The perinatal database has a number of attributes, which prompted its use in this 
study. A major strength of the study is the available sample size. This study is strong due 
to the quality and comprehensive nature of the data. The internal validity of the study is 
strong because every birth at St. Joseph’s Hospital and Victoria Hospital was captured. 
The results will be important for both obstetricians and neonatologists managing high-
risk pregnancies and infants with extreme birth and placental weights.  
 
This research is novel in its ability to combine the proposed physiological 
mechanisms along with a theoretic framework to examine the relationships between 
various risk factors and their associations with atypical PWRs. The strong theoretical 
framework, based on biologically plausible mechanistic literature, combined with 
epidemiological literature provides a strong base for this study. This approach also allows 
the complexity of the relationships that exist between factors to be conserved and 
provides an understanding of how these factors relate within this population. 
 
Like other studies that use administrative databases, this study was unable to 
assess a few covariates that may influence the PWR such as residing at high altitude and 
ethnicity. Future studies which can incorporate this information may be useful. However, 
residing at high altitude is a form of preplacental hypoxia which was evaluated by other 
variables, and is not believed to be a variable of great significance for many women 
living in the region. Ethnicity has been shown to influence the PWR in previous studies, 
but the effect was small.
11,14
 
 
We were limited by the data available in the database, so the available variables 
are categorized into their respective sections in the discussion. However, we did not have 
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uterine artery Doppler’s or timing of preeclampsia, so we speculated based on the scope 
of our data.  
 
Height and weight data contributing to the calculation for pre-pregnancy came 
from variable sources, including self-report, therefore misreporting may have influenced 
the accuracy of BMI. We speculate it may have produced an underestimate in BMI. The 
situation is similar for smoking because women sometimes fail to report such behaviours.  
 
Although quality control measures are in place, human error was expected. Any 
missing data however was expected to be missing completely at random. A more detailed 
description of missing data with regards to placental weight can be found in Appendix Q.  
 
5.4.3 Conclusions and Future Directions 
 
Our results propose that adverse obstetric conditions are associated with either 
placental growth restriction or placental hypertrophy in relation to birth weight, and even 
both, based on gestational age at delivery. The majority of the risk factors assessed 
resulted in increased odds of a PWR ≥90th percentile. This suggests that the placenta may 
have particular compensatory responses to maternal obstetric conditions, each with a 
distinct pathophysiologic mechanism, but similar PWR outcome. Further research is 
justified to elucidate the biological mechanisms underlying the associations between 
anemia, gestational diabetes, hypertensive disease, maternal pre-pregnancy BMI, and 
umbilical cord complications with abnormal placental growth relative to fetal growth.  
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Table 5.1: Descriptive Statistics of Risk Factors by Gestational Age Category  
 
Predictor Variables (Binary/Categorical) ≥37 Weeks 
Gestation 
Between 32-37 
Weeks Gestation 
≤32 Weeks 
Gestation 
TOTAL  24713 1370 987 
Parity 0 
 
≥1 
10808(43.74%) 
 
13902(56.26%) 
651(47.52%) 
 
719(52.48%) 
305(56.80%) 
 
232(43.20%) 
Smoking during 
Pregnancy 
No 
 
Yes  
20357(82.38%) 
 
4354(17.62%) 
1046(76.35%) 
 
324(23.65%) 
412(76.72%) 
 
125(23.28%) 
Maternal Asthma No 
 
Yes 
23648(95.69%) 
 
1065(4.31%) 
1284(93.72%) 
 
86(6.28%) 
494(91.99%) 
 
43(8.01%) 
Maternal Age <21 years 
 
21-34 years 
 
>34 years 
2166(9.01%) 
 
18150(75.51%) 
 
3719(15.47%) 
129(9.66%) 
 
970(72.66%) 
 
236(17.68%) 
51(9.85%) 
 
384(74.13%) 
 
83(16.02%) 
Pre-Pregnancy 
Body Mass Index 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
7417(30.01%) 
 
11724(47.44%) 
 
3331(13.48%) 
 
2241(9.07%) 
385(28.10%) 
 
695(50.73%) 
 
169(12.34%) 
 
121(8.83%) 
154(28.68%) 
 
259(48.23%) 
 
60(11.17%) 
 
64(11.92%) 
Gestational 
Diabetes 
No 
 
Yes 
23742(96.07%) 
 
971(3.93%) 
1291(94.23%) 
 
79(5.77%) 
507(94.41%) 
 
30(5.59%) 
Preeclampsia No 
 
Preeclampsia 
24180(97.87%) 
 
526(2.13%) 
1216(88.95%) 
 
151(11.05%) 
427(79.52%) 
 
110(20.48%) 
Placenta Previa No 
 
Yes 
24590(99.50%) 
 
123(0.50%) 
1323(96.57%) 
 
47(3.43%) 
512(95.34%) 
 
25(4.66%) 
Placental 
Abruption 
No 
 
Yes 
24461(98.98%) 
 
252(1.02%) 
1280(93.43%) 
 
90(6.57%) 
408(75.98%) 
 
129(24.02%) 
Umbilical Cord 
Complication 
No 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
Short, 2-vessel or 
velamentous cord 
16979(68.70%) 
 
7490(30.31%) 
 
 
 
 
 
244(0.99%) 
418(30.51%) 
 
927(67.66%) 
 
 
 
 
 
25(1.82%) 
396(73.74%) 
 
129(24.02 %) 
 
 
 
 
 
12(2.23%) 
Gestational 
Weight Gain 
Normal  
<10lb at 30 weeks’ or <20 
lbs at term 
>40 lbs at term 
22409(90.68%) 
 
242(0.98%) 
 
 
 
1288(94.01%) 
 
20 (1.46%) 
 
 
 
521(97.02%) 
 
6(1.12%) 
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2062(8.34%) 
 
62(4.53%) 
 
10(1.86%) 
Birth Weight 
Category 
SGA 
AGA 
LGA 
1960(7.95%) 
 
20128(81.65%) 
 
2564(10.40%) 
117(8.54%) 
 
1092(79.71%) 
 
161(11.75%) 
66(12.29%) 
 
430(80.07%) 
 
41(7.64%) 
Anaemia No 
 
Yes 
23777(96.75%) 
 
798(3.25%) 
1293(94.86%) 
 
70(5.14%) 
482(90.09%) 
 
53(9.91%) 
Placenta Delivery Spontaneous 
 
Expressed or assisted 
 
Manual 
 
Retained 
16640(67.98%) 
 
2661(10.87%) 
 
 
5053(20.64%) 
 
125(0.51%) 
851(62.71%) 
 
105(7.74%) 
 
 
385(28.37%) 
 
16(1.18%) 
245(45.79%) 
 
12(2.24%) 
 
 
257(48.04%) 
 
21(3.93%) 
Predictor Variables (Continuous)    
Maternal Height 
(inches) 
 64.78(±2.48) 64.49(±2.42) 64.(±2.49) 
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Predictors Gestational Age ≥37 Weeks’ Gestational Age between 32-37 
Weeks’ 
Gestational Age ≤32 Weeks’ 
Odds Ratio for 
PWR <10
th
 
Percentile 
(95% 
Confidence 
Interval) 
Odds Ratio for 
PWR >90
th
 
Percentile 
(95% 
Confidence 
Interval) 
Odds Ratio for 
PWR <10
th
 
Percentile 
(95% 
Confidence 
Interval) 
Odds Ratio for 
PWR >90
th
 
Percentile 
(95% 
Confidence 
Interval) 
Odds Ratio for 
PWR <10
th
 
Percentile 
(95% 
Confidence 
Interval) 
Odds Ratio for 
PWR >90
th
 
Percentile 
(95% 
Confidence 
Interval) 
Parity 0 
 
≥1 
- 
 
0.915 
(0.832, 1.006) 
- 
 
1.073 
(0.979, 1.176) 
- 
 
0.687 
(0.435, 1.084)* 
- 
 
1.686   
 (1.094, 2.598)* 
- 
 
0.604  
(0.339, 1.077)* 
- 
 
2.170 
(1.128, 4.174)* 
Smoking 
During 
Pregnancy 
No (ref) 
 
Yes 
 - 
 
0.647 
(0.559, 0.749)* 
- 
 
1.795 
 (1.616, 1.994)* 
- 
 
0.493 
(0.256, 0.947)* 
- 
 
1.518   
(0.970, 2.378) 
- 
 
0.938 
(0.494, 1.779) 
- 
 
0.630 
(0.271, 1.465) 
Maternal 
Asthma 
No (ref) 
 
Yes 
- 
 
0.809 
(0.642, 1.020) 
- 
 
1.085 
(0.890, 1.322) 
- 
 
0.965 
(0.405, 2.298) 
- 
 
1.075 
(0.500, 2.308) 
- 
 
0.878 
(0.331, 2.332) 
- 
 
0.492 
(0.114, 2.119) 
Maternal 
Height 
For every 10cm 
increase 
1.013 
(0.993, 1.033) 
1.001 
(0.982, 1.020) 
1.027 
(0.933, 1.130) 
1.034 
(0.946, 1.131) 
1.123 
(1.004, 1.255)* 
1.139 
(0.993, 1.306) 
Maternal Age <21 years 
 
21-34 years 
 
>34 years 
0.881 
(0.736, 1.055) 
- 
 
1.079 
(0.949, 1.226) 
1.217 
(1.042, 1.421)* 
- 
 
0.998 
(0.877, 1.136) 
0.265 
(0.064, 1.104) 
- 
 
1.283 
(0.744, 2.211) 
1.206 
(0.596, 2.439) 
- 
 
1.291 
(0.767, 2.173)* 
0.679 
(0.231, 2.000) 
- 
 
0.578 
(0.237, 1.410)* 
1.148 
(0.381, 3.464) 
- 
 
1.139 
(0.476, 2.721) 
Pre-
pregnancy 
BMI 
≤18.5 kg/m2 
 
18.5-24.9 
kg/m
2 
(ref) 
 
25.0-29.9 
kg/m
2 
 
>30.0 kg/m
2
 
0.923 
(0.829, 1.027) 
- 
 
0.827 
(0.709, 0.965)* 
 
0.805 
(0.670, 0.967)* 
1.296 
(1.161, 1.446)* 
- 
 
1.218 
(1.050, 1.413)* 
 
1.522 
(1.296, 1.787)* 
1.018 
(0.610, 1.698) 
- 
 
0.807 
(0.379, 1.718) 
 
0.708 
(0.263, 1.902) 
1.494    
(0.891, 2.505) 
- 
 
1.137 
(0.549, 2.357) 
 
2.326 
(1.141, 4.744) 
0.569 
(0.314, 1.030) 
- 
 
0.416 
(0.151, 1.144) 
 
0.313 
(0.104, 0.942)* 
0.898 
(0.427, 1.891) 
- 
 
0.863 
(0.292, 2.555) 
 
0.814 
(0.276, 2.403) 
Gestational 
Diabetes 
No (ref) 
Yes 
- 
 
0.707 
- 
 
1.513 
- 
 
0.194 
- 
 
1.014 
- 
 
0.475 
- 
 
0.342 
Table 5.2: Univariable Analyses Stratified by Gestational Age Categories: Factors Associated with Low and High PWR’s 
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(0.533, 0.937)* (1.240, 1.846)* (0.026, 1.422) (0.424, 2.423) (0.110, 2.052) (0.045, 2.583) 
Preeclampsia No (ref) 
 
Preeclampsia 
- 
 
0.979 
(0.691, 1.387) 
- 
 
1.775 
(1.364, 2.309)* 
- 
 
1.028 
(0.479, 2.206 
- 
 
1.834 
(1.026, 3.276)* 
- 
 
1.173 
(0.615, 2.237)* 
- 
 
1.397 
(0.673, 2.902) 
Placental 
Previa 
No (ref) 
 
Yes 
- 
 
0.747 
(0.344, 1.619) 
- 
 
0.980 
(0.507, 1.895) 
- 
 
0.341 
(0.046, 2.527) 
- 
 
0.282 
(0.038, 2.085) 
- 
 
1.500 
(0.415, 5.424) 
- 
 
3.919 
(1.324, 11.601)* 
Placental 
Abruption 
No (ref) 
 
Yes 
- 
 
1.223 
(0.795, 1.881) 
- 
 
2.077 
(1.485, 2.903)* 
- 
 
0.523 
(0.160, 1.705) 
- 
 
2.268 
(1.216, 4.229)* 
- 
 
0.592 
(0.290, 1.212)* 
- 
 
1.678 
(0.857, 3.285)* 
Umbilical 
Cord 
Complications 
None (ref) 
 
Cord around 
the neck or 
body, knot in 
the cord, 
prolapsed or 
lacerated cord 
 
Short, 2-vessel 
or velamentous 
cord 
- 
 
0.810  
(0.728, 0.901)* 
 
 
 
 
1.990 
(1.390, 2.850)* 
- 
 
1.189 
(1.080, 1.309)* 
 
 
 
 
1.180 
(0.753, 1.851) 
- 
 
0.973 
(0.594, 1.592) 
 
 
 
 
0.771 
(0.092, 5.482) 
- 
 
1.545 
(1.001, 2.386) 
 
 
 
 
3.622 
(1.269, 10.338)* 
- 
 
0.850 
(0.439, 1.646) 
 
 
 
 
6.603 
(1.835, 23.755)* 
- 
 
0.816 
(0.376, 1.774) 
 
 
 
 
3.661 
(0.681, 19.674) 
Gestational 
Weight Gain 
<10lb at 30 
weeks’ or <20 
lbs at term 
 
Normal (ref) 
 
>40 lbs at term 
0.713 
(0.427, 1.190) 
 
 
- 
 
0.821 
(0.690, 0.977) 
1.002 
(0.654, 1.537) 
 
 
- 
 
1.014 
(0.868, 1.184) 
0.579 
(0.076, 4.398) 
 
 
- 
 
0.474 
(0.113, 1.993) 
∞ 
(0, ∞) 
 
 
- 
 
1.646 
(0.752, 3.605) 
1.278 
(0.147, 11.131) 
 
 
- 
 
0.799 
(0.098, 6.502) 
∞ 
(0, ∞) 
 
 
- 
 
1.149 
(0.140, 9.421) 
Birth Weight 
Category 
SGA 
 
AGA (ref) 
 
LGA 
1.130 
(0.952, 1.342) 
- 
 
0.829 
 (0.701, 0.981)* 
1.242 
(1.057, 1.461)* 
- 
 
1.096 
(0.946, 1.270) 
1.444 
(0.689, 3.026) 
- 
 
1.419 
(0.738, 2.728) 
1.322 
(0.654, 2.669) 
- 
 
1.462 
(0.808, 2.647) 
0.691 
(0.262, 1.822) 
- 
 
1.110 
(0.410, 3.006) 
1.708 
(0.742, 3.929) 
- 
 
0.343 
 (0.045, 2.603) 
Anaemia  - - - - - - 
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*-Covariates with a significance level of p<0.05 
 
 
 
 
 
 
 
 
 
 
 
 
No (ref) 
 
Yes 
 
0.767 
 (0.560, 1.052) 
 
1.898  
(1.538, 2.342 )* 
 
0.799 
 (0.242, 2.643) 
 
2.420 
(1.170, 5.008)* 
 
0.849 
 (0.320, 2.253) 
 
2.677 
(1.187, 6.037)* 
Placental 
Delivery 
Spontaneous 
(ref) 
 
Expressed or 
assisted 
 
Manual 
 
Retained 
- 
 
 
1.186 
(1.006, 1.397)* 
 
1.108 
(0.987, 1.244)* 
3.832 
(2.344, 6.264)* 
- 
 
 
0.915 
(0.771, 1.086) 
 
1.010 
(0.903, 1.130) 
1.450 
(0.737, 2.854)* 
- 
 
 
1.131 
(0.432, 2.963) 
 
1.054 
(0.630, 1.762) 
5.657 
(1.374, 23.290)* 
- 
 
 
1.393 
(0.604, 3.212) 
 
1.329 
(0.845, 2.090) 
1.658 
(0.196, 14.010) 
- 
 
 
1.144 
(0.129, 10.114) 
 
0.659 
(0.369, 1.176) 
3.119 
(1.077, 9.033)* 
- 
 
 
0 
(0, ∞) 
 
2.156 
(1.060, 4.383)* 
4.159 
(1.022, 16.931)* 
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Table 5.3: Final Multivariable Logistic Regression model of Baseline Pregnancy Factors Hypothesized to Influence a 
Placental Weight Ratio either ≤10th or ≥90th percentile by Gestational Age Category 
 Odds Ratio (95% Confidence Interval) 
 Gestational Age ≥37 Weeks’ Gestational Age between 32 and 37 
Weeks’ 
Gestational Age ≤32 Weeks’ 
Predictors PWR <10
th
 
Percentile 
 
PWR >90
th
 
Percentile 
 
PWR <10
th
 
Percentile 
 
PWR >90
th
 
Percentile 
 
PWR <10
th
 
Percentile 
 
PWR >90
th
 
Percentile 
 
Parity 
0 
 
≥1 
 
- 
 
0.928 
(0.841, 1.024)* 
 
- 
 
1.067 
(0.969, 1.176)* 
 
- 
 
0.661 
 (0.412, 1.059)* 
 
- 
 
1.612 
(1.011, 2.570)**
 
 
- 
 
0.576 
(0.306, 1.084)* 
 
- 
 
2.224 
(1.060, 4.664)** 
Smoking During 
Pregnancy 
No (ref) 
 
Yes 
 
 
- 
 
0.609 
(0.522, 0.711)** 
 
 
- 
 
1.808 
(1.618, 2.019)** 
 
 
- 
 
0.542 
(0.278, 1.055)* 
 
 
- 
 
1.583 
(0.987, 2.540)** 
X 
 
X 
Maternal Age 
<21 years 
 
21-34 years 
 
>34 years 
X X 
X 
 
X 
 X X 
Maternal Height 
For every 10cm increase 
X X
 
X X 
1.131 
(1.005, 1.272)** 
1.139 
(0.984, 1.318)* 
Pre-pregnancy BMI 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
(ref) 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
 
0.907 
(0.811, 1.014)* 
- 
 
0.813 
(0.694, 0.953)** 
0.806 
(0.666, 0.975)** 
 
1.263 
(1.126, 1.417)** 
- 
 
1.223 
(1.050, 1.426)** 
1.402 
 (1.184, 1.661)** 
X X X X 
Gestational Diabetes 
No (ref) 
 
- 
 
- 
X 
 
X X 
X 
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Gestational Diabetes 
 
0.734 
(0.551, 0.979)** 
 
1.442 
(1.176, 1.770)** 
Preeclampsia 
No (ref) 
 
Preeclampsia 
X
 
 
- 
 
1.684 
(1.281, 2.213)** 
X
 
 
- 
 
1.938 
(1.040, 3.610)** 
X X 
Placental Previa 
No (ref) 
 
Yes 
X X X X 
 
X
 
 
- 
 
3.333 
(0.904, 12.285)** 
Placental Abruption 
No (ref) 
 
Yes 
X 
 
- 
 
2.084 
(1.481, 2.931)** 
X
 
 
  - 
 
1.991 
(1.027, 3.861)** 
X X 
Umbilical Cord 
Complications 
None (ref) 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
Short, 2-vessel or 
velamentous cord 
 
 
- 
 
0.821 
(0.735, 0.916)** 
 
 
 
1.932 
(1.338, 2.790)** 
 
 
- 
 
1.183 
(1.071, 1.308)** 
 
 
 
X 
X
 
 
 
- 
 
1.453 
(0.918, 2.298)* 
 
 
 
3.745 
(1.240, 11.307)** 
 
 
- 
 
X 
 
 
 
 
5.298 
(1.395, 20.128)* 
X
 
Birth Weight Category 
SGA 
 
AGA (ref) 
 
LGA 
 
1.153 
(0.963, 1.381)* 
- 
 
0.824 
(0.693, 0.980)** 
 
1.109 
(0.934, 1.317)* 
- 
 
1.114 
(0.955, 1.298)* 
 
X 
 
X 
 
X 
X 
Anaemia 
No (ref) 
 
Yes 
 
X
 
 
  - 
 
1.876 
X 
 
- 
 
2.068 
X X 
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*-Covariates with a significance level of p<0.20; **-Covariates with a significance level of p<0.05; Factors considered but not significant 
in any of the models were maternal asthma and gestational weight gain 
(1.507, 2.336)** (0.961, 4.448)* 
Placental Delivery 
Spontaneous (ref) 
 
Expressed or assisted 
 
Manual 
 
Retained 
 
- 
 
1.163 
(0.976, 1.387)* 
1.104 
(0.981, 1.243)* 
4.053 
(2.461, 6.675)** 
 
 
X 
 
 
X X 
 
- 
 
X 
 
0.616 
(0.324, 1.174)* 
3.452 
(1.095, 10.881)** 
X 
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CHAPTER 6: INTEGRATED DISCUSSION 
 
This chapter summarizes the thesis results and implications, provides a detailed 
discussion where appropriate, identifies limitations and strength and provides 
recommendations for future research. While multiple objectives were addressed, the main 
purpose of this thesis was twofold: to established norms for the placental weight ratio 
(PWR) across gestational age, and compare these norms between small, average and 
large for gestational age infants (SGA, AGA and LGA) and to use the PWR norms we 
established to identify risk factors associated with atypical PWRs in different gestational 
age categories.  
 
6.1 Brief Summary of Results 
6.1.1 Population-Based Placental Weight Ratio Distributions 
The placental and birth weight distributions show that placental growth has to 
some degree levelled off while fetal growth continues at an accelerated pace. This pattern 
is reflective of the second half of gestation. Comparing the city-wide population to the 
total sample PWR distributions revealed them to be similar, with small differences 
presenting themselves at the extreme percentiles at the earlier gestational ages. In general, 
the females have higher PWR’s than males. These PWR distribution curves make a 
substantial contribution to the literature. They show how the PWR changes across 
gestation by percentile.  
The curves that are stratified by fetal growth adequacy are the first of their kind. 
Distinctly, they show that SGA infants had much higher PWR’s in early gestation than 
both LGA and AGA infants at the early gestations. On the other hand, LGA infants have 
lower PWR’s at the lower gestational ages when compared to AGA infants. However, the 
PWR’s at term gestations are nearly identical in both SGA and LGA infants. In fact, 
LGA infants have slightly higher median ratios at term than both SGA and AGA infants. 
6.1.2 Determinants of Atypical Placental Weight Ratios  
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The results presented in Chapter 5 suggest that adverse obstetric conditions are 
associated with either placental growth restriction or placental hypertrophy, or both, 
based on gestational age at birth. Inferences are sharpened by the use of PWR, rather than 
merely placental weight, since PWR presents an opportunity to look at placental growth 
in relation to birth weight.  
For infants born at ≥37 weeks gestation, factors associated with an increased risk 
of PWR<10
th
 percentile were: a short, 2-vessel or velamentous umbilical cord insertion, 
SGA infants, and any assisted placental delivery methods. On the other hand, multiparity, 
smoking, abnormal BMI, preeclampsia, placental abruption, a cord around the neck or 
body, a knot in the cord, or a prolapsed or lacerated cord, both SGA and LGA infants and 
maternal anaemia increased the odds of a PWR>90
th
 percentile.  
For infants born between 32 and 37 weeks gestation, multiparity and smoking 
attenuated the odds of a PWR<10
th
 percentile. Alternatively, multiparity, preeclampsia, 
placental abruption, a cord around the neck or body, a knot in the cord, or a prolapsed or 
lacerated cord, a short, 2-vessel or velamentous umbilical cord insertion, and maternal 
anaemia all increased the odds of a PWR >90
th
 percentile. 
For infants born ≤32 weeks gestation, increasing maternal height and a short, 2-
vessel or velamentous umbilical cord insertion increased the odds of a PWR <10
th
 
percentile. Multiparity, increasing maternal height and placental previa all increased the 
odds of a PWR >90
th
 percentile. 
The majority of the risk factors considered resulted in increased odds of a PWR 
≥90th percentile. This proposes that the placenta may have compensatory responses to 
maternal obstetric conditions, potentially each with a distinct pathophysiologic 
mechanism, but similar PWR outcome. 
6.1.3 Integration of Findings 
 
Collectively, the results from this thesis supplement the literature on the PWR by 
first creating population standards and comparing the standards between SGA, AGA and 
LGA infants. Subsequently, we examined various risk factors proposed to be associated 
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with atypical placental and fetal growth using the standards we created. The results of the 
distributions allowed us to use gestational age and sex specific population-based 
standards to identify infants as having a PWR<10
th
 percentile or >90
th
 percentile. 
Furthermore, it afforded us the opportunity to examine multiple maternal obstetric 
conditions and baseline factors that might influence the PWR using large scale population 
standards.  
 
6.2 Detailed Discussion of Determinants of Placental Weight Ratios 
 
The framing of the findings in the context of hypoxia of various mechanisms is a useful 
framework in which to interpret the findings of Chapter 5. The following section presents 
a more detailed discussion which expands on points introduced in Chapter 5.  
 
Ischemic Placental Disease 
Ischemic placenta disease (IPD), which describes fetal growth restriction, 
placental abruption and preeclampsia have been shown to apply its effects differently in 
term and preterm infants.
1,2
 Among infants with IPD, the frequency of SGA is higher in 
term, than preterm, infants.
1
 Interestingly, SGA was only significantly associated with 
atypical PWRs in term infants after controlling for other factors in our analyses. 
Furthermore, when PWRs have been compared between AGA and SGA infants based on 
gestational age, SGA infants are found to have higher ratios than AGA infants.
3
 Our 
results agree with both of these separate, yet dependant observations, and provide further 
evidence that the role of the placenta in relation to fetal weight differs between 
complications and timing during pregnancy.  
Ananth et al.
1
 have shown that IPD in preterm infants is more likely to include the 
mother and the fetus through SGA, preeclampsia and placental abruption, than in term 
infants. A common pathophysiology between preeclampsia and placental abruption is 
indicated by the sharing of a large proportion of risk factors.
4
 Our results have shown that 
preeclampsia and placental abruption increase the odds of a PWR ≥90th percentile in the 
highest two gestational age categories. Furthermore, the effect of placental abruption and 
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preeclampsia in infants born between 32 and 37 weeks on a PWR ≥90th percentile is 
slightly increased compared to term infants.  
 
Preplacental Hypoxia  
Preplacental hypoxia, a reduction in maternal blood oxygen content, occurs when 
the placenta and fetus become hypoxic due to conditions such as maternal asthma and 
maternal anaemia.
5
 Correlations between mild to severe anaemia and heavier than 
average placentas have been noted in numerous studies.
6–11
 These studies have also 
shown that hypoxia resulted in a smaller fetus, and therefore the PWR increased.
6–11
 For 
term infants, maternal anaemia was associated with amplified odds of having a 
PWR≥90th percentile. Our results are in agreement with the proposed physiological 
mechanism. The increased size of the placenta has been understood as a compensatory 
mechanism to overcome the lack of oxygen in the maternal blood, as well as the 
increased trophoblastic proliferation and placental angiogenesis that result from 
anaemia.
12
 In response to a lack of oxygen, the extravillous trophoblast of the placenta 
bed shows an increased depth of invasion and the villi appear hypercapillarized.
13
 
 
Uteroplacental Hypoxia 
 
Uteroplacental hypoxia occurs when normally oxygenated maternal blood has 
restricted entry into the uteroplacental tissues due to either occlusion or failed trophoblast 
invasion of the uteroplacental arterioles. This situation represents late onset growth 
restriction with preserved end diastolic flow volume, and term preeclampsia.
5
 Both low 
and high placental weight has been shown in the literature to be associated with term 
preeclampsia.
14
 Our results indicate that individuals with preeclampsia who deliver an 
infant at term have increased odds of a PWR ≥90th percentile. These results are congruent 
with current literature which shows that the PWR is often increased in pregnancies that 
are complicated by preeclampsia.
15,16
 This suggests that there is compensatory growth of 
placental villi in an attempt to overcome an unfavourable maternal environment.
17,18
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Our results do not show increased odds for having a PWR ≤10th percentile, 
thereby indicating a potentially smaller placenta. However, since we do not have the 
timing of diagnosis for preeclampsia, we were only looking at infants born at term whose 
mothers had preeclampsia. Nevertheless, the majority of pregnancies with preterm 
preeclampsia do result in a preterm delivery.
19
  
Postplacental Hypoxia 
 
Postplacental hypoxia is when oxygenated maternal blood enters the intervillous 
space at a normal or reduced rate, but a defect in fetoplacental perfusion prevents the 
fetus from receiving sufficient oxygen.
5
 Placental adaptations in mothers with pre-
gestational diabetes resemble those adaptations seen in other postplacental hypoxia 
conditions. Placentas from women with gestational diabetes are often increased in weight 
when compared to women who had only one abnormal oral glucose tolerance test.
20–25
 
However, the literature is inconclusive on the effect of gestational diabetes on the 
PWR.
21,26
  
 
In our highest gestational age categories, gestational diabetes was associated with 
increased odds of a PWR ≥90th and was protective against a PWR ≤10th percentile. 
Levels of haemoglobin and erythropoietin provide evidence that fetuses in mothers with 
pre-diabetes are hypoxic. The literature suggests that the surface and exchange areas are 
enlarged as a result of the hypoproliferation and hypervascularization in gestational 
diabetes. Therefore, the maternal placental oxygen supply is reduced, and the fetal 
oxygen demand is increased.
27,28
 This phenomenon could be explained by aerobic 
metabolism which is stimulated by fetal hypersinsulinemia which can result in reduced 
trophoblast proliferation. The low oxygen levels up regulate transcriptional synthesis of 
leptin, VEGF and fibroblast growth factor which promotes placental endothelial cell 
proliferation. The result is enhanced vascularisation of the placenta.
29,30
 
 
Carbon Monoxide Hypoxia 
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Maternal smoking is associated with carbon monoxide hypoxia which reduces 
oxygen content in maternal blood. While this seems similar to preplacental hypoxia, and 
the changes in fetal capillaries and peripheral villi do mirror the effects in cases such as 
anaemia, the morphology and oxygen diffusion conductances are not consistent with 
other cases of preplacental hypoxia.
31,32
 However, these differences may be confounded 
by some of the other toxins in cigarettes.
33
  
Cigarette smoking is associated with a decreased fetal weight, but of the few studies 
that have examined the association between maternal smoking and placental weight, there 
has been no significant effect found.
9,34–38
 Some studies that investigated the PWR found 
significantly higher ratios in smokers versus non-smokers.
36,39
 On the other hand, another 
study found a significantly lower PWR for smokers than non-smokers.
34
 Our results 
account for such discrepancies as we found that smoking increases the odds of having a 
PWR ≥90th percentile and attenuates the odds of having a PWR ≤10th percentile. When a 
mother smokes during pregnancy, the placenta and fetus become hypoxic because of a 
reduction of oxygen content within the maternal blood along with an increased vascular 
resistance on the fetal side of the placenta. These conditions result in reduced 
intraplacental oxygen content, predominately branching angiogenesis and reduced 
vascular impedance. The increase in branching angiogenesis, and thereby reduced 
vascular impedance, is an adaptive mechanism to the hypoxic state. This mechanism is 
associated with excessive placental weight.
40
  
 
Placental and Umbilical Cord Complications  
Placentas with a non-centrally inserted umbilical cord, such as a velamentous 
insertion, tend to be heavier.
41
 Any force that compresses umbilical cords may lead to 
diminished blood flow in umbilical vessels and subsequent fetal hypoxia or circulatory 
compromise. Mechanical cord compression can be caused by cord entanglements 
(nuchal/body cords) and cord prolapse; or it may take place as a result of an abnormal 
configuration of the cord such as true knots, hypercoiling, abnormally short or long cords, 
abnormal cord insertions, or strictures.
42
 These complications are often associated with 
decreased fetal weight, and both marginal and velamentous cord insertion are associated 
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with an decreased placental weight, an increased PWR and a reduced metabolic 
efficiency.
3,41,43
 On the contrary, a single umbilical artery is also associated with a 
reduced placental weight.
43
 Abnormal cord insertion has also been found to be associated 
with a high PWR.
44
 Our results show that a short, 2-vessel or velamentous cord insertion 
are associated with increased odds of a PWR ≥90th percentile in infants born between 32 
and 37 weeks, and increased odds of a PWR ≤10th percentile in terms infants and infants 
born ≤32 weeks. However, a cord around the neck or body, knot in the cord, prolapsed or 
lacerated cord is also associated with a PWR ≥90th percentile in all infants born at >32 
weeks.  
As indicated within the literature, some placental factors, such as placenta 
abruption, placenta previa and antepartum hemorrhage are not individually associated 
with placental weight,
43
 but as a group are associated with a decreased PWR.
45
 Our 
results partially disagree with these findings. We found that placenta previa has no 
significant association, but that placental abruption strengthened the odds of having a 
PWR ≥90th percentile.  
 
6.3 Study Implications  
 
Findings from this thesis have potentially important implications for implementing the 
population based PWR standards in research.  
 
6.3.1 Applications of the Placental Weight Ratio Distributions in Research 
 
Future research directions can make use of the PWR distributions for identifying 
infants with atypical PWRs. Previous studies that have looked at atypical PWRs have not 
used a population standard to identify abnormal PWRs.15–17 Furthermore, the SGA, AGA 
and LGA distribution curves can provide new dimension in future similar studies.  
 
6.4 Strengths and Limitations  
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A major strength of the study is the available sample size. The perinatal database 
provided a large number of observations with a placental weight, birth weight and 
gestational age. This allowed for the creation of accurate standards. It also allowed for the 
percentile curves to be stratified by fetal growth adequacy which required large enough 
sample sizes in each of the fetal growth adequacy categories. This study is strong due to 
the quality and comprehensive nature of the data. The internal validity of the study is 
strong because every birth at St. Joseph’s Hospital and Victoria Hospital was captured; 
this is a population-based, representative sample. The results will be important for both 
obstetricians and neonatologists managing high risk pregnancies and infants with extreme 
birth and placental weights. 
 
This research is novel in the approach of considering a modern framework of 
proposed physiological mechanisms along with a theoretic framework to examine the 
relationships between various risk factors and their associations with atypical PWRs. The 
strong theoretical framework, based on biologically plausible mechanistic literature, 
combined with epidemiological literature provides a strong base for this study. This 
approach also allows the complexity of the relationships that exist between factors to be 
conserved and provides an understanding of how these factors relate within this 
population. 
 
The appropriate use of quantile regression (QR) is a principle strength of the 
study since it does not make any distributional assumption beforehand. It is able to model 
data with heterogeneous conditional distributions, and it is robust to extreme values of the 
outcome. Furthermore, compared to other statistical methods QR is more stable and is 
able to reveal departures from underlying assumption of parametric models.
50
 
 
Like other studies that use administrative databases, this study was unable to 
assess a few covariates that may influence the PWR. Examples include residing at high 
altitude and ethnicity. However, residing at high altitude, a form of preplacental hypoxia, 
is not a variable of great significance for many women living in the region. Preplacental 
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hypoxia was represented by other variables in the study. Ethnicity has been shown to 
influence the PWR in previous studies, but the effect was small.
9,53
 
 
Height and weight data contributing to the calculation for pre-pregnancy came 
from variable sources, including self-report, therefore misreporting may have influenced 
the accuracy of BMI. We speculate it may have produced an underestimate in BMI. The 
situation is similar for smoking because women sometimes fail to report such behaviours. 
Generally, because these are secondary data from an administrative data source, we 
cannot be certain as to how error-free the data are. We have excluded implausible values 
as an effort to control the data quality. 
 
6.5 Future Directions  
 
Further studies are warranted to provide comparisons in other populations. Birth 
weights are known to vary from country to country.
52,54
 Therefore, the creation of PWR 
distribution curves in other populations is recommended, as percentiles can best be used 
as a standard in research studies if they can be argued to be comparable to the population 
in which the studies are conducted.   
 
Our data are cross-sectional. This is typical of studies which establish growth 
standards based on birth outcomes.
52
 However, neonates at early gestations are likely not 
representative of their same-gestation peers who remain in utero. It would be of interest 
to conduct longitudinal studies looking at serial estimates of placental and fetal growth in 
order to further understand the timelines attached to growth deviations. Longitudinal 
studies following a cohort of placentas throughout the pregnancy would require serial 
ultrasound estimation; however, ultrasound weight estimations have their inaccuracies.
51
  
 
Further research is justified to elucidate the biological mechanisms underlying the 
associations between anemia, gestational diabetes, hypertensive disease, maternal pre-
pregnancy BMI, and umbilical cord complications with abnormal placental growth 
relative to fetal growth. Additionally, understanding the biological mechanisms in infants 
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at different gestational ages is vindicated based on the differing results seen in the three 
gestational age categories we examined for risk factors such as preeclampsia and 
placental previa.  
 
 Additionally, future cohort studies should examine these associations to determine 
if children with either low or high PWRs are at a greater risk for certain medical 
conditions. Limited literature exists that examines later child health outcomes in infants 
with atypical PWRs.  
 
 All of the aforementioned prospective directions can make use of the PWR 
standards we created, as they provide a large population-based standard to define atypical 
PWRs in across the second half of pregnancy. Furthermore, the stratified curves may 
provide a new dimension in future studies.  
 
6.6 Conclusions  
The PWR distribution curves make a substantial contribution to the literature. 
They show how the PWR changes across gestation by percentile. Further, the PWR 
distribution curves provide a standard that clinicians and researchers can apply as a 
reference standard to identify infants who have abnormal PWRs. Identifying infants with 
high PWRs is important for patient care in both the short and long term. Previous 
literature has shown that neonates with a high PWR had increased incidence of short-
term complications.
55
 Furthermore, in recent years, birthweight, sometimes in 
conjunction with placental weight, has been associated with the development of a series 
of diseases later in life.
56
 However, the relative magnitude of the PWR, in terms of 
standards, is not available for all gestational ages in a Canadian population. As well, 
PWR has not been documented for SGA, AGA and LGA infants. Thus, the distributions 
estimated in this study may provide a useful tool for adding this dimension in future 
similar studies.  
Using the population-based standards we created to define the PWR we found that 
both maternal obstetric conditions and maternal baseline factors are either associated with 
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placental growth restriction or placental hypertrophy in relation to birth weight, and even 
both, based on gestational age at delivery. The majority of the risk factors assessed 
resulted in increased odds of a PWR ≥90th percentile. This suggests that the placenta may 
have particular compensatory responses to maternal obstetric conditions, each with a 
different pathophysiologic mechanism, but comparable PWR outcome.  
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Appendix A: Definitions  
 
Asymmetrical Small for Gestational Age- an infant with a ponderal index less than the 
10
th
 percentile, based on population standards for each sex by gestational age.  
Average for Gestational Age- an infant with a birth weight between the 10
th
 and 90
th
 
percentile after controlling for gestational age and sex, as defined by the World Health 
Organization in the International Classification of Diseases Version 10, as per code 
P05.1. 
Blastocyst- a structure formed in the early embryogenesis of mammals, after the 
formation of the morula. It contains an inner cell mass which eventually forms the fetus, 
and the outer cell mass containing trophoblasts which later forms the placenta.  
Body Mass Index- the individuals weight in kilograms divided by their height in meters 
squared. 
Decidua- is the uterine lining which forms the maternal part of the placenta.  
Extravillous Trophoblasts- cells which originate from the trophoblasts. Extravillous 
trophoblast grow out from the placenta and penetrate into the decidualised uterus. This 
process attaches the placenta to the mother, and alters the vasculature in the uterus to 
allow it to provide an adequate blood supply to the growing fetus as pregnancy 
progresses.  
Fetal Growth Restriction- a fetus that has not reached its growth potential because of 
genetic or environmental factors. 
Lacunae- one of the blood spaces of the placenta in which the fetal villi are found.  
Large for Gestational Age- an infant who exceed the 90
th
 percentile for birth weight 
after controlling for gestational age and sex, as defined by the World Health Organization 
in the International Classification of Diseases Version 10, as per code P05.1. 
Morula- an embryo at an early stage of embryonic development, consisting of a ball of 
about 16 undifferentiated cells contained inside the zona pellucida.  
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Placental Weight Ratio- the ratio of the placental weight in grams to the fetal weight in 
grams. 
Ponderal Index- the birth weight in kilograms divided by the length in meters cubed, 
according to Rohrer(1908).  
Preeclampsia- is a conditional that occurs when a pregnant woman develops high blood 
pressure (>140/90mmHg) and protein in the urine after the 20
th
 week of pregnancy. 
Small for Gestational Age- an infant that weighs less than the 10
th
 percentile for their 
gestational age and sex, as defined by the World Health Organization in the International 
Classification of Diseases Version 10, as per code P05.1 
Symmetrical Small for Gestational Age- an infant with a ponderal index greater than 
the 10
th
 percentile, based on population standards for each sex by gestational age.  
Syncytiotrophoblast- the thick layer of cell boundary that forms the endometrial stroma. 
It secretes human chorionic growth hormone in order to maintain progesterone secretion 
and sustain pregnancy. It is a specialized epithelium covering the villous tree and has 
several functions, such as transport of gases, nutrients, and waste products and synthesis 
of peptide and steroid hormones that regulate placental, fetal, and maternal systems 
Trophoblasts- cells forming the outer layer of the blastocyst.  
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Appendix C: Conceptual Model of Risk Factors Associated with Reduced Placental 
Weight and SGA 
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Appendix D: Conceptual Model of Risk Factors Associated with Increased Placental 
Weight and LGA 
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Appendix E: Conceptual Model of the Risk Factors Association with an Atypical PWR 
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Appendix F: Tables of References for Risk Factors Associated with SGA, LGA and both Reduced and Increased Placental 
Weights 
 
Risk Factors References for SGA References for Reduced 
Placental Weight 
References for LGA References for Increased 
Placental Weight 
Short Maternal Height (Xun et al., 2007)(M. S. 
Kramer, 1987)(Voigt et al., 
2010) 
(L. A. Williams et al., 
1997) 
  
Low Maternal Weight (Reader, 2007)(Voigt et al., 
2010)(Hibbert et al., 1999) 
(Thame et al., 2001)(Junichi 
Hasegawa et 
al.,2011)(Hibbert et al., 
1999)(Naeye, 1987) 
(L. A. Williams et al., 
1997)(Baptiste-Roberts et 
al., 2008) 
  
Low Pregnancy Weight 
Gain 
(Reader, 2007)(Berghella, 
2007)(Mamun et al., 
2011)(Hellerstedt et al., 
1997)  
(Siega-Riz et al., 
2009)(Crane et al., 
2009)(Margerison Zilko et 
al., 2010) 
(L. A. Williams et al., 
1997)(Naeye, 1987) 
 
  
Low Parity (X. Zhang et al., 2007) (L. A. Williams et al., 
1997)(Baptiste-Roberts et 
al., 2008) 
  
High levels of 
Psychosocial Stress 
(Wadhwa et al., 
2004)(Goland et al., 
1993)(Gracka-
Tomaszewska, 2010) 
(Rondó et al., 2003) 
(Adams, Eberhard-Gran, 
Hofoss, & Eskild, 2011) 
(Chrousos & Gold, 1992) 
  (Tegethoff, Greene, Olsen, 
Meyer, & Meinlschmidt, 
2010). 
Smoking (M. S. Kramer, 
1987)(Romo et al., 
2009)(Figueras et al., 
2008)(Rasmussen & Irgens, 
2006) (Hellerstedt et al., 
(R. E. Christianson, 1979; 
H. C. Miller, Hassanein, & 
Hensleigh, 1976; 
Mochizuki, Maruo, 
Masuko, & Ohtsu, 1984; 
 (Pfarrer et al., 1999) (R. E. 
Christianson, 1979; H. C. 
Miller, Hassanein, & 
Hensleigh, 1976; 
Mochizuki, Maruo, 
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1997)(Aagaard-Tillery et 
al., 2008)  
(Lieberman et al., 
1994)(Spinillo et al., 
1994)(Aliyu et al., 
2010)(Martin & Bracken, 
1986) (C. Ward, Lewis, & 
Coleman, 2007a)(C. Ward, 
Lewis, & Coleman, 2007b)  
(Ira M Bernstein et al., 
2005)(Berghella, 
2007)(Lesley M E 
McCowan et al., 2009) 
(Polakowski, Akinbami, & 
Mendola, 2009) 
(Lieberman et al., 
1994)(Prabhu et al., 2010) 
Carolyn M. Salafia, 
Vintzileos, Lerer, & 
Silberman, 1992; Wingerd, 
Christianson, Lovitt, & 
Schoen, 1976)(Baptiste-
Roberts et al., 2008) 
Masuko, & Ohtsu, 1984; 
Carolyn M. Salafia, 
Vintzileos, Lerer, & 
Silberman, 1992; Wingerd, 
Christianson, Lovitt, & 
Schoen, 1976)(Baptiste-
Roberts et al., 2008) 
Alcohol Consumption 
during Pregnancy 
(Patra et al., 2011) 
(Romo et al., 2009) 
(C. M. O’Leary et al., 2009) 
   
Excessive Aerobic 
Exercise during 
Pregnancy 
(M. K. Campbell & 
Mottola, 2001) 
(Hopkins et al., 2010) 
(Lesley M E McCowan et 
al., 2009) 
(Erkkola et al., 1992) 
   
Chronic Hypertension (Lawrence, 2006) 
(Catov et al., 2008) 
   
Gestational Hypertension (Buchbinder, Sibai, Caritis, 
Macpherson, Hauth, 
Lindheimer, Klebanoff, 
Vandorsten, Landon, Paul, 
Miodovnik, Meis, & 
Thurnau, 2002b)(J. C. 
Hauth et al., 2000)(José 
Villar et al., 2006) 
(Buchbinder, Sibai, Caritis, 
Macpherson, Hauth, 
Lindheimer, Klebanoff, 
Vandorsten, Landon, Paul, 
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Miodovnik, Meis, & 
Thurnau, 2002a)(Baha M 
Sibai, 2003) 
Preeclampsia (Eskenazi et al., 
1993)(Saftlas, Beydoun, & 
Triche, 2005)(Rasmussen & 
Irgens, 2003)(Long et al., 
1980)(M. P. Moore & 
Redman, 1983) 
(MacKay, Berg, & Atrash, 
2001)(X Xiong & Fraser, 
2004) (Lars J Vatten & 
Skjaerven, 2004) 
(Odegard et al., 2000) 
(Xu Xiong et al., 2002) 
(J Hasegawa et al., 2010)(A 
Eskild et al., 2009) 
(A Eskild & Vatten, 
2010)(Baptiste-Roberts et 
al., 2008)(Leung et al., 
2001) 
 (Thomson et al., 1969) 
(Soma et al., 1982)(P. A. 
Boyd et al., 1986)(P. M. 
Coan et al., 
2010)(Dahlstrøm et al., 
2008) 
Nutritional Deprivation (PW Nathanielsz, 
2000)(Nørgård et al., 1999) 
(R. L. Bergmann et al., 
2008) 
(Lumey, 1998)(J. M. 
Wallace, Aitken, Milne, & 
Hay, 2004a) Heasman, 
Clarke, Stephenson, & 
Symonds, 1999) 
(L. J. Edwards & 
McMillen, 2001) 
(Dandrea et al., 2001)(C. 
Steyn et al., 2001) 
  
 
 
Low and High Maternal 
Age 
(Aldous & Edmonson, 
1993) 
(Strobino et al., 1995) 
(Haavaldsen et al., 2011)   
Short Interpregnancy 
Interval 
(van Eijsden et al., 2008). 
(Conde-Agudelo et al., 
2006) 
   
Toxins (P. S. Bernstein & Divon, 
1997)(Shi Wu Wen et al., 
2008) 
   
Residing at High Altitude (H L Galan et al., 2001)(L. 
G. Moore et al., 2001) 
(Mortola et al., 2000) 
(Kametas et al., 2004) 
  (J. Kingdom, Huppertz, 
Seaward, & Kaufmann, 
2000a) 
Abnormal umbilical cord 
insertion 
 (Junichi Hasegawa et al., 
2011) 
(S Heinonen et al., 2001) 
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Abnormal cord length  (Junichi Hasegawa et al., 
2011) 
  
Abnormal or Absent 
Umbilical artery 
 (Junichi Hasegawa et al., 
2011) 
  
Placental Conditions 
(Previa, Abruption, 
Hemorrhage) 
 (Little et al., 2003)   
Infant Sex (Female)  (S Heinonen et al., 2001) 
(Naeye, 1987) 
  
Anemia  (Steer, 1992) 
(Godfrey et al., 1991) 
 (Agboola, 1975) 
(Akhter et al., 2010) 
(Baptiste-Roberts et al., 
2008)(Lao & Wong, 
1997)(Lao & Tam, 2000) 
(Levario-Carrillo et al., 
2003) 
Ethnicity (African 
American and Asian) 
 (Baptiste-Roberts et al., 
2008) 
(Perry et al., 1995) 
  
Gestational Diabetes   (Langer et al., 2005) 
(Rodrigues et al., 2000) 
(Casey et al., 1997) 
(Hardy, 1999)(Di Cianni et 
al., 2003) 
(Stephens et al., 2001) 
(P. Thureen et al., 2006) 
(Rosenn, 2008) 
(Makhseed et al., 2004) 
(Kucuk & Doymaz, 
2009)(Taricco, Radaelli, 
Nobile de Santis, & Cetin, 
2003b) (Desoye & 
Hauguel-de Mouzon, 
2007)(Johnston, 
1995)(Ericsson et al., 
2007)(Makhseed et al., 
2004)(Kucuk & Doymaz, 
2009). 
 
Diabetes Mellitus    (Thomson et al., 1969) 
(Nummi, 1972)(Clarson et 
al., 1989) 
High Maternal Weight 
(Obesity) 
  (Baeten et al., 2001) 
(Rosenberg et al., 
2003)(Cnattingius et al., 
1998)(Langer et al., 2005) 
(L. A. Williams et al., 
1997)(Baptiste-Roberts et 
al., 2008) 
Increased Maternal 
Weight Gain 
  (Kahn & Flier, 2000) 
(Rodriguez et al., 
(Baptiste-Roberts et al., 
2008)(L. A. Williams et al., 
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1999)(Okun et al., 
1997)(Reader, 2007) 
1997) 
Multiparity   (Brunskill et al., 1991). 
(J. A. O’Leary & Leonetti, 
1990) 
(L. A. Williams et al., 
1997)(Baptiste-Roberts et 
al., 2008) 
Infant Sex (Male)   (Brunskill et al., 1991) 
(Lackman, Capewell, 
Richardson, et al., 2001) 
(S Heinonen et al., 
2001)(Naeye, 1987) 
Pregnancy Nutrition  (L. J. Edwards & 
McMillen, 2001) (Dandrea 
et al., 2001)(C. Steyn et al., 
2001) 
(Denguezli et al., 
2009)(Lumey, 1998) 
 
(L. J. Edwards & McMillen, 
2001) (Dandrea et al., 
2001)(C. Steyn et al., 
2001)(Woodall et al., 1996) 
(Lumey, 1998)  
High Maternal Age    (Haavaldsen et al., 2011) 
Decompensated Cardiac 
Disease 
   (Clavero & Botellallusia, 
1963) 
High Levels of 
Psychosocial Stress 
   (Tegethoff et al., 2010) 
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Appendix G: Preplacental Hypoxia Pathways 
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Appendix H: Uteroplacental Hypoxia Pathways 
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Appendix I: Postplacental Hypoxia Pathways 
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Appendix J: Calculations for the Removal of Birth Weights Three Standard Deviations 
from the Mean 
J.1.Males Calculations  
Gestational 
Week 
Mean  Standard 
Deviation 
3 SD’s 
Below the 
Mean 
3 SD’s 
Above the 
Mean 
22 507.07 48.56 361.40 652.74 
23 622.72 82.59 374.96 870.49 
24 651.85 81.45 407.50 896.19 
25 747.82 143.02 318.75 1176.89 
26 910.21 143.17 480.70 1339.72 
27 1066.63 312.56 128.96 2004.31 
28 1124.75 323.15 155.29 2094.21 
29 1344.45 250.12 594.10 2094.80 
30 1616.97 464.91 222.24 3011.71 
31 1682.85 320.60 721.04 2644.66 
32 1861.19 357.40 789.01 2933.38 
33 2184.94 430.18 894.40 3475.48 
34 2426.94 481.33 982.94 3870.93 
35 2637.10 444.17 1304.60 3969.60 
36 2903.94 461.97 1518.04 4289.84 
37 3137.07 479.18 1699.52 4574.63 
38 3376.84 461.46 1992.46 4761.23 
39 3527.79 446.39 2188.63 4866.95 
40 3686.96 442.43 2359.66 5014.26 
41 3806.74 449.57 2458.02 5155.46 
42 3948.84 532.46 2351.47 5546.20 
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J.2.Females Calculations  
Gestational 
Week 
Mean  Standard 
Deviation 
3 SD’s 
Below the 
Mean 
3 SD’s 
Above the 
Mean 
22 432.89 68.95 226.04 639.74 
23 542.62 81.20 299.01 786.22 
24 594.46 77.89 360.79 828.12 
25 795.53 205.16 180.05 1411.01 
26 878.03 179.77 338.71 1417.34 
27 958.51 218.68 302.49 1614.54 
28 1118.46 198.04 524.35 1712.57 
29 1220.42 265.88 422.78 2018.07 
30 1388.42 320.18 427.88 2348.96 
31 1626.87 270.82 814.42 2439.31 
32 1777.17 335.55 770.52 2783.83 
33 2069.75 383.85 918.19 3221.30 
34 2278.60 455.73 911.41 3645.79 
35 2581.60 458.61 1205.76 3957.44 
36 2805.16 495.61 1318.34 4291.99 
37 3044.04 474.75 1619.80 4468.28 
38 3259.82 448.94 1912.99 4606.66 
39 3404.52 426.01 2126.48 4682.57 
40 3548.62 431.27 2254.80 4842.44 
41 3643.93 437.09 2332.67 4955.20 
42 3732.27 433.71 2431.14 5033.40 
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Appendix K: Macro for Quantile Regression 
 
ods graphics on;  
ods html;  
 
%macro quantiles(NQuant, Quantiles); 
%do i=1 %to &NQuant; 
proc quantreg data=x4 algorithm=INTERIOR(TOLERANCE=1E-4 
KAPPA=0.25)PLOT=FITPLOT(NODATA);  
model fpratio = GESTWK GESTWK*GESTWK/ quantile=%scan(&quantiles,&i,'',''); 
output out=outp&i pred=p&i; 
run; 
%end; 
%mend; 
 
%let quantiles = %str(.03,.05,.10,.25,.5,.75,.90,.95,.97); 
%quantiles(10,&quantiles);  
 
ods graphics off; 
ods html close;  
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Predictor Variables (Binary/Categorical) n Frequency (%) Missing  
Parity 0 
 
≥1 
53954 23968(44.42) 
 
29985(55.58) 
3 
Smoking during Pregnancy No 
 
Yes  
53954 44986(83.38) 
 
8968(16.62) 
2 
Gestational 
Hypertension/Preeclampsia 
No 
 
Preeclampsia 
 
Gestational Hypertension 
53943 49169(91.15) 
 
1827(3.39) 
 
2947(5.46) 
13 
Body Mass Index ≤18.5 kg/m
2 
 
18.5-24.9 kg/m
2 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
53956 19696 (36.50) 
 
19856(36.80) 
 
8675(16.08) 
 
5729(10.62) 
0 
Anaemia No 
 
Yes 
26674 25710(96.51)  
 
930(3.49) 
27316 
Sex Male 
 
Female 
53956 27636(51.22)  
 
26320 (48.78)   
0 
Maternal Asthma No 
 
Yes 
53956 52748(97.76) 
 
1208(2.24) 
0 
Placenta Delivery Spontaneous 
 
Expressed or assisted 
 
Manual 
 
Retained 
53411 40246(75.34) 
 
280(5.24) 
 
10095(18.90) 
 
270(0.52) 
547 
Placenta Previa No 
 
Yes 
53956 53579(99.30) 
 
377(0.70) 
0 
Placental Abruption No 
 
Yes 
53956 52776(97.80) 
 
1180(2.20) 
0 
Gestational Diabetes No 
 
Yes 
53952 50834(94.22) 
 
3118(5.78) 
4 
Cord Complication No 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
53956 37220(68.98) 
 
16259(30.13) 
 
 
 
 
0 
Appendix L: Descriptive Statistics for Sample: Binary, Categorical and Continuous 
Variables  
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Short, 2-vessel or 
velamentous cord 
477(0.88) 
Gestational Weight Gain Normal  
<10lb at 30 weeks or <20 
lbs at term 
>40 lbs at term 
53956 46802(86.74) 
 
1514(2.81) 
 
 
5640(10.45) 
 
Birth Weight Category SGA 
AGA 
LGA 
53834 4259(7.91) 
 
43697(81.17) 
 
5878(10.92) 
122 
Predictor Variables (Continuous) n Mean (±S.D.) Missing 
Maternal Age (years)  52227 29.14(±5.11) 1729 
Maternal Height (inches)  50534 64.80(±2.47) 3422 
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Appendix M: Distributions of Key Variables 
M.1. Gestational Age Distribution 
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M.2. Birth Weight Distribution 
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M.3. Placenta Weight Distribution 
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Appendix N: Detailed Description of SGA and LGA Placental Weight Ratios  
N.1. Description of SGA PWR Curves 
Infants were defined as SGA based on Kramer’s gestational age and sex specific 
standards. There are 1677 males and 1533 females who are included in the analysis after 
the exclusion criteria were applied and missing data were removed. The 3
rd
 percentile 
reached statistical significance at p<0.05, the 5
th
 at p<0.01 and the remaining percentiles 
at p<0.001. The median gestational age was 39 weeks for both males and females which 
was the same as for the overall population. The mean gestational ages for males and 
females are 38.5 (SD=2.49) and 37.5(2.34) respectively. While the mean gestational ages 
are similar to that of the overall population, the standard deviations were larger for the 
SGA group.  
Males have a mean PWR of 0.2036 (SD=0.0537) and a median PWR of 0.1955. 
The means at the 3
rd
, 5
th
, 10
th
, 25
th
, 50
th
, 75
th
, 90
th
, 95
th
, 97
th
 are 0.1391, 0.14500.1562, 
0.1756, 0.1986. 0.2242, 0.2559, 0.2794 and 0.2950. Females have a mean PWR of 
0.2059 (SD=0.0516) and a median PWR of 0.1990. The means at the 3
rd
, 5
th
, 10
th
, 25
th
, 
50
th
, 75
th
, 90
th
, 95
th
, 97
th
 are 0.1434, 0.1503, 0.1623, 0.1792, 0.2011, 0.2260, 0.2575, 
0.2803 and 0.2979. Again the PWR decreases as gestational age increases and there was 
more dispersion in the lower gestational ages than at the higher gestational ages for both 
males and females.  
Through examination of Table 4.5 and 4.6, which show the exact PWR at each 
gestational age by percentile, it was evident that the SGA infants have higher PWR’s than 
the overall population. Similar to the overall population, the females have higher PWR’s 
than males, yet not significantly different from each other. Again, there was more 
dwaspersion at the lower gestational ages for both males and females. There was a 
greater range of PWR values at the 50
th
 percentile for males than females. The range for 
the PWR between 22 and 42 weeks at the 50
th
 percentile was 0.3171 and 0.3021 for 
males and females respectively. The same pattern of a higher range of PWR’s at 
particular percentile for males than females also holds true for extremes, as shown in the 
10
th
 and 90
th
 percentile.  
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N.2. Description of LGA PWR Curves 
Infants were defined as LGA based on Kramer’s gestational age and sex specific 
standards. There are 2566 males and 1813 females who are included in the analysis after 
the exclusion criteria were applied and the missing data were removed. The median 
gestational age for males was 39 weeks and for females it was 40 weeks. The mean 
gestational age for males was 38.8 weeks (SD=2.06) and 38.9 weeks (SD=2.05) for 
females. The range of gestational ages for females was between 25 and 42 weeks, and for 
males it was between 23 and 42 weeks. Statistically significance was not achieved at a 
level of p<0.05 for the 3
rd
 and 5
th
 percentiles for both males and females, therefore, they 
were not included.  
Males have a median PWR of 0.1956 and a mean PWR of 0.1998 (SD=0.0374). 
The means at the 10
th
, 25
th
, 50
th
, 75
th
, 90
th
, 95
th
, 97
th
 are 0.1602, 0.1776, 0.1947, 0.2188, 
0.2403, 0.2576 and 0.2685 respectively. Females have a median PWR of 0.2020 and a 
mean PWR of 0.2072 (SD=0.0422). The means at the 10
th
, 25
th
, 50
th
, 75
th
, 90
th
, 95
th
, 97
th
 
are 0.1649, 0.1816, 0.2043, 0.2293, 0.2523, 0.2700 and 0.2868 respectively.  
Again, females had higher PWR’s than males across percentiles, but the 
difference was not significant. There was a greater range in PWR’s at the 50th percentile 
across gestations for females than for males. Furthermore, this pattern holds true at the 
extreme percentiles. There was a greater range in PWR’s between the 25th and 42nd week 
of gestation at the 10
th
 and 90
th
 percentile in females than in males. The graphical 
representation for these distributions can be found in Figure 4.10 and 4.11, and the exact 
values for each percentile by gestational age can be found in Table 4.9 and 4.10.  
N.3. Differences between SGA, AGA and LGA Curves 
The figures below show graphically how the PWR changes across gestation 
between SGA, AGA and LGA infants at the median. Specifically, they show that there 
was a greater dispersion in the PWR in SGA infants than in AGA and LGA infants, 
especially in the lower gestational ages. The range of PWR’s between the 3rd and 97th 
percentiles at 22 and 23 weeks for male SGA infants was 0.7295 and 0.6640 respectively. 
The range of PWR’s between the 3rd and 97th percentiles at 22 and 23 weeks for female 
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SGA infants was 0.8513 and 0.7758 respectively. However, the range of PWR’s between 
the 3
rd
 and 97
th
 percentiles at 22 and 23 weeks for male AGA infants was 0.4776 and 
0.440 respectively. Also, the range of PWR’s between the 3rd and 97th percentiles at 22 
and 23 weeks for female AGA infants was 0.6073 and 0.5567 respectively. Therefore, it 
was evident that there was more dispersion in the PWR’s at the earlier gestations in SGA 
infants than in AGA infants. To provide a similar comparison, the range of values 
between the 10
th
 and 97
th
 percentile for LGA male infants at 22 and 23 weeks gestation 
are 0.2196 and 0.1782. The ranges for female LGA infants between the 10
th
 and 97
th
 
percentiles at 22 and 23 weeks are 0.4778 and 0.4315 respectively. Comparing these 
results to the male and female AGA ranges for between the 10
th
 and 97
th
 percentile, the 
dispersion in LGA infants was less than in AGA infants. It can then be concluded that the 
dispersion at the lower gestational ages was greatest in SGA infants than in both LGA 
and AGA infants. When comparison was made between LGA and AGA infants the AGA 
infants show more dispersion at the lower gestational ages than do the LGA infants.  
Furthermore, at the earlier gestational ages both male and female SGA infants 
have higher PWR’s than male and female AGA and LGA infants. The differences in 
PWR’s were the most pronounced at the higher percentiles and at the earlier gestational 
ages. SGA infants had much higher PWR’s in early gestation than both SGA and AGA 
infants at the early gestation. At the 90
th
, 95
th
 and 97
th
 percentile SGA infants have 
PWR’s that were a lot higher than the AGA and LGA infants. On the other hand, LGA 
infants have lower PWR’s at the lower gestational ages when compared to AGA infants.  
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N.4. SGA Male Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.2987 0.2954 0.3157 0.3971 0.5085 0.5673 0.7931 0.9229 1.0282 
23 0.2827 0.2805 0.2995 0.3736 0.4749 0.5320 0.7346 0.8533 0.9467 
24 0.2675 0.2664 0.2842 0.3515 0.4431 0.4986 0.6794 0.7877 0.8699 
25 0.2531 0.2531 0.2696 0.3306 0.4132 0.4670 0.6275 0.7258 0.7978 
26 0.2394 0.2404 0.2559 0.3109 0.3852 0.4372 0.5788 0.6679 0.7303 
28 0.2146 0.2172 0.2310 0.2754 0.3348 0.3831 0.4912 0.5634 0.6093 
29 0.2034 0.2067 0.2197 0.2596 0.3124 0.3588 0.4523 0.5170 0.5558 
30 0.1930 0.1970 0.2093 0.2450 0.2919 0.3363 0.4167 0.4744 0.5070 
31 0.1834 0.1879 0.1997 0.2316 0.2732 0.3156 0.3843 0.4357 0.4629 
32 0.1745 0.1796 0.1909 0.2196 0.2564 0.2968 0.3552 0.4007 0.4234 
32 0.1745 0.1796 0.1909 0.2196 0.2564 0.2968 0.3552 0.4007 0.4234 
33 0.1665 0.1719 0.1829 0.2087 0.2415 0.2798 0.3294 0.3697 0.3886 
34 0.1593 0.1650 0.1758 0.1992 0.2285 0.2646 0.3069 0.3425 0.3585 
35 0.1529 0.1589 0.1694 0.1909 0.2173 0.2512 0.2876 0.3191 0.3330 
36 0.1473 0.1534 0.1639 0.1838 0.2080 0.2396 0.2716 0.2996 0.3122 
37 0.1425 0.1487 0.1592 0.1780 0.2005 0.2299 0.2588 0.2839 0.2961 
38 0.1384 0.1446 0.1553 0.1735 0.1950 0.2220 0.2494 0.2721 0.2847 
39 0.1352 0.1413 0.1522 0.1702 0.1913 0.2159 0.2432 0.2641 0.2779 
40 0.1328 0.1387 0.1500 0.1682 0.1895 0.2116 0.2402 0.2600 0.2758 
41 0.1312 0.1369 0.1486 0.1675 0.1895 0.2092 0.2405 0.2597 0.2783 
42 0.1304 0.1357 0.1480 0.1680 0.1914 0.2085 0.2441 0.2633 0.2856 
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N.5. SGA Female Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 Percentile 
Gestational 
Age 
3rd 
Percentile 
5th 
Percentile 
10th 
Percentile 
25th 
Percentile 
50th 
Percentile 
75th 
Percentile 
90th 
Percentile 
95th 
Percentile 
97th 
Percentile 
22 0.3107 0.3079 0.3692 0.4060 0.4924 0.5633 0.7303 1.1694 1.1620 
23 0.2923 0.2909 0.3479 0.3825 0.4623 0.5280 0.6817 1.0716 1.0681 
24 0.2749 0.2749 0.3278 0.3603 0.4338 0.4946 0.6355 0.9794 0.9794 
25 0.2586 0.2598 0.3087 0.3393 0.4068 0.4631 0.5919 0.8927 0.8960 
26 0.2433 0.2457 0.2908 0.3196 0.3814 0.4334 0.5509 0.8116 0.8178 
27 0.2291 0.2324 0.2739 0.3011 0.3577 0.4057 0.5124 0.7360 0.7450 
28 0.2159 0.2202 0.2582 0.2838 0.3354 0.3798 0.4764 0.6660 0.6773 
29 0.2038 0.2088 0.2436 0.2677 0.3148 0.3558 0.4430 0.6016 0.6150 
30 0.1927 0.1984 0.2301 0.2529 0.2958 0.3337 0.4121 0.5427 0.5579 
31 0.1827 0.1890 0.2177 0.2393 0.2783 0.3134 0.3837 0.4894 0.5060 
32 0.1737 0.1805 0.2064 0.2269 0.2624 0.2951 0.3579 0.4416 0.4595 
33 0.1657 0.1729 0.1962 0.2158 0.2481 0.2786 0.3346 0.3994 0.4182 
34 0.1588 0.1663 0.1871 0.2058 0.2353 0.2640 0.3138 0.3627 0.3821 
35 0.1530 0.1606 0.1791 0.1971 0.2242 0.2513 0.2956 0.3316 0.3513 
36 0.1482 0.1558 0.1722 0.1897 0.2146 0.2405 0.2799 0.3060 0.3258 
37 0.1445 0.1520 0.1664 0.1834 0.2066 0.2316 0.2668 0.2860 0.3055 
38 0.1418 0.1491 0.1618 0.1784 0.2002 0.2245 0.2562 0.2716 0.2905 
39 0.1401 0.1472 0.1582 0.1747 0.1953 0.2193 0.2481 0.2627 0.2808 
40 0.1395 0.1462 0.1557 0.1721 0.1921 0.2161 0.2426 0.2593 0.2763 
41 0.1399 0.1461 0.1544 0.1708 0.1904 0.2146 0.2396 0.2616 0.2771 
42 0.1414 0.1470 0.1542 0.1707 0.1903 0.2151 0.2392 0.2693 0.2832 
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N.6. LGA Male Placental Weight Ratios Gestational Age for the 3
rd
 through the 97
th
 Percentile 
Gestational Age 10th Percentile 25th Percentile 50th Percentile 75th Percentile 90th Percentile 95th Percentile 97th Percentile 
23 0.2513 0.3199 0.3673 0.4110 0.4568 0.4690 0.4710 
25 0.2352 0.2928 0.3360 0.3745 0.4170 0.4295 0.4295 
26 0.2276 0.2802 0.3214 0.3576 0.3984 0.4111 0.4104 
27 0.2203 0.2682 0.3075 0.3415 0.3808 0.3936 0.3925 
28 0.2134 0.2569 0.2942 0.3263 0.3639 0.3770 0.3757 
29 0.2068 0.2463 0.2817 0.3119 0.3480 0.3614 0.3600 
30 0.2005 0.2363 0.2699 0.2984 0.3330 0.3466 0.3455 
31 0.1946 0.2269 0.2588 0.2858 0.3188 0.3327 0.3321 
32 0.1890 0.2182 0.2483 0.2741 0.3055 0.3198 0.3198 
33 0.1837 0.2101 0.2386 0.2632 0.2931 0.3077 0.3086 
34 0.1787 0.2027 0.2296 0.2531 0.2816 0.2966 0.2986 
35 0.1741 0.1960 0.2212 0.2440 0.2709 0.2863 0.2897 
36 0.1698 0.1899 0.2136 0.2356 0.2611 0.2770 0.2819 
37 0.1658 0.1844 0.2067 0.2282 0.2523 0.2686 0.2752 
38 0.1622 0.1796 0.2004 0.2216 0.2442 0.2610 0.2697 
39 0.1588 0.1755 0.1949 0.2159 0.2371 0.2544 0.2653 
40 0.1559 0.1720 0.1900 0.2110 0.2309 0.2487 0.2620 
41 0.1532 0.1691 0.1859 0.2070 0.2255 0.2439 0.2599 
42 0.1509 0.1669 0.1824 0.2039 0.2210 0.2400 0.2589 
 
 
 
 
 
 
 
 
 
 
 
 
194 
 
 
 
N.7. LGA Female Placental Weight Ratios by Gestational Age for the 3
rd
 through the 97
th
 Percentile 
Gestational Age 10th Percentile 25th Percentile 50th Percentile 75th Percentile 90th Percentile 95th Percentile 97th Percentile 
25 0.2835 0.3131 0.3782 0.4769 0.5365 0.6261 0.7623 
26 0.2711 0.2988 0.3581 0.4475 0.5020 0.5836 0.7026 
27 0.2593 0.2853 0.3391 0.4199 0.4697 0.5435 0.6467 
28 0.2480 0.2725 0.3212 0.3940 0.4395 0.5061 0.5947 
29 0.2374 0.2604 0.3045 0.3699 0.4114 0.4712 0.5465 
30 0.2273 0.2490 0.2890 0.3476 0.3854 0.4389 0.5022 
31 0.2178 0.2384 0.2746 0.3270 0.3616 0.4091 0.4618 
32 0.2089 0.2285 0.2614 0.3081 0.3398 0.3819 0.4253 
33 0.2006 0.2193 0.2494 0.2910 0.3202 0.3573 0.3926 
34 0.1929 0.2109 0.2385 0.2756 0.3027 0.3353 0.3638 
35 0.1857 0.2031 0.2287 0.2620 0.2874 0.3158 0.3388 
36 0.1792 0.1961 0.2201 0.2501 0.2741 0.2989 0.3177 
37 0.1732 0.1899 0.2127 0.2399 0.2630 0.2846 0.3005 
38 0.1679 0.1844 0.2064 0.2316 0.2540 0.2728 0.2872 
39 0.1631 0.1796 0.2013 0.2249 0.2471 0.2636 0.2777 
40 0.1589 0.1755 0.1973 0.2200 0.2423 0.2570 0.2721 
41 0.1553 0.1721 0.1945 0.2169 0.2396 0.2529 0.2703 
42 0.1523 0.1695 0.1929 0.2155 0.2391 0.2514 0.2724 
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N.8. SGA Male Placental Weight Ratio Distributions by Gestational Age 
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N.9. SGA Female Placental Weight Ratio Distributions by Gestational Age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
197 
 
 
 
N.10. LGA Male Placental Weight Ratio Distributions by Gestational Age 
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N.11. LGA Female Placental Weight Ratio Distributions by Gestational Age 
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Appendix O: Results of Interaction Terms between Smoking and Preeclampsia with 
Gestational Age Category  
 
O.1. Interaction Terms and Significance Levels 
Effect Degrees of 
Freedom 
Wald Chi-Square P-value 
Gestational Age 
Category 
4 1.95 0.7446 
Preeclampsia 2 38.51 0.0001 
Smoking 2 250.98 0.0001 
Gestational Age 
Category x  
Preeclampsia 
4 9.90 0.0420 
Gestational Age 
Category x  
Smoking 
4 9.52 0.0494 
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Appendix P: Full Blocked Logistic Regression Models of Baseline and Pregnancy Factors Hypothesized to Influence a PWR 
P.1. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight  
Ratio ≤10th Percentile for Infants Born at ≥37 Weeks 
 Odds Ratio (95% Confidence Interval) 
  Blockwise Model Building at p<.20 Restricted to p<.05 
Predictors Univariable Model 1
1 
Model 2
2 
Model 3
3 
Model 4
4 
Final Model
5 
Parity 
0 
 
≥1 
 
- 
 
0.915 
(0.832, 1.006)* 
 
- 
 
0.886 
(0.800, 0.980)** 
 
- 
 
0.909 
(0.826, 1.001)* 
 
- 
 
0.913 
(0.829, 1.005)* 
 
- 
 
0.928 
(0.841, 1.024)* 
X 
Smoking During Pregnancy 
No (ref) 
 
Yes 
     
- 
 
0.647 
(0.559, 0.749)* 
 
- 
 
0.664 
(0.568, 0.776)** 
 
- 
 
0.631 
(0.543, 0.733)** 
 
- 
 
0.630 
(0.542, 0.732)** 
 
- 
 
0.609 
(0.522, 0.711)** 
 
- 
 
0.612 
(0.527, 0.711)** 
Maternal Asthma 
No (ref) 
 
Yes 
 
- 
 
0.809 
(0.642, 1.020) 
X X X X 
 
X 
Maternal Age 
<21 years 
 
21-34 years(ref) 
 
>34 years 
 
0.881 
(0.736, 1.055) 
- 
 
1.079 
(0.949, 1.226) 
X X X 
 
X 
 
X 
Maternal Height 
For every 10cm increase 
1.013 
(0.993, 1.033) 
X X X X X 
Pre-pregnancy BMI 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
(ref) 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
 
0.923 
(0.829, 1.027) 
- 
 
0.827 
(0.709, 0.965)* 
0.805 
(0.670, 0.967)* 
 
0.901 
(0.806, 1.008)* 
- 
 
0.820 
(0.702, 0.957)** 
0.798 
(0.662, 0.961)** 
 
0.934 
(0.838, 1.041)* 
- 
 
0.826 
(0.707, 0.966)** 
0.811 
(0.673, 0.978)** 
 
0.933 
(0.837, 1.039)* 
- 
 
0.826 
(0.707, 0.965)** 
0.813 
(0.674, 0.980)** 
 
0.907 
(0.811, 1.014)* 
- 
 
0.813 
(0.694, 0.953)** 
0.806 
(0.666, 0.975)** 
 
0.925 
(0.829, 1.032)* 
- 
 
0.817 
(0.698, 0.956)** 
0.826 
(0.685, 0.996)** 
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Preeclampsia 
No (ref) 
 
Preeclampsia 
 
- 
 
0.707 
(0.533, 0.937)* 
 
 
 
- 
 
0.985 
(0.695, 1.398)
6 
 
- 
 
0.990 
(0.697, 1.405)
6 
 
- 
 
0.999 
(0.703, 1.420)
6 
 
- 
 
0.998 
(0.703, 1.417)
6 
Gestational Diabetes 
No (ref) 
 
Yes 
 
- 
 
0.979 
(0.691, 1.387) 
  
- 
 
0.737 
(0.555, 0.979)** 
 
- 
 
0.735 
(0.553, 0.976)** 
 
- 
 
0.734 
(0.551, 0.979)** 
 
- 
 
0.729 
(0.547, 0.971)** 
Placental Previa 
No (ref) 
 
Yes 
 
- 
 
0.747 
(0.344, 1.619) 
  
X X X 
Placental Abruption 
No (ref) 
 
Yes 
 
- 
 
1.223 
(0.795, 1.881) 
   
- 
 
1.229 
(0.791, 1.909)
6 
 
- 
 
1.231 
(0.792, 1.914)
6 
 
- 
 
1.273 
(0.826, 1.963)
6
 
Cord Complications 
None (ref) 
 
Cord around the neck or body, 
knot in the cord, prolapsed or 
lacerated cord 
 
Short, 2-vessel or velamentous 
cord 
 
- 
 
0.810  
(0.728, 0.901)* 
 
 
1.990 
(1.390, 2.850)* 
   
- 
 
0.815 
(0.731, 0.908)** 
 
 
1.989 
(1.381, 2.864)* 
 
- 
 
0.821 
(0.735, 0.916)** 
 
 
1.932 
(1.338, 2.790)** 
 
- 
 
0.816 
(0.730, 0.912)** 
 
 
1.969 
(1.369, 2.831)** 
Gestational Weight  
Gain 
<10lb at 30 weeks or <20 lbs at 
term 
 
Normal (ref) 
 
>40 lbs at term 
 
 
0.713 
(0.427, 1.190) 
 
- 
 
0.821 
(0.690, 0.977) 
   
 
X 
X 
Birth Weight Category 
SGA 
 
1.130 
    
1.153 
 
1.180 
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1
-Baseline Factors; 
2
-Baseline +Mid-Pregnancy Factors; 
3
-Cord and Placental Complications; 
4
-Late and Post-Pregnancy Factors; 
5
-Only 
Factors with a significance level of p<0.05;
6
-Variable remains in model despite not reaching statistical significance for the specified level 
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of 
p<0.20; **-Covariates with a significance level of p<0.05 
 
 
 
 
 
AGA (ref) 
 
LGA 
(0.952, 1.342) 
- 
 
0.829 
 (0.701, 0.981)* 
(0.963, 1.381)* 
- 
 
0.824 
(0.693, 0.980)** 
(0.990, 1.408)* 
- 
 
0.811 
(0.683, 0.962)** 
Anaemia 
No (ref) 
 
Yes 
 
- 
 
0.767 
 (0.560, 1.052) 
    
- 
 
0.787 
(0.569, 1.089)
6 
 
- 
 
0.768 
(0.557, 1.057)* 
Placental Delivery 
Spontaneous (ref) 
 
Expressed or assisted 
 
Manual 
 
Retained 
 
- 
 
1.186 
(1.006, 1.397)* 
1.108 
(0.987, 1.244)* 
3.832 
(2.344, 6.264)* 
    
- 
 
1.163 
(0.982, 1.376)* 
1.104 
(0.981, 1.243)* 
4.053 
(2.461, 6.675)** 
 
- 
 
1.183 
(1.001, 1.398)** 
1.119 
(0.995, 1.258) 
4.022 
(2.446, 6.612)** 
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P.2. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight 
Ratio ≥90th Percentile for Infants Born at ≥37 Weeks 
 Odds Ratio (95% Confidence Interval) 
  Blockwise Model Building at p<.20 Restricted to p<.05 
Predictors Univariable Model 1
1 
Model 2
2 
Model 3
3 
Model 4
4 
Final Model
5 
Parity 
0 
 
≥1 
 
- 
 
1.073 
(0.979, 1.176) 
 
- 
 
1.074 
(0.972, 1.187)* 
 
- 
 
1.087 
(0.989, 1.195)* 
 
- 
 
1.087 
(0.989, 1.195)* 
 
- 
 
1.067 
(0.969, 1.176)* 
X
 
Smoking During 
Pregnancy 
No (ref) 
 
Yes 
 
- 
 
1.795 
 (1.616, 1.994)* 
 
- 
 
1.767 
(1.576, 1.981)** 
 
- 
 
1.805 
(1.619, 2.011)** 
 
- 
 
1.794 
(1.609, 1.999)** 
 
- 
 
1.808 
(1.618, 2.019)** 
 
- 
 
1.798 
(1.615, 2.001)** 
Maternal Asthma 
No (ref) 
 
Yes 
 
- 
 
1.085 
(0.890, 1.322) 
X
 
X
 
X
 
X
 
X 
Maternal Age 
<21 years 
 
21-34 years(ref) 
 
>34 years 
 
1.217 
(1.042, 1.421)* 
- 
 
0.998 
(0.877, 1.136) 
 
X
 
 
X
 
 
X
 X X 
Maternal Height 
For every 10cm increase 
1.001 
(0.982, 1.020) 
X
 
X
 
X
 
X
 
X 
Pre-pregnancy BMI 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
(ref) 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
 
1.296 
(1.161, 1.446)** 
- 
 
1.218 
(1.050, 1.413)** 
1.522 
(1.296, 1.787)** 
 
1.272 
(1.134, 1.426)** 
- 
 
1.250 
(1.075, 1.453)** 
1.477 
(1.252, 1.742)** 
 
1.260 
(1.127, 1.410)** 
- 
 
1.221 
(1.050, 1.421)** 
1.409 
(1.193, 1.664)** 
 
1.268 
(1.133, 1.418)** 
- 
 
1.219 
(1.047, 1.418)** 
1.409 
(1.193, 1.664)** 
 
1.263 
(1.126, 1.417)** 
- 
 
1.223 
(1.050, 1.426)** 
1.402 
(1.184, 1.661)** 
 
1.265 
(1.132, 1.414)** 
- 
 
1.217 
(1.046, 1.414)** 
1.448 
(1.229, 1.708)** 
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Preeclampsia 
No (ref) 
 
Preeclampsia 
 
- 
 
1.513 
(1.240, 1.846)* 
  
- 
 
1.757 
(1.342, 2.301)** 
 
- 
 
1.743 
(1.330, 2.283)** 
 
- 
 
1.684 
(1.281, 2.213)** 
 
- 
 
1.661 
(1.269, 2.174)** 
Gestational Diabetes 
No (ref) 
 
Yes 
 
- 
 
1.775 
(1.364, 2.309)* 
  
- 
 
1.441 
(1.176, 1.765)** 
 
- 
 
1.434 
(1.170, 1.757)** 
 
- 
 
1.442 
(1.176, 1.770)** 
 
- 
 
1.433 
(1.169, 1.756)** 
Placental Previa 
No (ref) 
 
Yes 
 
- 
 
0.980 
(0.507, 1.895) 
  
X X X 
Placental Abruption 
No (ref) 
 
Yes 
 
- 
 
2.077 
(1.485, 2.903)* 
   
- 
 
2.062 
(1.468, 2.896)** 
 
- 
 
2.084 
(1.481, 2.931)** 
 
- 
 
2.034 
(1.446, 2.858)** 
Cord Complications 
None (ref) 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
Short, 2-vessel or 
velamentous cord 
 
- 
 
1.189 
(1.080, 1.309)* 
 
 
 
1.180 
(0.753, 1.851) 
   
- 
 
1.182 
(1.071, 1.304)** 
 
 
 
1.106 
(0.697, 1.757) 
 
- 
 
1.183 
(1.071, 1.308)** 
 
 
 
1.137 
(0.715, 1.807) 
 
- 
 
1.180 
(1.070, 1.301)** 
 
 
 
1.172 
(0.744, 1.845) 
Gestational Weight  
Gain 
<10lb at 30 weeks or <20 
lbs at term 
 
Normal (ref) 
 
>40 lbs at term 
 
 
1.002 
(0.654, 1.537) 
 
- 
 
1.014 
(0.868, 1.184) 
   
 
 
X 
X 
Birth Weight Category       
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1
-Baseline Factors; 
2
-Baseline +Mid-Pregnancy Factors; 
3
-Cord and Placental Complications; 
4
-Late and Post-Pregnancy Factors; 
5
-Only 
Factors with a significance level of p<0.05;
6
-Variable remains in model despite not reaching statistical significance for the specified level 
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of 
p<0.20; **-Covariates with a significance level of p<0.05 
 
 
 
SGA 
 
AGA (ref) 
 
LGA 
1.242 
(1.057, 1.461)* 
- 
 
1.096 
(0.946, 1.270) 
1.109 
(0.934, 1.317)* 
- 
 
1.114 
(0.955, 1.298)* 
1.126 
(0.954, 1.328)*
 
- 
 
1.111 
(0.955, 1.291)
 
Anaemia 
No (ref) 
 
Yes 
 
- 
 
1.898  
(1.538, 2.342 )* 
    
  - 
 
1.876 
(1.507, 2.336)** 
 
- 
 
1.862 
(1.503, 2.305)** 
Placental Delivery 
Spontaneous (ref) 
 
Expressed or assisted 
 
Manual 
 
Retained 
 
- 
 
0.915 
(0.771, 1.086) 
1.010 
(0.903, 1.130) 
1.450 
(0.737, 2.854)* 
    
- 
 
0.903 
 (0.755, 1.080)
6 
0.979 
(0.872, 1.100)
6 
1.400 
(0.706, 2.776)
6 
 
- 
 
0.907 
(0.761, 1.081)
6 
0.972 
(0.867, 1.090)
6 
1.337 
 (0.675, 2.649)
6 
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P.3. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight 
Ratio ≤10th Percentile in Infants born between 32 and 37 Weeks 
 Odds Ratio (95% Confidence Interval) 
  Blockwise Model Building at p<.20 Restricted to p<.05 
Predictors Univariable Model 1
1 
Model 2
2 
Model 3
3 
Model 4
4 
Final Model
5 
Parity 
0 
 
≥1 
 
- 
 
0.687 
(0.435, 1.084)* 
 
- 
 
0.631 
(0.388, 1.025)* 
 
- 
 
0.686 
(0.432, 1.089)* 
 
- 
 
0.710 
(0.446, 1.130)* 
 
- 
 
0.661 
 (0.412, 1.059)* 
 
- 
 
0.695 
(0.440, 1.099)* 
Smoking During 
Pregnancy 
No (ref) 
 
Yes 
 
- 
 
0.493 
(0.256, 0.947)* 
 
- 
 
0.629 
(0.322, 1.232)
6 
 
- 
 
0.513 
(0.266, 0.989)** 
 
- 
 
0.525 
(0.272, 1.013)* 
 
- 
 
0.542 
(0.278, 1.055)* 
 
- 
 
0.494 
(0.257, 0.950)* 
Maternal Asthma 
No (ref) 
 
Yes 
 
- 
 
0.965 
(0.405, 2.298) 
 
X 
 
X 
 
X 
 
X 
 
X 
Maternal Age 
<21 years 
 
21-34 years(ref) 
 
>34 years 
 
0.265 
(0.064, 1.104) 
- 
 
1.283 
(0.744, 2.211) 
X X X X X 
Maternal Height 
For every 10cm increase 
1.027 
(0.933, 1.130) 
X X X X X 
Pre-pregnancy BMI 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
(ref) 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
 
1.018 
(0.610, 1.698) 
- 
 
0.807 
(0.379, 1.718) 
0.708 
(0.263, 1.902) 
 
X 
 
X 
X X X 
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Preeclampsia 
No (ref) 
 
Preeclampsia 
 
- 
 
0.194 
(0.026, 1.422) 
  
- 
 
1.028 
(0.473, 2.235) 
 
- 
 
0.927 
(0.429, 2.006)* 
 
- 
 
0.835 
(0.372, 1.878)
6 
 
X 
 
 
Gestational Diabetes 
No (ref) 
 
Yes 
 
- 
 
1.028 
(0.479, 2.206 
 
X X X 
 
 
X 
 
Placental Previa 
No (ref) 
 
Yes 
 
- 
 
0.341 
(0.046, 2.527) 
  
X X X 
Placental Abruption 
No (ref) 
 
Yes 
 
- 
 
0.523 
(0.160, 1.705) 
   
- 
 
0.575 
(0.175, 1.893)
6 
 
- 
 
0.593 
(0.179, 1.965)
6 
 
- 
 
0.615 
(0.295, 1.282)* 
Cord Complications 
None (ref) 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
Short, 2-vessel or 
velamentous cord 
 
- 
 
0.973 
(0.594, 1.592) 
 
 
 
0.771 
(0.092, 5.482) 
   
- 
 
0.966 
(0.588, 1.587)
6 
 
 
 
0.716 
(0.092, 5.564)
6
 
 
- 
 
0.919 
(0.554, 1.525)
6 
 
 
 
0.637 
(0.080, 5.078)
6 
X 
Gestational Weight  
Gain 
<10lb at 30 weeks or <20 
lbs at term 
 
Normal (ref) 
 
>40 lbs at term 
 
0.579 
(0.076, 4.398) 
 
 
- 
 
0.474 
(0.113, 1.993) 
   
 
X 
X 
Birth Weight Category      X 
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1
-Baseline Factors; 
2
-Baseline +Mid-Pregnancy Factors; 
3
-Cord and Placental Complications; 
4
-Late and Post-Pregnancy Factors; 
5
-Only 
Factors with a significance level of p<0.05;
6
-Variable remains in model despite not reaching statistical significance for the specified level 
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of 
p<0.20; **-Covariates with a significance level of p<0.05 
 
 
 
 
SGA 
 
AGA (ref) 
 
LGA 
1.444 
(0.689, 3.026) 
- 
 
1.419 
(0.738, 2.728) 
X 
Anaemia 
No (ref) 
 
Yes 
 
- 
 
0.799 
 (0.242, 2.643) 
    
- 
 
0.884 
(0.263, 2.967)
6 
X 
Placental Delivery 
Spontaneous (ref) 
 
Expressed or assisted 
 
Manual 
 
Retained 
 
- 
 
1.131 
(0.432, 2.963) 
1.054 
(0.630, 1.762) 
5.657 
(1.374, 23.290)* 
   
X 
 
X 
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P.4. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight 
Ratio ≥90th Percentile for Infants Born between 32 and 37 Weeks 
 Odds Ratio (95% Confidence Interval) 
  Blockwise Model Building at p<.20 Restricted to p<.05 
Predictors Univariable Model 1
1 
Model 2
2 
Model 3
3 
Model 4
4 
Final Model
5 
Parity 
0 
 
≥1 
 
- 
 
1.686    
 (1.094, 2.598)* 
 
- 
 
1.571 
(0.980, 2.517)* 
 
- 
 
1.774 
(1.138, 2.764)** 
 
- 
 
1.644 
(1.049, 2.575)** 
 
- 
 
1.612 
(1.011, 2.570)**
 
 
- 
 
1.674 
(1.085, 2.583)** 
Smoking During 
Pregnancy 
No (ref) 
 
Yes 
 
- 
 
1.518    
(0.970, 2.378) 
 
- 
 
1.388 
(0.852, 2.261) 
 
- 
 
1.586 
(1.007, 2.498) 
 
- 
 
1.509 
(0.952, 2.393)* 
 
- 
 
1.583 
(0.987, 2.540)* 
 
- 
 
1.488 
(0.949, 2.334)* 
Maternal Asthma 
No (ref) 
 
Yes 
 
- 
 
1.075 
(0.500, 2.308) 
 
X 
 
X 
 
X 
 
X 
 
X 
Maternal Age 
<21 years 
 
21-34 years(ref) 
 
>34 years 
 
1.206 
(0.596, 2.439) 
- 
 
1.291 
(0.767, 2.173)* 
X X X X X 
Maternal Height 
For every 10cm increase 
1.034 
(0.946, 1.131) 
X X X X X 
Pre-pregnancy BMI 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
(ref) 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
 
1.494    
(0.891, 2.505) 
- 
 
1.137 
(0.549, 2.357) 
2.326 
(1.141, 4.744) 
X 
X 
 
X 
 
X X 
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Preeclampsia 
No (ref) 
 
Preeclampsia 
 
- 
 
1.014 
(0.424, 2.423) 
  
- 
 
2.103 
(1.153, 3.837)* 
 
- 
 
1.969 
(1.082, 3.582)* 
 
- 
 
1.938 
(1.040, 3.610)** 
X 
Gestational Diabetes 
No (ref) 
 
Yes 
 
- 
 
1.834 
(1.026, 3.276)* 
 
X X X 
X 
 
Placental Previa 
No (ref) 
 
Yes 
 
- 
 
0.282 
(0.038, 2.085) 
  
X X X 
Placental Abruption 
No (ref) 
 
Yes 
 
- 
 
2.268 
(1.216, 4.229)* 
   
- 
 
1.965 
(1.033, 3.740)** 
 
  - 
 
1.991 
(1.027, 3.861)** 
 
- 
 
2.038 
(1.323, 3.138)** 
Cord Complications 
None (ref) 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
Short, 2-vessel or 
velamentous cord 
 
- 
 
1.545 
(1.001, 2.386) 
 
 
 
3.622 
(1.269, 10.338)* 
   
- 
 
1.511 
(0.969, 2.357) 
 
 
 
3.214 
(1.096, 9.421)** 
 
- 
 
1.453 
(0.918, 2.298)* 
 
 
 
3.745 
(1.240, 11.307)** 
X 
 
Gestational Weight  
Gain 
<10lb at 30 weeks or <20 
lbs at term 
 
Normal (ref) 
 
>40 lbs at term 
 
 
∞ 
(0, ∞) 
 
- 
 
1.646 
(0.752, 3.605) 
   
 
X 
X 
Birth Weight Category     X X 
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1
-Baseline Factors; 
2
-Baseline +Mid-Pregnancy Factors; 
3
-Cord and Placental Complications; 
4
-Late and Post-Pregnancy Factors; 
5
-Only 
Factors with a significance level of p<0.05;
6
-Variable remains in model despite not reaching statistical significance for the specified level 
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of 
p<0.20; **-Covariates with a significance level of p<0.05 
 
 
SGA 
 
AGA (ref) 
 
LGA 
1.322 
(0.654, 2.669) 
- 
 
1.462 
(0.808, 2.647) 
 
Anaemia 
No (ref) 
 
Yes 
 
- 
 
2.420 
(1.170, 5.008)* 
    
- 
 
2.068 
(0.961, 4.448)* 
X 
Placental Delivery 
Spontaneous (ref) 
 
Expressed or assisted 
 
Manual 
 
Retained 
 
- 
 
1.393 
(0.604, 3.212) 
1.329 
(0.845, 2.090) 
1.658 
(0.196, 14.010) 
   
X 
 
 
X 
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P.5. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight 
Ratio ≤10th Percentile in Infants born at ≤32 Weeks 
 Odds Ratio (95% Confidence Interval) 
  Blockwise Model Building at p<.20 Restricted to p<.05 
Predictors Univariable Model 1
1 
Model 2
2 
Model 3
3 
Model 4
4 
Final Model
5 
Parity 
0 
 
≥1 
 
- 
 
0.604  
(0.339, 1.077)* 
 
- 
 
0.544 
(0.290, 1.020)* 
 
- 
 
0.548 
(0.294, 1.021)* 
 
- 
 
0.617 
(0.327, 1.162)* 
 
- 
 
0.576 
(0.306, 1.084)* 
 
- 
 
0.537 
(0.293, 0.986)** 
Smoking During 
Pregnancy 
No (ref) 
 
Yes 
 
- 
 
0.938 
(0.494, 1.779) 
 
X 
X 
X 
 
X 
 
X 
 
Maternal Asthma 
No (ref) 
 
Yes 
 
- 
 
0.878 
(0.331, 2.332) 
 
X 
 
X 
 
X 
 
X 
 
X 
Maternal Age 
<21 years 
 
21-34 years(ref) 
 
>34 years 
 
0.679 
(0.231, 2.000) 
- 
 
0.578 
(0.237, 1.410)* 
X X X X 
 
Maternal Height 
For every 10cm increase 
1.123 
(1.004, 1.255)* 
1.151 
(1.023, 1.295)** 
1.151 
(1.023, 1.294)** 
1.166 
(1.035, 1.314)** 
1.139 
(0.984, 1.318)* 
1.133 
(1.011, 1.269)** 
Pre-pregnancy BMI 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
(ref) 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
 
0.569 
(0.314, 1.030) 
- 
 
0.416 
(0.151, 1.144) 
0.313 
(0.104, 0.942)* 
 
X 
 
X 
X X X 
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Preeclampsia 
No (ref) 
 
Preeclampsia 
 
- 
 
0.475 
(0.110, 2.052) 
 
X X
 
 
 
X X 
Gestational Diabetes 
No (ref) 
 
Yes 
 
- 
 
1.173 
(0.615, 2.237)* 
 
X X X 
X 
 
Placental Previa 
No (ref) 
 
Yes 
 
- 
 
1.500 
(0.415, 5.424) 
   
- 
 
1.590 
(0.393, 6.437)
6 
 
- 
 
2.045 
(0.488, 8.574)
6 
X 
Placental Abruption 
No (ref) 
 
Yes 
 
- 
 
0.592 
(0.290, 1.212)* 
  
X X X 
Cord Complications 
None (ref) 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
Short, 2-vessel or 
velamentous cord 
 
- 
 
0.850 
(0.439, 1.646) 
 
 
 
6.603 
(1.835, 23.755)* 
   
- 
 
0.780 
(0.386, 1.576) 
 
 
 
5.424 
(1.439, 20.451)** 
 
- 
 
0.811 
(0.407, 1.616) 
 
 
 
5.298 
(1.395, 20.128)** 
X 
Gestational Weight  
Gain 
<10lb at 30 weeks or <20 
lbs at term 
 
Normal (ref) 
 
>40 lbs at term 
 
 
1.278 
(0.147, 11.131) 
 
- 
 
0.799 
(0.098, 6.502) 
   
 
X 
X 
Birth Weight Category       
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1
-Baseline Factors; 
2
-Baseline +Mid-Pregnancy Factors; 
3
-Cord and Placental Complications; 
4
-Late and Post-Pregnancy Factors; 
5
-Only 
Factors with a significance level of p<0.05;
6
-Variable remains in model despite not reaching statistical significance for the specified level 
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of 
p<0.20; **-Covariates with a significance level of p<0.05 
 
 
 
 
 
 
SGA 
 
AGA (ref) 
 
LGA 
0.691 
(0.262, 1.822) 
- 
 
1.110 
(0.410, 3.006) 
X X 
Anaemia 
No (ref) 
 
Yes 
 
- 
 
0.849 
 (0.320, 2.253) 
   
X X 
Placental Delivery 
Spontaneous (ref) 
 
Expressed or assisted 
 
Manual 
 
Retained 
 
- 
 
1.144 
(0.129, 10.114) 
0.659 
(0.369, 1.176) 
3.119 
(1.077, 9.033)* 
    
- 
 
0.813 
(0.087, 7.567)
6 
0.616 
(0.324, 1.174)
6 
3.452 
(1.095, 10.881)** 
 
 
X 
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P.6. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight 
Ratio ≥90th Percentile in Infant Born at ≤32 Weeks 
 Odds Ratio (95% Confidence Interval) 
  Blockwise Model Building at p<.20 Restricted to p<.05 
Predictors Univariable Model 1
1 
Model 2
2 
Model 3
3 
Model 4
4 
Final Model
5 
Parity 
0 
 
≥1 
 
- 
 
2.170 
(1.128, 4.174)* 
 
- 
 
2.081 
(1.006, 4.306)** 
 
- 
 
2.136 
(1.026, 4.444)** 
 
- 
 
1.768 
(0.848, 3.688)* 
 
- 
 
2.224 
(1.060, 4.664)** 
 
- 
 
2.185 
(1.084, 4.408)**
 
Smoking During 
Pregnancy 
No (ref) 
 
Yes 
 
- 
 
0.630 
(0.271, 1.465) 
X 
X 
 
X X X 
Maternal Asthma 
No (ref) 
 
Yes 
 
- 
 
0.492 
(0.114, 2.119) 
 
X 
X X X X 
Maternal Age 
<21 years 
 
21-34 years(ref) 
 
>34 years 
 
1.148 
(0.381, 3.464) 
- 
 
1.139 
(0.476, 2.721) 
X
 
X
 
X
 
X X 
Maternal Height 
For every 10cm increase 
1.139 
(0.993, 1.306) 
1.119 
(0.970, 1.290)* 
1.120 
(0.972, 1.291)* 
1.104 
(0.955, 1.275)* 
1.139 
(0.984, 1.318)* 
1.125 
(0.981, 1.290)* 
Pre-pregnancy BMI 
≤18.5 kg/m2 
 
18.5-24.9 kg/m
2 
(ref) 
 
25.0-29.9 kg/m
2 
 
>30.0 kg/m
2
 
 
0.898 
(0.427, 1.891) 
- 
 
0.863 
(0.292, 2.555) 
0.814 
(0.276, 2.403) 
X X X X X 
216 
 
 
 
Preeclampsia 
No (ref) 
 
Preeclampsia 
 
- 
 
0.342 
(0.045, 2.583) 
 
X X 
 
 
X 
X 
 
Gestational Diabetes 
No (ref) 
 
Yes 
 
- 
 
1.397 
(0.673, 2.902) 
  
 
X X 
 
 
X X 
Placental Previa 
No (ref) 
 
Yes 
 
- 
 
3.919 
(1.324, 11.601)* 
   
- 
 
3.944 
(1.072, 14.507)** 
 
- 
 
3.333 
(0.904, 12.285)** 
X 
Placental Abruption 
No (ref) 
 
Yes 
 
- 
 
1.678 
(0.857, 3.285)* 
  
X X
 
X 
Cord Complications 
None (ref) 
 
Cord around the neck or 
body, knot in the cord, 
prolapsed or lacerated 
cord 
 
Short, 2-vessel or 
velamentous cord 
 
- 
 
0.816 
(0.376, 1.774) 
 
 
 
3.661 
(0.681, 19.674) 
   
- 
 
0.720 
(0.307, 1.691)
6 
 
 
 
1.281 
(0.116, 14.137)
6 
 
- 
 
0.694 
(0.290, 1.663)
6 
 
 
 
1.932 
(0.176, 21.260)
6 
X 
Gestational Weight  
Gain 
<10lb at 30 weeks or <20 
lbs at term 
 
Normal (ref) 
 
>40 lbs at term 
 
 
∞ 
(0, ∞) 
 
- 
 
1.149 
(0.140, 9.421) 
   
X X 
Birth Weight Category     X X 
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1
-Baseline Factors; 
2
-Baseline +Mid-Pregnancy Factors; 
3
-Cord and Placental Complications; 
4
-Late and Post-Pregnancy Factors; 
5
-Only 
Factors with a significance level of p<0.05;
6
-Variable remains in model despite not reaching statistical significance for the specified level 
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of 
p<0.20; **-Covariates with a significance level of p<0.05 
 
 
 
 
SGA 
 
AGA (ref) 
 
LGA 
1.708 
(0.742, 3.929) 
- 
 
0.343 
 (0.045, 2.603) 
Anaemia 
No (ref) 
 
Yes 
 
- 
 
2.677 
(1.187, 6.037)* 
   
X X 
Placental Delivery 
Spontaneous (ref) 
 
Expressed or assisted 
 
Manual 
 
Retained 
 
- 
 
0 
(0, ∞) 
2.156 
(1.060, 4.383)* 
4.159 
(1.022, 16.931)* 
    
- 
 
0 
(0, ∞) 
1.432 
(0.628, 3.267) 
2.204 
(0.407, 11.937) 
X 
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Appendix Q: Detailed Description of Missing Placental Weights 
Overall, LGA infants had 22.03% missing, AGA infants had 22.71% missing, and 
SGA infants had 23.48% missing. Therefore, since the missingness is evenly distributed 
among categories it is speculated that the missingness was random. Furthermore, the 
distribution of missingness by gestational age category was as follows: in term infants 
22.81% had missing placental weight, in infants born between 33 and 36 weeks gestation 
there was 25.50% missing, and in infants born at ≤32 weeks there was 9.85% missing for 
placental weight. It was proposed that placentas were not weighed in high risk 
pregnancies, but the missingness is less in extreme preterm and SGA babies, so that 
theory is not likely plausible. The missingness by hospital revealed differences between 
Victoria Hospital with 54.16% missing and, St. Joseph’s with 0.38% missing placental 
weights. This discrepancy is due largely to the placental weight not being collected at 
Victoria Hospital for the first 2 and a half year of the study time period. Furthermore, the 
placental weights between the two hospitals revealed very close similarities. The mean 
placental weight at Victoria Hospital is 670g (S.D.=161.32) and 660g (S.D.=160.94) at 
St. Joseph’s hospital. The 10th and 90th percentiles are 505g and 486g and 885g and 872g 
for Victoria and St. Joseph Hospital respectively. Therefore, the differences between the 
two hospitals are not substantial. 
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